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SUMMARY
Aromatic compounds are synthesized via the shikimate pathway. The first activity, DAHP 
synthase, has been implicated in the regulation of the pathway in a number of organisms. This 
activity was investigated in the organism S.coelicolor and an assessment made of its 
regulatory importance.
Methods have been developed for the purification of the S.coelicolor DAHP synthase to 
obtain electrophoretically homogeneous enzyme. The purified S.coelicolor DAHP synthase 
has a native Mr of 107 000 with a subunit Mr of 54 000 and appears likely to be a 
homodimer.
In minimal medium-grown cells a single DAHP synthase activity was detected, making it 
unlikely that S.coelicolor possesses isoenzyme forms.This activity was subject to feedback 
inhibition by the pathway end-product tryptophan, but was unaffected by phenylalanine or 
tyrosine, or the pathway intermediates p-aminobenzoate and anthranilate. Preliminary 
evidence suggests that, in common with DAHP synthases from other organisms, a thiol group 
or a metal ion are essential for activity. Repression control appeared to be absent as this 
activity was constitutively expressed in complex medium-grown cells.
The TV-terminal sequence of the S.coelicolor DAHP synthase has been determined for the 
first twenty-six residues. The sequence of internal peptides has also been determined. The 
S.coelicolor DAHP synthase A -^terminal sequence does not resemble that from E.coli, 
S.cerevisiae or potato.
These sequences were used to design oligonucleotide probes corresponding to regions of the 
S.coelicolor DAHP synthase structural gene. These probes were then used to screen a 
genomic sub-library constructed in pUC18 and a genomic library constructed in ^GEM-11. 
Two positive signals were isolated from the X library. One of these was further characterised 
and appears likely to contain the DAHP synthase gene.
(xii)
For my parents.
Chapter 1 Introduction
1.1 The shikimate pathway General introduction
In microorganisms and plants, chorismate is the common metabolic precursor of the 
aromatic amino acids, vitamin E and K, folic acid, ubiquinone, plastiquinone, enterochelin 
and various secondary metabolites.This compound is synthesised by way of the seven-step 
shikimate pathway (Haslam, 1974; Weiss and Edwards, 1980) (Figure 1.1).
Other organisms lack this biosynthetic ability and require a supplementary dietary intake of 
aromatic amino acids. Consequently, attention has focussed on this pathway as a potential 
target for pesticides and herbicides. Already, herbicides active against shikimate pathway 
enzymes are of great commercial importance (Grossbard and Atkinson, 1986), and in the 
future a greater understanding of the range of applications for plant and microbial 
secondary products derived from aromatic metabolism may result in a vast increase in their 
commercial exploitation.
Chorismate is synthesised by the action of the same seven activities in all plants and 
microorganisms, but the control and organisation of these activities varies radically. For 
example, in E.coli the seven steps are separable and catalysed by monofunctional proteins 
(Berlyn and Giles, 1969) and their genes are unlinked in the bacterial genome (Pittard and 
Wallace, 1966), whereas the fungal (N.crassa) pathway includes a pentafunctional 
polypeptide (the arom protein) which catalyses reactions two to six of the common 
pathway, and is the product of a single gene (Giles et al., 1967 ; Lumsden and Coggins, 
1977 ; Gaertner and Cole, 1977).
From the information outlined above it becomes apparent that studies on the shikimate 
pathway could provide information and answers pertinent to the following research topics:-
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Figure 1.1 The reactions of the shikimate pathway
The numbers refer to the enzymes of the pathway: (1) 3-deoxy-D-ara6mo-heptulosonic 
acid 7-phosphate synthase (EC 4.1.2.15), (2) 3-dehydroquinate synthase (EC 4.6.1.3), (3) 
3-dehydroquinase (EC 5.2.1.10, alternative name 3-dehydroquinate dehydratase), (4) 
shikimate dehydrogenase (EC 1.1.1.25), (5) shikimate kinase (EC 2.7.1.71), (6) EPSP 
synthase (EC 2.5.1.19, alternative name 3-phosphoshikimate 1-carboxyvinyltransferase), 
(7) chorismate synthase (EC 4.6.1.4). The arom multifunctional enzyme catalyses the 
reactions numbered 2-6 in the above scheme.
2
(a) The rational design of herbicides:- A better understanding of the chemistry of individual 
enzyme catalysed reactions may lead to the design of novel herbicides and pesticides, or the 
elucidation of the mode of action of compounds in current use.
(b) The overproduction of aromatic compounds:- An increased awareness of the control of 
flux through the pathway may lead to the overproduction of commercially important amino 
acids, or aromatic containing secondary metabolites, through the logical manipulation of the 
relevant biosynthetic steps.
(c) The evolution of biosynthetic pathways:- The shikimate pathway provides a model 
system for addressing questions on the evolution of biosynthetic pathways and 
multifunctional proteins in particular. Through the cloning and sequencing of genes from 
different organisms, and their comparison, these questions may be answered.
This introduction will describe in detail each of the reactions comprising the common 
pathway, with particular emphasis on the crucial first step and the mechanisms of metabolic 
control exercised at this point. A brief introduction to the properties of the streptomycetes 
will be related, before an assessment of the prospects for the improved commercial 
exploitation of these organisms and in particular the over-production of antibiotics by 
logical manipulation of relevant control mechanisms. The objectives of this thesis will then 
be outlined.
1 .2  DAHP synthase
1.2.1 Reaction and mechanism
The oxidation of glucose via the glycolytic and pentose phosphate pathways yields
3
phosphoeno/pyruvate (PEP) and erythrose 4-phosphate (E4P), respectively, which are 
condensed to form the phosphorylated 7-carbon keto sugar acid, 3-deoxy-D-arabino- 
heptulosonate 7-phosphate (DAHP) and inorganic phosphate by the action of DAHP 
synthase (EC 4.1.2.15) (Srinivasan and Sprinson, 1959a) (step 1 Figure 1.1).
The mechanism of this reaction is still unclear but complementary lines of evidence indicate 
that it would appear not to follow the pattern of a simple aldol condensation as first 
proposed (Srinivasan and Sprinson, 1959b).
The simplest mechanism suggested nucleophilic attack at the phosphorous atom of PEP 
resulting in P-O cleavage and generation of a reactive enol pyruvate anion which can 
rapidly add to E4P. This explanation (Srinivasan and Sprinson, 1959b) was consistent 
with pyruvate kinase catalysed phosphorylations using PEP (Harrison et al., 1955).
Evidence from mechanistic studies precluded this explanation. The first employing a highly 
purified preparation was that of De Leo et al., (1973), who showed that for the 
S.typhimurium tyrosine-sensitive isozyme the reaction mechanism was ordered and 
sequential with PEP the first substrate to bind and DAHP the last product to leave. 
Subsequently other enzyme species were shown to follow the same order of addition of 
products and release of substrates (Simpson and Davidson, 1976; Schoner and Herrmann, 
1976; Dusha and Denes, 1976; Sugimoto and Shiio, 1980; Nimmo and Coggins,
1981b).
Furthermore, De Leo and Sprinson (1968) had shown that the condensation of PEP with 
E4P involved C-O rather than P-0 cleavage, that is when E4P reacted with PEP carrying an 
180 label in the C-O-P oxygen, l80 was recovered in the orthophosphate released rather 
than in DAHP itself. A mechanism was then proposed involving initial transfer to a
4
nucleophilic group on the enzyme, followed by elimination of the phosphate to restore the 
alkene which could then initiate the aldol condensation.
Deuterium labelling experiments ruled out this enzyme intermediate possessing a freely 
rotating methyl group on C-3 of PEP as suggested (De Leo and Sprinson, 1968) but 
instead implicated an era/pyruvyl-enzyme intermediate with phosphate retained within the 
complex (Floss et al., 1972).
Many DAHP synthases have been shown to be susceptible to inhibition by thiol-modifying 
reagents, (Staub and Denes, 1969a,b; Gorisch andLingens, 1971b ; Huisman and 
Kosuge, 1974; Sugimoto and Shiio, 1980 ;Ray and Bauerle, 1991) which has lead to the 
suggestion that sulfhydryl groups are involved either in the PEP binding site, or in the 
enzyme active site or in co-ordinating an essential metal co-factor.
A recent proposal about the mechanism by Ganem (1978) is consistent with the isotope 
labelling, product inhibition and chemical modification experiments. It proposes an 
enzyme-bound, sulphur-containing, enolpymvyl intermediate which undergoes sulphur- 
migration, phosphate elimination and then participates in a nucleophilic attack on the carbon 
atom of the carbonyl group of E4P (Figure 1.2).
This proposal affords no role to metal ions which are believed to be an essential co-factor 
(Gorisch and Lingens, 1971; McCandliss and Herrmann, 1978 ; Nimmo and Coggins, 
1980a; Paravicini et a l , 1989; Ray and Bauerle, 1991). Chelating agents such as EDTA 
and o-phenanthroline inactivate the enzyme and the endogeneous metal has been identified 
as ferrous iron in several cases. Indeed, it has been suggested (Ray and Bauerle, 1991) that 
PEP removal facilitates metal loss from the E.coli tryphophan-sensitive DAHP synthase 
and that their mutual binding provides a stable, active enzyme. The metal may then act by 
stabilising the carbanion formed on C-3 of the ewo/thiopyruvate intermediate, as found for
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the class II metalloaldolases (Rutter, 1964).
1.2.2 Control of activity
Branched, purely biosynthetic pathways exhibit a diversity of control mechanisms in 
different species. The aromatic amino acid biosynthesis pathway is no exception, with 
different control and organisation of the constituent enzymes well documented ( Herrmann 
and Somerville, 1983). Carbon flow through the shikimate pathway is controlled at the first 
step by modulation of DAHP synthase activity either by feedback inhibition, transcriptional 
regulation or specific degradation.
1.2 .2 .1 Regulation of DAHP synthase by feedback inhibition
Diverse patterns of enzyme control have been described for DAHP synthases from different 
organisms ( Byng et al., 1982). An organism may posses from one to three isoenzymes 
feedback inhibited either by pathway end-products, pathway intermediates, a combination 
of the two or, exceptionally, the enzyme may be unregulated. Where an enzyme is 
responsive to more than one effector, they may act in a concerted, synergistic or cumulative 
manner.
The pathway end-products phenylalanine, tryptophan and tyrosine are the most common 
allosteric ligands but arogenate, chorismate and prephenate sensitive DAHP synthases have 
also been reported (Nakatsukasa and Nester, 1972; Ganson et al., 1986; Ahmad et al., 
1986).It should be noted that some of the reported effects are of doubtful validity because 
of uncertainty about the quality, purity and stability of the pathway intermediates employed 
and whether the concentrations used reflect physiological conditions.
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1.2.2.1 (a) Superfamily B prokaryotes
The best understood but probably least common regulation pattern is the three isozyme 
system of the enteric bacteria first described in E.coli ( Doy and Brown, 1965). In the 
three isozyme system, each one is subordinated to a single end-product amino acid. In 
E.coli, the phenylalanine and tyrosine sensitive isozymes can be inhibited up to a 
maximum of 95% of control activity ( Schoner and Herrmann, 1976 ; McCandliss et al> 
1978), the tryptophan isozyme is somewhat less sensitive, inhibited to a maximum of 70% 
of activity (Ray and Bauerle, 1991).
This pattern of regulation appears hard to rationalise with respect to the cells metabolic 
requirements when one considers the relative abundance of the three activities under normal 
conditions. In wild-type E.coli, 80% of the total activity is contributed by the 
phenylalanine-sensitive isoenzyme, 20% by the tyrosine-sensitive isoenzyme and less than 
1% by the tryptophan-sensitive isoenzyme (Jensen and Nasser, 1968).
The three isoenzymes share similar kinetic properties, subunit size (Tables 3.9,3.10) and 
amino acid sequence. Between the three sequences, 41% of residues are identical, and there 
are many clusters of identical residues. The most conserved region is a stretch between 
residues 52 and 190. Indeed from comparison of the first 40 !V-terminal amino acids it 
was originally wrongly concluded that the isozymes had evolved independently (Poling et 
al., 1978), since the sequence in this region contained only six conserved residues and is 
by far the least conserved region.
This high sequence similarity would suggest a common evolutionary origin (Pittard, 1987). 
However, the variations in sequence homology in different regions of the polypeptides had 
led to the proposal that the isoenzymes may have been constructed from the fusion of an
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ancestral catalytic core with different effector binding domains (Schultz et al., 1984). 
Definitive proof in favour of a common origin and against the domain recruitment model 
was provided from the results of random mutagenesis experiments on the tryptophan 
sensitive enzyme. This mutational analysis showed that catalytic mutants invariably 
occurred in conserved residue positions whereas regulatory mutants, with one exception, 
resulted from changes in non-conserved residues (Ray et a/., 1988). Both types of 
mutation were interspersed throughout the sequence and the feedback and catalytic regions 
were not physically separate and may therefore comprise overlapping sequences.
Evidence has now been gathered to support the existence of a common allosteric aromatic 
binding site for the isozymes which may be specifically tailored to accomodate individual 
amino acids (Ray et al., 1988, Weaver and Herrmann, 1990).
The enteric bacteria are members of the Superfamily B group of Gram-negative 
prokaryotes, and a diverse pattern of control mechanisms for DAHP synthase has been 
described for these organisms (Jensen and Ahmad, 1988) following basic enzymic 
characterisation ( Figure 1.3), although as yet little physical and no sequence information 
has been obtained. None the less, these regulatory properties have been used to delineate 
genealogical clusters among these Gram-negative prokaryotes which match phylogenies 
defined by 16S rRNA homologies and an attempt made to deduce evolutionary events 
which may have led from an ancestral state to the present control properties (Jensen and 
Ahmed, 1988) (Figure 1.3).
1.2.2.1 (b) Gram-positive bacteria
Examples from this group of bacteria possess DAHP synthases which have either a single 
unimetabolite-responsive monofunctional isozyme or have their DAHP synthase complexed 
with another activity in a bifunctional polypeptide.
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Erwinia carotovora  
Erwmia amylovora
Proteus mirabilis 
Proteus vulgaris 
Morganella morganii  
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Figure 1.3 Evolution and phylogenetic distribution of DAHP synthase 
isoenzymes in Superfamily-B prokaryotes
The organisms have been classified according to 16S rRNA sequence data. Symbols : IT two 
isozymes, one unregulated, one tyrosine sensitive; ~—  two isozymes, one tyrosine sensitive, one 
tryptophan (mainly) and chorismate sensitive; ■ ■ ■  two isozymes, one tyrosine sensitive, one 
tryptophan sensitive ; ~rm  one enzyme, chorismate (mainly) and tryptophan sensitive ; O E 3  three 
isozymes, one tyrosine sensitive, one tryptophan sensitive, one phenylalanine sensitive. Adapted from 
Jensen and Ahmed, 1982.
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No evidence for the existence of isoenzymes has been reported in the Actinomycetales 
genus, with studies focussing on Nocardia and Streptomyces species (Lowe and 
Westlake, 1970; Gorisch and Lingens, 1971a; Murphy and Katz, 1980; Tianhui and 
Ghiao, 1989 ; de Boer etal., 1989). At physiologically relevant concentrations the single 
activity was inhibited only by tryptophan.
In the Corynebacterium, Brevibacterium flavum, a single DAHP synthase was co- 
purified with component A of chorismate mutase, these activities residing on a 55kDa 
bifunctional polypeptide. A distinct polypeptide, component B, was associated and 
essential for chorismate mutase activity (Shiio and Sugimoto, 1979a,b). The DAHP 
synthase activity was synergistically inhibited by phenylalanine and tyrosine and unaffected 
by tryptophan (Shiio and Sugimoto,1980). The two activities possess discrete active sites 
but seem likely to share a common feedback effector site (Shiio and Sugimoto, 1979a,b).
In Bacillus subtilis the picture is more complicated; a trifunctional complex containing 
DAHP synthase was described from strain 168, a pleiotropic mutant (Nester et al.,
1967). It consisted of a bifunctional 38 kDa protein containing DAHP synthase and 
chorismate mutase activities and another polypeptide carrying shikimate kinase activity 
(Nakatsukasa and Nester, 1972; Huang et al., 1974). The DAHP synthase constituent 
was feedback inhibited only by chorismate and prephenate, the product and substrate of 
chorismate mutase. Later studies showed this arrangement was almost certainly due to 
mutation. The wild-type Bacillus subtilis DAHP synthase was in fact a monofunctional, 
prephenate inhibitable species of identical native Mr and kinetic properties to the mutant 
enzyme (Llewellyn et al., 1980). Indeed, in the mutant a second, discrete chorismate 
mutase species existed which accounted for the bulk of this activity and whose purification 
and characteristics mirrored those of the wild-type enzyme. It was postulated that an active 
site capable of undertaking the chorismate mutase reaction had evolved from the allosteric
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effector binding site for prephenate, and produced a second chorismate mutase activity.
1.2.2.1 (c) Lower eukaryotes
All yeast and fungi so far studied possess at least two isoenzymes inhibited by 
phenylalanine and tyrosine, respectively (Lingens etal., 1966 ; Bode and Bimbaum, 1978 
; Fiske and Kane, 1984 ; Bode et al., 1985 ; Koll et al., 1988). In addition, the yeast, 
Sporoblomyces salmonicolor, and the fungus, Neurospora crassa, possess a third 
tryptophan inhibitable isoenzyme (Jensen and Nasser, 1968 ; Bode et al., 1986).
Both of the Saccharomyces cerevisiae isoenzymes have been cloned and sequenced 
(Paravicini et al., 1988 ; G.Braus, personal communication, 1991). The genes AR03 and 
AR04 encode the phenylalanine and tyrosine sensitive polypeptides, respectively, which 
although slightly larger are remarkably similar in sequence to the E.coli isoenzymes. In 
overlapping regions the identity with the individual E.coli isoenzymes can reach 53% 
(Figure 4.8).
Both isoenzymes are monomeric in structure and the AR03 protein has been purified 
1250-fold from an overproducing strain where the AR04 gene had been deleted 
(Paravicini et al., 1989). The enzyme is an Fe protein, and is inactivated by EDTA ; the 
inhibition is reversed by bivalent metal ions. The enzyme is sensitive to inhibition by 
phenylalanine with a Ki of 10 p.M, a value similar to that found for the E.coli isoenzyme.
One of the N.crassa isoenzymes, the least abundant tryptophan sensitive species, has been 
purified to homogeneity (Nimmo and Coggins, 1981a). It comprises 14% of the total 
enzyme activity compared to 54% and 32% provided by the tyrosine and phenylalanine 
sensitive isoenzymes, respectively (Nimmo and Coggins, 198la). It had a larger subunit
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Mr, 52kDa, was tetrameric and EDTA sensitive. No sequence data is yet available.
1.2.2.1 (d) Plants
The control of the shikimate pathway in plants may satisfy different criteria from those in 
microorganisms. The quantatitive importance of the pathway in plants is much greater, 
providing as it does, in addition to vitamins and amino acid requirements, secondary 
products, lignins and other aromatics. Additionally the pathway may be regulated in a 
tissue-specific manner or developmentally. Finally the location of the pathway within a cell 
may be plastidic or cytosolic (Jensen, 1986).
Present evidence indicates the existence of at least two isozymic forms of DAHP synthase 
as found in a variety of higher plants (Rubin et al., 1982; Rubin and Jensen, 1985 ; 
Ganson et al., 1986; Morris et al., 1989). They differ in their metal ion requirements 
(being Mn and Co dependant, respectively), pH optimum, substrate kinetics, susceptibility 
to inhibition by DTT, and subcellular location (the Mn isozyme is believed to be plastidic, 
the Co isozyme cytosolic). The plant enzyme followed an orthodox pattern of inactivation 
by chelating agents and sulfhydryl modifying reagents (Huisman and Kosuge, 1974).
A third isozyme has been resolved in pea extracts (Rothe et al., 1976) and carrot cell 
extracts (Suzich etal., 1985), but there is the suggestion that this could represent another 
sugar aldolase capable of mimicking the DAHP synthase reaction (Morris et al., 1989).
The pattern of response to allosteric effectors is as varied as found in any other group of 
organisms. In one case, that of Cinchona succirubra, the enzyme was responsive to 
inhibition by phenylalanine, tyrosine and tryptophan (Schmauder et al., 1985), but more 
often a completely feedback resistant isozyme has been found, such as those described 
from cauliflower (Huisman and Kosuge, 1974, Camellia sinensis (Saijo and Takeo, 1979)
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and maize root (Graziana and Boudet, 1980). Contrastingly, in an example of differential 
tissue-specific regulation, enzyme prepared from maize shoot was inhibited by tryptophan 
(Graziana and Boudet, 1980). A more complex pattern has been described for the Mn- 
dependant isozyme from mung bean. Prephenate, arogenate, and to a lesser extent 
tryptophan, inhibited this isozyme, wheras chorismate enhanced the activity. The separable 
Co-dependant activity was inhibited solely by the secondary metabolite, caffeic acid. This 
pattern was rationalised as a sequential feedback inhibition mechanism, controlling the 
entire flux through the pathway (Rubin and Jensen, 1985).
Other enzyme species from carrot and potato tubers were insensitive to feedback inhibition 
and instead are activated by pathway end-products tryptophan (mainly) and tyrosine (to a 
lesser extent) (Suzich et a l, 1985 ; Pinto et al., 1986). This feedback activation may be a 
response to wounding and promote the production of lignins for callous formation (Suzich 
etal., 1985).
The two plant DAHP synthases which have been purified to homogeneity from carrot and 
potato are dimers of apparent subunit Mr of 53kDa (Suzich et al., 1985 ; Pinto et al.,
1986). A cDNA encoding the potato enzyme has been cloned, and the deduced amino acid 
sequence indicates a polypeptide of Mr 56,153 (Dyer et al., 1990). cDNA/RNA 
hybridisations and antibody cross-reactivities indicate the close sequence and structural 
similarities of a range of plant DAHP synthases across diverse evolutionary distant species 
(Dyer et al., 1990). Overall sequence identity between the plant and bacterial enzymes is 
less than 25%, and the plant enzyme possesses an additional 140 amino acid residues at the 
carboxy terminus whose function is not known (Dyer et a l , 1990).
A goal of future work must be to clone and sequence different plant isozymes, compare 
them, and identify individual residues important in conferring the different kinetic
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properties and effector sensitivity.
1 .2 .3  Transcriptional regulation of DAHP synthase
1.2.3 (a) Superfamily B prokaryotes
The isozymes of enteric bacteria, alone among this group, have been shown to possess 
repression/depression control by the corresponding amino acids (Wallace and Pittard, 1967 
; Jensen and Nasser, 1968 ; Ahmad et al., 1987).
In E.coli, the structural genes aroF, aroG, and aroH encode the tyrosine-sensitive, 
phenylalanine-sensitive and tryptophan-sensitive isozymes, respectively. The control of 
expression of the genes is exercised at the transcriptional rather than the translational stage, 
and with the possible exception of aroF, this control is mediated solely by repressor 
proteins with product amino acids acting as corepressors.
The expression of aroFl is controlled by tryptophan mediated through trpR (Pittard et al., 
1969). Repression alone is thought to be the method of transcriptional control as the DNA 
sequence of the monocistronic operon precludes attenuation control (Zurawski et al.,
1981). The variation in aroH expression found has not been reported, possibly due to the 
very low levels of transcript which would exist even under de-repressed conditions.
The transcription of both the aroF and aroG genes is controlled by the tyrR gene product 
(Wallace and Pittard, 1969; Brown and Somerville, 1971; Im et al., 1971; Mattem and 
Pittard, 1971; Camakaris and Pittard, 1973 ; Im and Pittard, 1973). The TyrR protein acts 
on a specific operator sequence, a 17 nucleotide long palindrome known as the TYR box 
(DeFeyter et al., 1986). Eight genes are under the control of the TyrR protein, they 
possess at least a single TYR box at the operator loci and are known as the tyrR regulon 
(Pittard, 1987). The expression of aroG is co-repressed by phenylalanine and tryptophan,
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with this varying over a two-fold range and not fully repressible. aroF and tyrA, the 
structural gene for chorismate mutase-prephenate dehydrogenase, form the tyr operon 
under the control of tyrosine mediated by tyrR (Gollub and Sprinson, 1969 ; Mattem and 
Pittard, 1971). The expression can vary over 100 fold and can be repressed completely. In 
addition, aroF expression may be under some form of attenuation control (Camakaris et 
al, 1980, Hudson and Davidson, 1984)
Therefore, the various operators associated with the genes of the tyrR regulon differ in 
their ability to bind the corepressor forms of the TyrR protein (eg. repressor-tyrosine, 
repressor phenylalanine). These phenomena can be explained with respect to the quantity 
and sequence of the TYR boxes, as TyrR protein molecules can bind cooperatively at 
adjacent boxes and some box sequences bind TyrR protein more avidly.
In addition to these control mechanisms, under Starvation conditions the tyrosine isozyme 
is specifically degraded (DeLucia et al, 1979; Tribe and Pittard, 1979) with the tyrA 
product unaffected (DeLucia and Herrmann, 1983).
Although the repressor control systems play an important role in regulating pre-formed 
enzyme levels, it is the control of intact enzyme by feedback inhibition which appears the 
quantitatively major regulatory mechanism of flux through the common pathway in vivo 
(Ogino et a l, 1982).
1.2.3 (b) Gram-positive bacteria
No convincing evidence for repression control of the expression of shikimate pathway 
genes has been reported in the genus Actinomycetales (discussed in section 3.13).
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In Brevibacterium flavum, the synthesis of both polypeptides comprising the DAHP 
synthase/chorismate mutase bifunctional complex is subject to regulation by tyrosine (Shiio. 
and Sugimoto, 1979b). Tyrosine is also involved in the mediation of transcriptional control 
of the Bacillus subtilis DAHP synthase (Nester et al., 1969) with biosynthesis of the 
aromatic amino acids and histidine perhaps sharing mutual regulatory elements (Chapman 
and Nester, 1968).
1.2.3 (c) Lower eukaryotes
In Saccharomyces cerevisiae AR03 and AR04 are under the control of at least two 
promoters (Paravicini et a/.,. 1989; G.Braus, personal communication, 1991) recognised 
by different transcriptional factors whose binding is mutually exclusive. Basal expression 
of the genes is amino acid independent, but under starvation conditions the genes are 
derepressed to a higher transcription rate by GCN4, the general control activator protein, 
acting at the second promoter site. This mechanism may facilitate cell growth in the 
presence of tyrosine and phenylalanine, when tryptophan would still be required.
No other transcriptional control mechanisms have yet been reported from other organisms 
in this group with respect to DAHP synthase.
1.2.3 (d) Plants
Levels of DAHP synthase in plants vary during development and in response to 
environmental influences. The specific activity of the enzyme increases during seed 
germination of Vigna radiata (Minamikawa, 1967), Pisum sativum (Rothe et al., 1976), 
Zea mays (Graziana and Boudet, 1980) and during shoot formation from Nicotinia 
tobacum (Beaudoin-Egan and Thorpe, 1983).
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Potato DAHP synthase activity is elevated in response to stress by the herbicide glyphosate 
by de novo synthesis of the plastidic enzyme (Pinto et al., 1988). Glyphosate inhibits 
EPSP synthase, and the signal for DAHP synthase induction may be the depletion of 
aromatic amino acids or secondary products. Wounding potato or tomato tissue also 
induces synthesis of DAHP synthase (Dyer et al., 1989) as does treatment of parsley cells 
with a fungal elicitor (McCue and Conn, 1989). Finally, light treatment of parsley cells 
increases levels of the plastidic isozyme, whilst the cytosolic species is unaffected.
The control elements which may lie upstream of the DAHP synthase protein coding region 
remain uninvestigated, and their elucidation may provide the answer to questions about 
transcriptional control mechanisms and implicate the protein factors involved.
1.3 3-Dehydroquinate synthase
The second reaction of the shikimate pathway, namely the conversion of DAHP to DHQ, is 
catalysed by 3-dehydroquiriate synthase (EC 4.6.1.3) (step 2 Figure 1.1). This reaction 
was first demonstrated in 1963 (Srinivasan et al., 1963), following the earlier isolation 
and identification of DHQ as a pathway intermediate from the culture supernatant of 
aromatic auxotrophs of E.coli (Weiss et al., 1953).
Following experiments involving substituted analogues and radiolabelled substrates, the 
reaction was shown to involve an intramolecular exchange of the DAHP ring oxygen with 
C-7, accompanied by an oxidation at C-6 and a reduction at C-2 (LeMarechal and Azerad, 
1976; Rotenberg and Sprinson, 1970,1978). The driving force for the reaction is the 
cleavage of the phosphoester. It was shown that both NAD+ and a divalent metal were 
essential for activity, with a crucial step in the overaU conversion being the oxidation and 
then reduction of the C-5 of DAHP involving NAD+ (Srinivasan et al., 1963). The
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enzyme is believed to recognise the pyranose form of DAHP (Lambert et al., 1985).
A monomeric protein of 40 kDa Mr catalyses the reaction in E.coli, with a Km for DAHP 
of 33 juM (Maitra and Sprinson, 1978 ; Frost et al., 1984). In Bacillus subtilis the 
enzyme has a Mr of 17 kDa, a Km for DAHP of 130 fiM, and is only active when 
associated with chorismate synthase and a flavin reductase in a trifunctional complex.
In E.coli, DHQ synthase appears to be synthesised constitutively, and the activity found in 
wild-type extracts is calculated to be about five-fold greater than would be required to 
satisfy the aromatic requirements of vigorously growing cells (Tribe et al., 1976). In 
strains of E.coli with a feedback-resistant DAHP synthase (tyrosine), DHQ synthase 
activity becomes rate-limiting for flux through the pathway with consequent accumulation 
of DAHP (Ogino et al., 1982).
1.4  3-Dehydroquinase
The enzyme 3-dehydroquinase (EC 4.2.1.10) catalyses the third step of the shikimate 
pathway, namely the stereospecific (syn) elimination of water to yield 3-dehydroshikimate 
(step 3 Figure 1.1). This compound contains the first double bond of the aromatic ring 
system (Salamon and Davis, 1953 ; Srinivasan et al., 1956; Hanson and Rose, 1963 ; 
Turner et al., 1975).
The reaction proceeds through the formation of a Schiff base between a lysyl side chain 
amino group and the keto group of 3-dehydroquinate (Butler et al., 1974; Chaudhuri et 
al., 1991). This causes a conformational change in the substrate, thereby facilitating the 
stereospecific course of the reaction (Vaz et al., 1975). A basic group, shown to be the 
imidazole side chain of a histidine residue participates in proton abstraction (Walsh, 1979;
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Chaudhuri et al., 1986).
Four types of enzyme have been described. Three comprise the biosynthetic 3- 
dehydroquinases, found in bacteria, plants, yeast and fungi wheras the fourth type is found 
only in fungi. The fourth type, the catabolic dehydroquinases, which are found only in 
fungi such as N.crassa and A.nidulans, are induced in response to quinic acid and are 
involved in the utilisation of quinic acid as carbon source for growth (Giles et al., 1985). 
The biosynthetic enzymes are either dimers of subunit size 27,000 (Chaudhuri et al, 1986) 
or form a domain within a multifunctional protein corresponding to this size (Duncan et 
al., 1987 ; Mousedale et al., 1987). The catabolic enzymes are large multimeric proteins 
(probably dodecamers) consisting of identical monofunctional subunits of Mr 16,000- 
18,000 (Hawkins etal., 1982; Da Silva et al., 1986).
There are two sub-types of multifunctional enzyme containing 3-dehydroquinase. In plants, 
shikimate dehydrogenase shares a single bifunctional polypeptide with the 3- 
dehydroquinase activity (Polley, 1978 ; Koshiba, 1978 ; Mousedale et al., 1987) while in 
fungi and yeast 3-dehydroquinase is one of the five catalytic components of the arom 
multifunctional enzyme (Lumsden and Coggins, 1977 ; Gaertner and Cole, 1977). When 
the sequences of the E.coli and fungal enzymes were compared they were found to be 
similar at the primary sequence level (Duncan et al., 1987).
Curiously, the biosynthetic 3-dehydroquinase of S.coelicolor displays physical and kinetic 
properties, and sequence similarities with the fourth type of 3-dehydroquinases the 
inducible catabolic type (White et al., 1990).These inducible enzymes show little similarity 
to the biosynthetic dehydroqunases at the primary sequence level (Duncan et al., 1987) 
and do not appear to catalyse the reaction via a Schiff base mechanism, as attempts to 
inactivate enzyme from S.coelicolor and A.nidulans with NaBH4 have failed (Walker, 
G.E., unpublished, 1990 ; Kleanthous, K., unpublished, 1990).
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1.5 Shikimate dehydrogenase
Shikimate dehydrogenase (EC 1.1.1.25) converts 3-dehydroshikimate to shikimate (Yaniv 
and Gilvarg, 1955) utilizing NADPH as proton donor in a stereospecific manner (Dansette 
and Azerad, 1974) (step 4 Figure 1.1).
In E.coli, the enzyme is a monomer of 32,000 Mr (Chaudhuri and Coggins, 1985) and the 
derived sequence contains a consensus nucleotide binding region which probably 
represents the NADPH binding site (Anton and Coggins, 1988). As mentioned previously 
(section 1.4), the activity resides with 3-dehydroquinase on a bifunctional protein in a 
variety of plants and on the arom multifunctional protein in yeast and fungi (Lumsden and 
Coggins, 1977 ; Hawkins, 1987 ; Duncan et al., 1987).
1.6 Shikimate kinase
Shikimate kinase (EC 2.7.1.71) catalyses the transfer of phosphate from ATP to the C-3 - 
OH group of shikimate to form shikimate 3-phosphate (Weiss and Mingioli, 1956) (step 5 
Figure 1.1).
No aromatic auxotrophs blocked in this reaction could be found in E.coli (Pittard and 
Wallace, 1966a) or S.typhimuriwn (Gollub et al., 1967) and it was established that both 
possessed isoenzyme forms (Morrell and Sprinson, 1968 ; Berlyn and Giles, 1969). While 
expression of shikimate kinase of S.typhimuriwn appears to be unregulated (Gollub et 
al., 1967) and the shikimate kinase I of E.coli is expressed constitutively, the second 
isozyme, shikimate kinase II, encoded by aroL, is under the specific control of the tyrR 
regulator gene, its synthesis being repressed by tyrosine or tryptophan.
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The existence of isofunctional enzymes frequently occurs in the first reaction of a pathway 
that later branches to different end-products (eg. DAHP synthase), furthermore specific 
modulation of gene expression usually affects genes encoding the first enzyme in a 
pathway and in the example of the shikimate pathway in E.coli only the three DAHP 
synthases and shikimate kinase II are subject to such control. This has led to the hypothesis 
that an unknown metabolic pathway branches from the shikimate pathway at this point or 
that in the evolutionary past, aromatic biosynthesis originated at this point (Pittard, 1987).
However, an examination of the kinetic properties of the E.coli isozymes indicated that 
shikimate kinase I may possess another function and only fortuitously catalyse this 
reaction. Shikimate kinase II has been cloned, sequenced and overexpressed and is a 
monomer of 20,000 Mr (DeFeyter et al., 1986; DeFeyter and Pittard, 1986; Millar et al., 
1986). The Km of shikimate kinase II for shikimate is 200 pM, whereas that of shikimate 
kinase I is in excees of 5 mM (cited in Pittard, 1987). Furthermore, the two genes would 
appear not to be homologous (cited in Pittard, 1987). The true function then for shikimate 
kinase I remains unknown.
In yeast and fungi shikimate kinase occurs on the arom multifunctional polypeptide 
(Lumsden and Coggins, 1977 ; Hawkins, 1987 ; Duncan et al., 1987).
1.7 EPSP synthase
Shikimate 3-phosphate and phosphoera/pyruvate react to form 5-era/pyruvyl-shikimate 
3-phosphate (EPSP) and inorganic phosphate via the action of EPSP synthase (EC 
2.5.1.19) (Levin and Sprinson, 1964) (step 6 Figure 1.1). This enzyme has arguably been 
studied more exhaustively than any other in the pathway in terms of mechanism and 
structure, for the good reason that this activity is the major target for inhibition by the broad
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spectrum herbicide, glyphosate (Steinrucken and Amrhein, 1980; Boocock and Coggins, 
1983), which is of considerable economic importance (Grossbaid and Atkinson, 1986).
The mechanism involves the protonation of C-3 of PEP and the transfer of the 
^no/pyruvate moiety of PEP onto the hydroxyl group at C-5 on the acceptor molecule, 
shikimate 3-phosphate, to form a tetrahedral intermediate. The cleavage of the C-0 bond at 
C-2 of PEP facilitates the elimination of the phosphate (Levin and Sprinson, 1964; 
Bondinell et al., 1971). This mechanism first proposed in 1964 has recendy been 
conclusively validated by the isolation of the predicted tetrahedral intermediate (Anderson 
et al., 1988a, b).
A number of amino acids have been implicated in catalysis including arginine, cysteine, 
glutamate, histidine and lysine residues (reviewed in Bentley, 1990). The role of these 
residues will become more apparent when a high resolution three-dimensional structure of 
the enzyme is available. Crystals diffracting to give medium-resolution are now available 
(Abdel-Meguid et al., 1985).
EPSP synthase from E.coli has been purified, sequenced and overexpressed (Lewendon 
and Coggins, 1983 ; Duncan et al., 1984; Duncan et al., 1985) and is a monomer of 
46,112 Mr. The crucial step in the purification from wild-type E.coli was substrate elution 
from phosphocellulose. Shikimate 3-phosphate and PEP together were the most effective in 
eluting the activity and indicate an ordered reaction in which shikimate 3-phosphate binds to 
the enzyme first.
This purification was followed by others from a range of bacteria and plants, including 
S.typhimuriwn (Stalker etal., 1985), K.pneumoniae (Steinrucken and Amrhein, 1984) 
and pea seedling (Mousedale and Coggins, 1984), with sequence data also being obtained
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for the first two. Subsequently other sequences were obtained from Bordetella pertussis 
(Maskell et a l, 1988), petunia (Gasser etal., 1988), pea (Granger, 1989), tomato and 
Arabidopsis thaliana (Klee et al., 1987), yeast (Duncan et a l, 1987), and Aspergillus 
nidulans (Charles et al., 1986). There is considerable homology between the plant, 
bacterial and fungal sequences.
As mentioned above, EPSP synthase is the site of action of glyphosate but despite a large 
amount of research the precise nature of this effect is not clear. It was shown for the EPSP 
synthase component of the N.crassa arom complex that the reaction proceeds sequentiady 
with shikimate 3-phosphate (S3P) the first substrate to bind fodowed by PEP. The enzyme 
was not able to bind PEP nor glyphosate in the absence of S3P. The inhibitory action of 
glyphosate results from its competition with PEP to bind the enzyme-S3P complex 
(Boocock and Coggins, 1983). The ionic form of glyphosate may act as a transition state 
analogue of PEP (Amrhein, 1986) and recent studies utilizing NMR chemical shift 
perturbations have elucidated the conformation of glyphosate bound within the enzyme 
dead-end complex (Castellino et al., 1989). Indeed, more potent EPSP synthase 
inhibitors, phosphonate analogues of the tetrahedral reaction intermediate have now been 
synthesised (Alberg and Bartlett, 1989).
1.8 Chorismate synthase
Chorismate synthase (EC 4.6.1.4) catalyses the seventh and last reaction of the shikimate 
pathway, namely the trans 1,4-edmination of orthophosphate from EPSP (Hid and 
Newkome, 1969; Onderka and Ross, 1969; Ross et al., 1972) to yield chorismate 
(Gibson and Jackman, 1963 ; Gibson and Gibson, 1964) (step 7 Figure 1.1). The enzyme 
is characterised by an absolute requirement for a reduced flavin cofactor to carry out the 
reaction, but this cofactor is not stoichiometrically consumed during the reaction and its role 
remains ambiguous.
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The complete sequence of the E.coli enzyme has been determined and the enzyme purified 
from an overproducing strain (White et al,, 1988). It is a tetramer of 38,000 Mr, whereas 
the enzyme from N.crassa is larger, comprising a tetramer of 50,000 Mr (White et al.,
1988).
The N.crassa chorismate synthase has the ability to reduce FMN in the presence of 
NADPH via an intrinsic flavin reductase (diaphorase) activity (Welch et al., 1974), 
indicating that each polypeptide of the homotetramer is bifunctional, possessing both 
chorismate synthase and diaphorase activity. The E.coli enzyme does not possess this 
intrinsic diaphorase activity and can only catalyse the formation of chorismate when 
supplied with exogenous reduced flavin (Morrel et al., 1967 ; White et al., 1987). It has 
been proposed that the N.crassa polypeptide consists of two domains, one catalysing the 
formation of chorismate from EPSP and one carrying diaphorase activity and responsible 
for providing reduced flavin cofactor (White et al., 1988). The smaller subunit E.coli 
enzyme may consist of a single catalytic activity and lack a diaphorase domain.
A monofunctional enzyme has been characterised from pea (Mousedale and Coggins, 
1986) and appears to be analogous to the E.coli type. A bifunctional enzyme complex was 
found in Bacillus subtilis (Hasan and Nester, 1978); in this case a monofunctional 
chorismate synthase polypeptide was associated with a 13,000 Mr NADPH -dependent 
flavin reductase. The Mr of this flavin reductase component is very similar to the size 
difference between the E.coli and N.crassa enzymes.
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1.9 An introduction to streptomycetes
The genus Streptomyces comprises a group of gram-positive obligately aerobic bacteria 
characterised by their morphological and metabolic capabilities. They inhabit soils, and as 
such derive much of their nutrition from insoluble organic detritus, such as leaves. The 
ability to produce and secrete extracellular hydrolytic enzymes such as cellulases, amylases, 
proteases and nucleases facilitates the digestion of insoluble materials to products suitable 
for uptake into the cell (Williams et al., 1983).
The morphology and life-style of the organism reflect this adaptation. They grow as a 
mycelium of branching hyphae able to penetrate substrate locations. The colony can secrete 
and produce a high local concentration of degradative enzymes, and as the hyphae within a 
colony are inter-connected, nutrients obtained at one location can be shared with nutrient- 
deficient regions of the colony.
The sedentary, mycelial habit exploits this ecological niche efficiently but upon nutrient 
limitation a mechanism is required to allow dispersal to a new environment. This is 
achieved by a reproductive phase following the termination of vegetative colonial growth. 
At this stage, the substrate mycelium gives rise to differentiated spore-bearing aerial hyphae 
which derive nutrients from the lysing substrate mycelium and antibiotics are also produced 
(Figure 1.4). The role of antibiotics may be to protect the producer organism at vulnerable 
stages of its life-cycle from motile microbes which may compete for the use of lysed 
substrate mycelia (Chater, 1984).
The antibiotics produced by streptomycetes are of considerable interest as a result of their 
medical, veterinary and agricultural importance (Berdy, 1980). Of the thousands of 
naturally ocurring antibiotics discovered so far, about two-thirds including many of great
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Figure 1.4 Schematic representation of the life-cycle of streptomycetes
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commercial importance are produced by streptomycetes and their relatives in the 
actinomycetes. Much research has therefore focussed on the biosynthesis of antibiotics and 
on the improvement of antibiotic yield from these organisms.
1 .9 .1  The choice of Streptomyces coelicolor
The organism of choice for our study on the shikimate pathway in streptomycetes was 
Streptomyces coelicolor. It is genetically the most extensively characterised streptomycte 
species, having been studied by both classical and molecular approaches (Hopwood,
1988). The opportunity to manipulate genes and regulatory mechanisms has been made 
possible through the development of host-vector systems for gene cloning (Hopwood et 
al., 1985). The availability of a chemically defined medium which permitted dispersed 
growth (Hobbs et al., 1989) was another important criterion. Finally, the fact that no 
commercially important products are produced by Streptomyces coelicolor ensures that 
their is a full range of literature published on disparate aspects of physiology, genetics and 
biochemistry of this essentially academic strain.
1 .9 .2  The secondary products of Streptomyces coelicolor
A secondary product is defined as a substance that occurs in a limited number of 
organisms, not universally, and the function of which, if known, is not that of an 
intermediate in metabolism (Weiss and Edwards, 1980). In plants, these products may be 
involved in product storage, detoxification and pigmentation (Weiss and Edwards, 1980). 
In streptomycetes, the association of the production of secondary metabolites with 
morphological differentiation alludes to the role of these products as either regulators of the 
process or as protectors of the producer organism during this process (reviewed in Chater,
1989).
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Streptomyces coelicolor produces at least five secondary products, three of which, 
actmorhodin,undecylprodigiosin and methylenomycin, have been extensively characterised 
(reviewed in Hopwood, 1988). Actinorhodin is a diffusible blue pigmented polyketide 
product, chromosomally encoded (Wright and Hopwood, 1976), the production of which 
is sensitive to inhibition by ammonia and to a lesser extent by phosphate, and is not growth 
associated (Hobbs et al., 1990). Undecylprodigiosin is also pigmented and 
chromosomally encoded (Rudd and Hopwood, 1980) being red in colour (Tsao et al., 
1985) and mycelially associated (Rudd and Hopwood, 1980). It is produced toward the 
end of exponential growth (Walker G.E, unpublished results, 1988) and the regulation of 
production differs from actinorhodin in being only slightly affected by ammonia and 
phosphate (Hobbs et al., 1990). The third identified product, methylenomycin, an 
epoxycyclopentanone, is colourless, diffusible, plasmid encodetj (a conjugative plasmid 
termed SCP1) (Kirby and Hopwood, 1977), with its mode of action and biosynthesis still 
unknown.
The sets of genes encoding the biosynthetic steps of these compounds have been cloned 
and analysed (Malpartida and Hopwood, 1984; Chater and Bruton, 1985 ; Malpartida et 
al., 1990).
None of the secondary products so far described from Streptomyces coelicolor contain 
chemical groups originating from the shikimate pathway.
1.10  Antibiotic biosynthesis in streptomycetes
As stated above, about two-thirds of the naturally occurring antibiotics presently identified 
are produced by streptomycetes and their relatives, the other significant producers being 
Bacillus sp., Myxobacterium sp. and mycelial fungi. Furthermore, these diverse producer
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organisms share the same characteristics of soil-habitat and spore formation.
Antibiotics are classified according to chemical structure and their inhibitory mode of action 
against target micro-organisms. Their specificity of action has made them invaluable in the 
fields of medicine and agriculture and as research tools in biochemistry. However, these 
structures arise from simple precursors derived from intermediary metabolism. Acetate, 
propionate, glucose, and amino acids are precursors for complex multi-step pathways. The 
final bio-active product may be synthesised either by the combination of separate precursor 
components, or the simple step-wise modification of a single molecule.
Antibiotic biosynthesis is exquisitely regulated and this regulation must be interpretated 
within an overall understanding of the differentiation process and life-cycle of the 
organism.
1 .10 .1  Organisation and regulation
By the nature of their biocidal activity and because of the metabolic expense of their 
production the biosynthesis of antibiotics must be tightly regulated.
It has been found that antibiotic synthesis is switched on late in growth, often being 
sensitive to repression by particular growth nutrients, including metaboliseable carbon 
sources, nitrogen (usually in the form of ammonia), and inorganic phosphate (Martin and 
Demain, 1980). Some other pathways are activated by hormone-like substances, for 
example the A-factor of S.griseus, S.bikiniensis and S.coelicolor, diffusing within a 
colony. These substances are also essential for normal spore development (Kokhlov et al., 
1973, Hara et al., 1983). Hence, some regulatory mechanisms link metabolic change to 
morphological differentiation.
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Producer organisms possess resistance mechanisms to protect themselves against the toxic 
effects of their own metabolites. Thus, if the mode of action of an antibiotic was anti- 
ribosomal (such as erythromycin), then the producer organism has the ability to modify and 
render unaffected its own ribosomal RNA. Other resistance mechanisms include 
intracellular inactivation eg. bialophos (Murakami et al., 1986), or active export eg. 
methylenomycin (Neal and Chater, 1987). Some organisms possess more than one 
resistance determinant, and speculation surrounds this feature. In the case where a complex 
antibiotic is composed of two or more independantly synthesized components then a 
resistance mechanism may reside with the set of biosynthesis genes for each component 
(Chater and Hopwood, 1989).
There is thus a close relationship between the genes encoding antibiotic resistance and the 
genes encoding biosynthetic enzymes. It is now accepted that the genes for the biosynthesis 
of most antibiotics are encoded by clusters of genes on the chromosome which contain 
regulatory elements and resistance genes. Indeed the strategy of cloning resistance genes 
has enabled the cloning of entire biosynthetic pathways which flank these determinants (eg. 
Murakami et a l , 1983).
The clustering of genes also raises the possibility of transferring the potential to produce 
one antibiotic from one organism to another and this has now been done several times (eg. 
Malpartida et a l, 1990). Furthermore, the production of hybrid antibiotics by the action of 
enzymes from different species within another is possible (Hopwood et al> 1985 ; Omura 
et al., 1986).
Transcriptional regulation within antibiotic clusters is complex. Multiple promoter regions 
and divergent directional transcription combine to facilitate complex transcriptional control. 
It is clear that there is transcriptional interplay between biosynthetic and resistance genes to
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ensure an organism is resistant before it embarks on production of the lethal metabolite. 
Multiple promoters recognised by RNA polymerases with distinct sigma factors may also 
be important in specific gene expression during differentiation and antibiotic production 
(Westpheling et al., 1985 ; Buttner et al., 1988).
1 .10 .2  Structural classes of antibiotics, their modes of action and 
their applications
The three chief starting materials for secondary metabolism are
(1) the shikimate pathway products, which are incorporated into several classes of 
antibiotics.
(2) other amino acids, which form components of peptide antibiotics, peptidolactones, 
penicillins and cephalosporins.
(3) acetate, the major constituent of the polyketides which include macrolide, polyene, 
ansamycin, tetracycline and anthracycline antibiotics.
Antibiotic structures may be composed solely from one of these groups or incorporate 
chemical groups from more than one.
1.10.2 (a) p-lactams
Among the P-lactam antibiotics, penicillins and cephalosporins are clinically the most 
valuable. Penicillin (Figure 1.5) is biosynthesised from the precursors L-a-aminoadipic 
acid, L-cysteine and L-valine; cephalosporins are derived from penicillins following further 
modification (Figure 1.6). The majority of antibiotics of this class are produced by 
streptomycetes, with a significant proportion contributed by mycelial fungi such as 
Penicillium sp. and Cephalosporiwn sp. (O'Sullivan and Ball, 1983).
The anti-microbial activity of penicillins is a consequence of their ability to inhibit bacterial
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cell wall synthesis. They form a covalent ternary complex with the bacterial transpeptidase 
enzyme, hence irreversibly inactivating the enzyme.
1.10.2 (b) Peptides
Peptide antibiotics produced by Bacillus species are synthesised from both the L-amino 
acids found in proteins and from unusual amino acids, such as D-isomers and N- 
methylderivatives. The process involves activation of the substrate amino acid, enzyme 
aminoacylation, amino acid racemization and peptide bond formation. These steps are 
carried out by large, multifunctional proteins using a "thiotemplate" (Kleinkauf and von 
Doren, 1983).
1.10.2 (c) Peptidolactones
Most peptidolactones are produced by the actinomycetes with a small minority produced by 
Bacillus species. These antibiotics consist of two parts a peptide chain, which 
incorporate unusual amino acids (see 1.10.2 (b)), and an acyl group. The two are joined 
together at the /^-terminal amino group of the peptide.
An example is the actinomycins, composed of a phenoxazinone chromophore and two 
pentapeptide chains (Figure 1.7). The sequence of the amino acids in the peptide chain 
differs between individual actinomycins. The chromophore unit is derived from 
tryptophan.
Actinomycins are biologically active against gram-positive bacteria but considerably less so 
against gram-negative bacteria and fungi. They also have been used in the treatment of 
cancers (Okumura, 1983).
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The sequence of the amino acids in the peptide chain differs between individual actinomycins.
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1.10.2 (d) Macrolides
These antibiotics contain a 12-, 14-, or 16-membered macrocyclic lactone ring which has 
substituted aminosugar and/or deoxysugar groups. Erythromycin, which has a 14- 
membered ring structure (Figure 1.8) is a typical example.
Their main therapeutic use is against gram-negative cocci and Mycoplasma, with protein 
synthesis being their inhibitory target (they inhibit ribosomal translocation). Most 
macrolides currently in clinical use are produced by streptomycetes and their relatives.
The aglycone moiety of the macrolide is synthesised from acetate and propionate precursors 
in a manner analagous to fatty acid synthesis (Dimroth et al., 1976) and macrolides 
constitute one type of polyketide antibiotic. Following the formation of the macrolide ring, 
sugars are attached to it to give the final product (Omura and Tanaka, 1983).
1.10.2 (e) Polyenes
These are a subgroup of the macrolide class of antibiotics, comprising a lactone ring of 26- 
38 atoms, a polyene chromophore, and usually one aminosugar group. They are produced 
by streptomycetes and fungi, possess potent anti-fungal activity, an example being 
candicidin (Figure 1.9), which is produced by Streptomyces griseus.
The lactone ring and aminosugar groups are synthesised in a manner analagous to that of 
macrolides (section 1.10.2 (d)). The polyene chromophore, containing alternating double 
bonds forming a ring, is usually synthesised from 4-aminobenzoic acid (PAB A), derived 
from the shikimate pathway, via chorismate. The enzyme responsible for this conversion, 
PAB A synthase, is a target for feedback inhibition by the aromatic amino acids (Martin,
37
HO
Me
' 0  ■ Me
Me Me OMe
HO OH
Me
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1983).
1.10.2.(f) Ansamycins
This class of antibiotic comprises an aliphatic chain, which forms an intramolecular link 
between two non-adjacent positions of the second component, an aromatic group. Around 
20 ansamycin producers have been isolated, from either Streptomyces or Nocardia sp..
The aromatic group can either be a napthalene or a benzene moiety, the former ansamycins 
having antibacterial properties (inhibiting the RNA polymerase), the latter are active against 
eukaryotic cells (inhibiting cell replication). The rifamycins (Figure 1.10) are the only 
group to have been exploited commercially.
The aliphatic chain is synthesised from acetate and propionate in a methylmalonate- 
malonate condensation mechanism (Dimroth et al.> 1976). The aromatic group precursor is 
derived from the shikimate pathway, although its precise identity is disputed (Lancini, 
1983).
1.10.2 (g) Tetracyclines
The polyketide antibiotics are widely used in medical therapy, the most important 
commercial compounds being tetracycline (Figure 1.11), chlortetracycline (produced by 
Streptomyces aureofaciens) and oxytetracycline (from Streptomyces rimosus). They are 
synthesised by the condensation of acetate units to form a 19-membeied chain which is 
then aromatised before further modification yields the final tetracyclic product 
Tetracyclines exhibit their antibacterial action by binding to ribosomes and hence inhibiting 
bacterial protein synthesis (Behai, 1983).
40
Me
Me
Me
OH OH
NH
Me CO
Me
OR
Me
Figure 1.10 General structure of rifamycin
The functional group at the R position differs between individual rifamycins.
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1.10.2.(h) Anthracyclines
These antibiotics resemble tetracyclines in their possession of an anthraquinone 
chromophore, but in addition one or more sugar groups may also be attached (Figure 
1.12). They are produced by streptomycetes, exhibit potent antibacterial activity, are highly 
toxic, and are mainly employed clinically in cancer treatment This potent antitumour 
activity is a consequence of the ability of the anthracyclines to intercalate within double­
stranded DNA (White, 1983).
1.10.2.(i) Chloramphenicol
The biosynthesis of chloramphenicol follows a less elaborate route than the antibiotics 
already described. Its structure consists of an aromatic ring with two substituted groups 
(Figure 1.13). It is produced by streptomycetes and closely related organisms, enjoys 
widespread clinical use, with its mode of action being to inhibit the procaryotic ribosomal 
peptidyl transferase activity. Chorismate is the branch-point intermediate for the synthesis 
of chloramphenicol (Malik, 1983).
1.10.2 (j) Aminoglycosides
The aminoglycosides comprise a large class of similar antibiotics which contain aminosugar 
groups. They are composed from a range of identical or related sugar molecules which 
undergo secondary modifications (eg. methylation) to yield a final product They are 
synthesized by different bacterial genera including Streptomyces, Micromomospora, 
Bacillus and Pseudomonas (Davies and Yagisawa, 1983). As an example, kanamycin is 
shown (Figure 1.14). The primary effect of these drugs is on the ribosome, resulting in 
inhibition of protein synthesis. Clinically, they are important in the treatment of gram-
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negative infections.
1.10.3 Possibilities for the over-production of antibiotics utilizing
molecular genetics
In the past, the improvement of antibiotic yield by industrially useful microorganisms has 
been achieved empirically. Conventional strain improvement involves chemical or radiation 
mutagenesis followed by direct screening for increased yield. This approach was also 
employed to generate strains producing altered secondary products. In the former cases 
regulatory genes and in the latter case biosynthetic genes may have been altered in function.
With the advances in the understanding of the organization and regulation of antibiotic 
biosynthesis, and the ease with which these genes may now be isolated, a rational, planned 
approach to the overproduction of a single antibiotic is now possible.
The clustering of biosynthetic genes facilitates the cloning of entire pathways into 
streptomycete plasmid vectors using a heterologous, amenable host, such as S.lividans.
An increase in gene copy number and a vigorously growing host would enhance 
production levels.
An increased understanding of the transcriptional regulation of these gene clusters has also 
lead to improved productivity. There is evidence that the clusters contain pathway-specific 
regulatory genes, which may act positively or negatively. In the case of methylenomycin, a 
negative regulatory gene has been described. Disruption or deletion (Chater and Bruton, 
1985 ; Fisher et al., 1987) of a fragment of DNA at one end of the cluster resulted in a 
significant increase in production. In other cases, pathway-specific positive regulators have 
been identified (Ohnuki et al., 1985 ; Hopwood et al., 1985). Their loss correlates with a
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total inability to produce antibiotic, and provision of additional copies of the regulatory 
gene leads to enhanced production. Interestingly, these regulatory genes can act on 
heterologous sets of biosynthetic genes for other polyketide antibiotics (Malpartida et al., 
1987).
At the next level of the hierarchy of regulation are elements implicated in morphological 
differentiation and antibiotic production. Pleiotrophic mutants have been identified in 
S.griseus lacking the ability to synthesize A-factor (Hara et al., 1983 ; section 1.10.1), 
that are retarded in antibiotic production and morphological development From mutants of 
S.coelicolor unable to synthesize several antibiotics, a DNA fragment was isolated and 
identified which was able to encode a putative DNA binding protein (Horinouchi et al., 
1986). Furthermore, extra copies of this gene stimulated antibiotic production (Horinouchi 
and Beppu, 1988).
As mentioned above (section 1.10.1) multiple promoters and discrete RNA polymerase 
sigma factors have been implicated in the control of secondary metabolite production. The 
substitution of strongly-expressing vegetative promoters at appropriate locations within an 
antibiotic cluster is another option for overproduction yet to be employed.
In conclusion then, the application of molecular biology to the study of pathway genes, 
pathway-specific regulatory elements, global regulatory elements, and the suitability of 
different promoters has led to the controllable overproduction of antibiotics.
The question pertinent to our interests is, at what point, following manipulation of these 
pathways does the provision of precursor molecules from intermediary metabolism become 
rate-limiting for the production of antibiotics ?
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1.10 .4 The shikimate pathway as a source of antibiotic precursors
As will have become apparent from the preceding sections, a wealth of information has 
been obtained regarding the intermediates, the genes, and the enzymes of various antibiotic 
pathways.
Three chemical structures predominate as precursors for commercially important 
antibiotics, however little or no basic work has been carried out on the pathways of central 
metabolism which furnish these structures. The paradox of the role of the shikimate 
pathway in particular deserves closer scrutiny. It has been shown (section 1.10.2) that a 
range of antibiotics including peptidolactones, polyenes, ansamycins and chloramphenicol, 
incorporate shikimate-derived precursors into antibiotic structures. During normal growth, 
the requirement for aromatic amino acids would not be regarded as a major metabolic route, 
considering the low abundance of such amino acids in most proteins, but following the 
cessation of growth and the initiation of aromatic-containing antibiotic production, an 
enormous metabolic load would be carried by the shikimate pathway.
How the pathway is regulated in these two strikingly different situations is of intrinsic as 
well as commercial interest In particular the nature of the regulation of D AHP synthase and 
its role, if any, in control of flux through the pathway needs to be investigated.
1.11 Aims of the project
DAHP synthase has been shown to be tightly regulated by feedback mechanisms, both at 
the level of intact protein and transcriptionally. It is the single most important site of 
regulation for the shikimate pathway. The shikimate pathway and DAHP synthase in 
particular, have not been extensively studied in S.coelicolor before. An understanding of 
the regulation of the pathway would be of interest in determining factors influencing
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provision of precursors for antibiotic biosynthesis. Although S.coelicolor itself does not 
produce aromatic containing antibiotics the principles learned could be applied to other 
organisms which do, alternatively the pathway for an aromatic antibiotic could be 
transferred to S.coelicolor.
The objectives of this work were therefore
(1) To purify and characterise DAHP synthase kinetically and physically.
(2) To investigate the possibility of isoenzyme forms.
(3) To determine the nature, if any, of feedback inhibition on these forms.
(4) To determine whether repression control was of importance.
(5) To obtain sequence data from intact DAHP synthase.
(6) To use these data to design oligonucleotide probes to facilitate the cloning of the enzyme 
gene by "reverse genetics".
(7) To obtain sequence data and carry out a comparison with other DAHP synthase 
sequences.
Outwith the immediate scope of this project, the intact gene could then be used as a tool to 
manipulate flux through the shikimate pathway during growth and antibiotic production in 
an appropriate streptomycete strain.
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Chapter 2 Materials and Methods
2.1 M aterials
2.1.1 Chemicals and biochemicals
Ampicillin, benzamidine, Bis-trispropane buffer, blue dextran, bromophenol blue, 
Coomassie brilliant blue, erythrose 4-phosphate, ethidium bromide, ficoll, MES buffer, 
shikimic acid, spermidine and TES buffer were obtained from Sigma Chemical Co., Poole, 
UK.
Bactotryptone, casamino acids, yeast extract and Bactotryptone (agar) were obtained from 
Difco, Detroit, USA.
ATP, DTT, NAD+, NADP+, NADPH, phosphoeno/pyruvate, phenylmethanesulphonyl 
fluoride (PMSF), N,N,N',N'- tetramethylethylene diamine (TEMED), and Tris buffer 
were obtained from Boehringer Mannheim, Lewes, UK.
Anthranilate, p-aminobenzoate, DMSO, phenylalanine, polyethylene glycol 8000, Triton 
X-100, tryptophan and tyrosine were obtained from BDH Chemicals, Poole, UK.
Agarose, isopropyl-B-D-thiogalactoside (IPTG), phenol (ultrapure), and 5-bromo-4- 
chloro-3-indoyl-B-galactoside (X-gal) were obtained from BRL, Gibco Ltd., Paisley, UK.
Acrylamide, bisacrylamide and SDS were obtained from FSA Laboratory Supplies, 
Loughborough, UK. Junlon PW110 was a gift from Honeywell and Stein Ltd., 
Wellington, UK.
Ammonium dehydroquinate was prepared following the procedure of Grewe and Haendler 
(1966) and was a gift from Professor J.R. Coggins. 3-Deoxy-D-araZ?mo-heptulosonate 7-
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phosphate (DAHP) was isolated from an aroB~ strain of E.coli (AB2847A) and prepared 
following the procedure of Lambert et al.,(1985), and was gift a from Professor J.R. 
Coggins.
[y_32p]_ ATP was obtained from Amersham International pic., Amersham, UK.
Oligonucleotides were synthesised on an Applied Biosystems Model 280A DNA 
synthesiser using phosphoramidite chemistry by Dr. V. Math.
All other chemicals were of analytical reagent grade and were obtained from one of the 
following suppliers: BDH Ltd., Poole, U K ; Formachem Ltd., Strathaven, UK; FSA 
Laboratory supplies, Loughborough, UK; Koch-Light Ltd., Haverhill, UK.
2.1.2 Enzymes and proteins.
The following enzymes were obtained from Boehringer Mannheim, Lewes, UK.
rabbit muscle aldolase (EC 4.1.2.1.3) 
bovine erythrocyte carbonic anhydrase (EC 4.2.1.1) 
bovine pancreas deoxyribonuclease 1 (EC 3.1.4.5) 
beef liver glutamate dehydrogenase (EC 3.1.4.5) 
pig muscle lactate dehydrogenase (EC 1.1.1.27) 
pig heart malate dehydrogenase (EC 1.1.1.37) 
rabbit muscle pyruvate kinase (EC 2.7.1.40)
A kit for molecular weight determination and the following enzymes and proteins were 
obtained from Sigma Chemical Co., Poole,UK.
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Clostridium histotyticum clostripain (EC 3.4.22.8) 
rabbit muscle fructose 6-phosphate kinase (EC 2.7.1.11) 
chicken egg white lysozyme (EC 3.2.1.17) 
bovine pancreas ribonuclease A (EC 3.1.27.5) 
bovine pancreas trypsin (EC 3.4.21.4)
All restriction enzymes, T4 DNA ligase, and T4 Polynucleotide kinase were obtained from 
BRL, Gibco Ltd., Paisley, UK.
Dehydroquinate synthase, dehydroquinase and shikimate dehydrogenase were purified 
from overproducing plasmid E.coli strains by Mr. J. Greene as described by Mehdi et al., 
(1987), Chaudhuri et al., (1987a) and Chaudhuri et al., (1987b), respectively.
2 .1 .3  Chromatography media
DEAE-Sephacel, Phenyl-Sepharose CL-4B and Sephadex G-50 were supplied by 
Pharmacia, Milton Keynes, UK. Phosphocellulose Pll was obtained from Whatman 
Biochemicals, Maidstone, UK. Bio-Gel Hydroxylapatite was purchased from Bio-Rad 
Laboratories Ltd., Watford, UK.
2.1.4 Pre-packed media
Pre-packed Mono Q, phenyl-Superose, Superose 6 and Superose 12 columns were 
obtained from Pharmacia and utilised on a Phaimacia f.p.l.c. system. |i Bondapak C18 
reverse phase columns were purchased from Waters Chromatography, Watford, UK and 
attached to a Beckman System Gold h.p.l.c. apparatus ( Beckman Instruments Inc., High 
Wycombe, UK).
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2 .1.5 Bacterial strains, plasmids, phage and phage libraries
The bacterial strains are derivatives of E.coli K12.The bacterial strains used during this 
study are shown in Table 2.1. The plasmid pUC18 was obtained from Pharmacia. X 
c857s7 DNA was obtained from BRL, Gibco Ltd., Paisley, UK. This DNA was cleaved 
with appropriate restriction enzymes and the mixture of fragments generated used 
exclusively as molecular weight size markers, and is referred to henceforth as X-DNA.
The Streptomyces coelicolor genomic library was constructed using the XGEM-11 
replacement vector supplied by Promega Corporation, Madison, USA, by Mr. R.D. 
Taylor, Departments of Biochemistry and Genetics, University of Glasgow.
2.2 General methods
2.2.1 pH measurement
pH measurements were made with a Radiometer Model pH meter, using a combination 
electrode calibrated at room temperature.
2.2.2 Conductivity
Conductivity measurements were made at 4°C with a Radiometer Model CDM2e 
conductivity meter.
2.2.3 Protein estimation
Protein was determined by the method of Bradford (1976), with bovine serum albumin as 
standard.
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Table 2.1 Bacterial strains used in this study
Bacterial strain Relevant characteristics
Streptomyces coelicolor A(3)2
JI3456 SCP1NF, SCP2'
E.coli
DS941
NM621
recF lacl q /<7rZdcIM15 
supE thy+ recD
Source or reference
D.A. Hopwood 
(John Innes Institute)
Stirling et al., 1988 
Whittaker et a l 1988
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2.2.4 Spectrophotometric measurement of nucleic acid
Nucleic acid concentrations were determined spectrophotometrically at 260 nm (Sambrook 
et al., 1989). In a 1 cm path length an absorbance value of 1.0 corresponds to 50 |ig/ml for 
double stranded DNA and 20 jig/ml for oligonucleotides.
2.3 Polyacrylamide gel electrophoresis
Electrophoresis in the presence of SDS was performed by the method of Laemmli (1970), 
with a 3% stacking gel and a 10% running gel. Non-denaturing electrophoresis was carried 
out by the method of Davis (1964) in 7% tube gels. The ratio of acrylamide: bis-acrylamide 
in all PAGE experiments was 30:0.8 and polymerization was induced by 0.03% (v/v) 
TEMED and 0.05% (w/v) ammonium persulphate. After electrophoresis gels were stained 
for protein by either the Coomassie or silver nitrate method (section 2.3.1).
2.3.1 Protein staining
Protein was localised on gels either by staining with Coomassie blue or with silver nitrate. 
The Coomassie reagent was 0.1% Coomassie brilliant blue G250 in 10% (v/v) glacial 
acetic acid, 50% (v/v) methanol and destain reagent was 10% acetic acid, 10% methanol. 
These procedures were carried out at 40°C. The silver reagent was 0.8% (w/v) AgNC>3, 
0.08% (w/v) NaOH, in 200 mM-(NH4)OH. The developer reagent was 0.02% (v/v) 
formaldehyde, in 0.24 mM-sodium citrate. The method was adapted from Wray et al., 
(1981). Gels were first soaked in 50% (v/v) methanol for at least 8 hours, then incubated 
for 8 minutes in freshly prepared silver reagent. After washing with distilled H2O for one 
hour the gel was developed with fresh developer until protein bands appeared. The reaction 
was then terminated by washing with distilled H2O and the gels stored in 10% (v/v) acetic 
acid, 10% (v/v) methanol.
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2.4 Enzyme assays
Direct or coupled spectrophotometric assays were performed at 30°C in a total volume of 1 
ml (unless stated otherwise). Either a Gilford/Unicam model 252 or a Philips PU 8720 
uv/vis spectrophotometer was used.
2.4.1 S .c o e l ic o lo r  DAHP synthase
(a) Stopped assay
S.coelicolor DAHP synthase was assayed by a modification of the method of Doy and 
Brown (1965). DAHP was treated with periodate to give p-formylpyruvate which reacted 
with thiobarbiturate to give a pink chromagen with an absorption maximum at 549 nm 
(E549nm = 6.8 x 104 M’1 cm'l). The assay mixture contained 50 mM-Bistrispropane/HCl 
buffer pH 7.4,0.4 mM - phosphoe/io/pyruvate, 0.4 mM-erythrose 4-phosphate in a 
volume of 0.2  ml.
(b) Coupled continuous assay
DAHP synthase activity was measured by coupling the formation of DAHP to the oxidation 
of NADPH by the intervening three enzyme activities of the shikimate pathway. The assay 
cocktail contained 50 mM-Bistrispropane/HCl buffer pH 7.0,0.5 mM- 
phosphoeno/pyruvate, 1.0 mM-erythrose 4-phosphate, 0.1 mM-NADPH, 10 pM-NAD+, 
0.1 units of E.coli dehydroquinate synthase, 0.05 units of E.coli dehydroquinase and 
0.05 units of E.coli shikimate dehydrogenase. The activity of individual coupling enzymes 
was measured under standard conditions (section 2.4.2). The oxidation of NADPH was 
monitored at 340 nm (E340nm = 6.18 x lO^M"* cm" )^.
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(c) Direct continuous assay
The method of Schoner and Herrmann (1976) is based on the absorbancy difference at 232 
nm between phosphoentf/pyruvate (E = 2.8 x 103 M-lcm-1) and DAHP (E = 4.15 x 102 
M'lcm-1). DAHP synthase activity was measured directly as phosphoe/w/pyruvate was 
depleted. The standard assay mixture contained 50 mM-Bistrispropane/HCl buffer, pH 
7.0,0.5 mM-phosphoe/10/pyruvate, 1.0 mM-erythrose 4-phosphate.
2.4.2 Coupling Enzymes
(a) Dehydroquinate synthase
DHQ synthase activity was measured by coupling the release of DHQ to the 3- 
dehydroquinase reaction (Lambert et al., 1985). The assays contained 50 mM-potassium 
phosphate buffer, pH 7.0, 40 p,M-NAD+, 0.2 mM-DAHP, 0.2 mM-CoCl2 , and 0.05 
units of E.coli 3-dehydroquinase. The formation of 3-dehydroshikimate was monitored at 
234 nm (E234 nm = 1-2 x 104 M-l cm-1).
(b) 3-Dehydroquinase
3 -Dehydroquinase activity was assayed by the direct measurement of 3-dehydroshikimate 
formation at 234 nm. The assays contained 100 pM-DHQ in 50 mM-potassium phosphate 
buffer, pH 7.0.
(c) Shikimate dehydrogenase
Shikimate dehydrogenase was measured in the reverse direction by monitoring the 
reduction of NADP+ at 340 nm. The assay mixture comprised 100 mM-Na2CQ3 buffer,
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pH 10.6,4 mM-shikimate, and 2 mM-NADP+.
2.5 Growth of S.coelicolor
2.5.1 Spores
(a) Preparation of pre-germinated spores
Spores were prepared and pre-germinated following the procedure given below which is 
adapted from Hopwood et a/.,(1985). The inoculum used originated from a single frozen 
spore stock culture. Spores were grown on slopes of sporulation agar (2% (w/v) mannitol, 
2% (w/v) soya bean meal flour, 1.6% (w/v) agar) and incubated for 10 days at 30°C. The 
spores were then harvested from the plates (5 ml distilled H2O per slope), filtered through 
cotton wool and pelleted by centrifugation (Centrax, 2500 ipm, 10 minutes). The pellet was 
resuspended in 5 ml of 50 mM-TES buffer/KOH pH 8 and incubated for 10 minutes at 
50°C. The suspension was cooled, then 5 ml of pre-germination medium (1% (w/v) Yeast 
extract, 1% (w/v) Casamino acids, 0.01 M-CaCl2) and 20 pi 5 M-CaCl2 was added and the 
mixture incubated at 37°C for 3 hours with agitation. The spore suspension was then 
harvested as before and washed twice with 5 ml distilled H2O. The spore pellet was finally 
resuspended in 5 ml of 40% (v/v) glycerol and stored at -20°C. The spore count was then 
determined (section 2.5.1 (c)).
(b) Preparation of fresh spores
Spores were prepared and freshly used following the procedure of Hobbs et al., (1989). A 
single slope was prepared as before (section 2.5.1 (a)) and used to inoculate several plates 
of sporulation agar which were incubated as before (2.5.1 (a)). Distilled water (5 ml) was 
added to each plate and the surface gently scraped to release the spores. Suspensions were
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harvested by centrifugation and washed twice with distilled watter. Before use as inocula, 
the spores were adjusted to a final concentration of 2 x 10^ spores/ml (section 2.5.1(c)).
(c) Spore counts
Colony forming units were determined by plating suitably diluted spore samples on 
mannitol/soya agar plates. Counts were made after incubation at 30°C for 5 days.
2.5.2 Cell growth
Cultures were grown in either 2 litre conical flasks containing 400 ml of medium at 30°C 
on an orbital shaker at 200 rpm or 10 litre flasks containing 4 litres on a magnetic stirrer. 
Flasks were inoculated with 2.5 x 105 spores/ml media and cells harvested 72 hours later 
following centrifugation (20 minutes 5,000 rpm, Beckman 6L centrifuge). Cells grown on 
minimal media (section 2.6.2) were iesuspended in extraction buffer (100 mM-potassium 
phosphate pH 7,0.4 mM-DTT, 1.2 mM-PMSF, 3.5 mM-benzamidine) and the cells lysed 
by French Pressing. Cells grown on YEME (section 2.6.1) were resuspended and washed 
twice in 1/lOth culture volume distilled H2O prior to resuspension in extraction buffer.
2.5.3. Cell breakage
Cell pellets were resuspended in ice-cold extraction buffer (1 ml buffer/4g wet weight of 
cells) and broken by two passages through an automatic French pressure cell at 98 mpa (14 
300 psi internal pressure). The cell was pie-cooled on ice before use (cat. no. 4-3398A, 
American Instruments Company, Maryland, U.S.A.).
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2.6 Growth media
Unless otherwise stated all media were sterilised by autoclaving at 15 psi.
2.6.1 Rich media
The rich media used for growth of microorganisms during the course of this project are 
listed below
Medium Composition (per litre)
L-broth (LB)
10 g bactotryptone 
5 g yeast extract 
lOgNaCl
(+ 5 ml 20% (w/v) glucose)
L-agar
X phage top agarose
as LB, +15 g agar
as LB, + 7 g agarose
2 x YT 16 g bactotryptone 
10 g yeast extract 
5 g NaCl
YEME 16g malt extract 
lOg bacto-yeast extract 
5g NaCl
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Sporulation agar 20 g mannitol 
20 g soya bean flour 
16 g agar
2.6.2 Minimal media
The minimal media used for S.coelicolor growth was developed by Hobbs et al.,(1989) 
and contained per litre of distilled water:
4 g glucose
4.5 g NaNo3
5g NaCl
5g Na2SC>4
1 g MgS04.6H20
0.5 g CaCl2
O.Olg ZnS04
1-2 g Tris buffer
1 g Junlon
20 g KH2P04 pH 7.2
The pH of the mixture was adjusted to pH 7 with NaOH prior to autoclaving at 5 psi for 50 
minutes. The phosphate was autoclaved separately and added prior to inoculation. To this 
was added 1 ml of a filter sterilized trace salts solution containing per litre :-2.04g ZnCl2 , 
1.015g MnCl2.4H20,0.310g H3BO3, 0.425g CuCl2.2H20,0.242g Na2Mo0 4 .2H2 0 , 
0.238g CaCl2.6H20, 8.775g FeCl3 and 0.415g Nal.
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2.6.3 Selection supplements
The following supplements were added to rich media to select and identify recombinant 
organisms.
(a) antibiotics
Ampicillin (Amp) was used at a final concentration of 50 ng/ml. A stock solution of 25 
mg/ml was filter sterilised and stored at -20°C. Hot L-agar was cooled to 55°C before 
ampicillin was added. L- Amp plates were stable for at least 4 weeks if stored at 4°C.
(b) chromogenic substrates
X-gal and IPTG were used at a final concentration of 20 ng/ml. A stock solution of IPTG 
of 20 mg/ml was filter sterilised and stored at -20°C. A stock solution of X-gal (20 mg/ml) 
was made up in DMSO and stored at -20°C.
2.7 Protein sequencing and composition analysis
2.7.1 Acid-washed glassware
Glassware for protein chemistry was heated for 1 hour in 6N HC1 or 6N HNO3 then left 
steeping overnight. It was then rinsed exhaustively with distilled water and dried in a hot 
oven.
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2.7.2 Preparation of peptides from S.coelicolor DAHP synthase
(a) Digestion with clostripain
A 16 nmol sample of the S.coelicolor DAHP synthase was digested with clostripain 
following the protocol of Mitchell and Harrington (1971). Clostripain was first activated by 
pre-incubation in 1 mM-calcium acetate/ 2 mM-DTT overnight at 40C. The digestion was 
carried out in 75 mM-sodium phosphate buffer pH 7.6,7.5 mM-DTT at a final protein 
concentration of 0.5 mg/ml. The previously activated clostripain was added to give a 
protein/protease ratio of 50:1 (w/w). The digest proceeded for 1 hour at room temperature 
and for a further 4 hours at 370C. The reaction was terminated by freezing, then the sample 
was lyophilized. The resulting peptides were purified by reverse-phase chromatography on 
a Waters p Bondapak C18 column.
(b) Digestion with trypsin
A 10 nmol sample of S.coelicolor DAHP synthase was digested with trypsin in 0.5%
(w/v) (NH4)HC03 pH 8.5 at a final protein concentration of 1 mg/ml. Trypsin was added 
to give a protein/protease ratio 50:1 (w/w). The digest proceeded for 3 hours at 37<>C by 
which time it appeared to have gone to completion. The reaction was terminated and 
peptides purified (section 2.7.2(a)).
2.7.3 Gas-phase sequencing
iV-terminal amino acid sequencing of intact S.coelicolor DAHP synthase was carried out 
using an Applied Biosystems model 470 protein sequencer with on-line detection of amino 
acid thiohydantoins by a model 120A analyser as described by White et al., (1990). The 
machine was operated by Mrs. J. Young of ICI Pharmaceuticals, Macclesfield, UK.
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2.7.4 Liquid-phase sequencing
Purified peptides of S.coelicolor DAHP synthase and a second sample of intact protein 
were sequenced on an Applied Biosystems model 4774 pulsed liquid phase sequencer with 
on-line detection of amino acid thiohydantoins by a model 120A analyser. The instrument 
was operated by Drs. M. Cusack and G.B. Curry, Department of Geology, University of 
Glasgow.
2.7.5 Solid-phase sequencing
Sequences of clostripain peptides of S.coelicolor DAHP synthase were determined on a 
Milligen 6600 Prosequencer with on-line h.p.l.c.. Peptides were covalently attached to 
Sequelon-DITC membrane discs, as described previously (Chalmers et a l ., 1991). This 
facility was operated by Dr. J.N. Keen, Department of Biochemistry, University of Leeds.
2.7.6 Amino acid composition analysis
Amino acid compositions were determined by Mrs. J.Young (ICI Pharmaceuticals, 
Macclesfield, UK) using either an Applied Biosystems Model 420 amino acid analyser or 
an LKB 4151 series 2 amino acid analyser. For the former, norleucine was included as an 
internal standard, the sample was automatically acid hydrolysed and converted to PITC 
amino acid derivatives which were analysed following reverse phase chromatography. For 
the latter, norleucine was also included as the internal standard, the sample was manually 
hydrolysed (6N HC1 containing phenol for 24 hours at 115°C), and amino acids separated 
by ion exchange chromatography and detected colorimetrically after reaction with 
ninhydrin.
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2.8 Molecular weight determinations
Standard molecular weight proteins were chosen from the list of proteins given in section 
2 .1.2 .
2.8.1 Subunit Mr
SDS PAGE was used to estimate the subunit Mr of the purified protein. Two mixtures of 
proteins were used to calculate subunit Mr, either a Sigma Chemical Co. molecular weight 
marker kit or a home-made kit The proteins used to produce standard curves of Rf against 
log Mr are listed below, those proteins contained in the Sigma kit are indicated by an 
asterix.
Protein Subunit Mr
rabbit muscle myosin * 205 000
E.coli p-galactosidase * 116000
rabbit muscle phosphorylase b * 97 400
rabbit muscle fructose 6-phosphate kinase 84000
bovine albumin * 66000
bovine liver glutamate dehydrogenase 53 000
egg albumin * 45 000
rabbit muscle aldolase 40 000
bovine erythrocyte carbonic anhydrase * 29 000
Values for subunit molecular weights were taken from Weber and Osborn (1969) and 
Mousedale et a/.,(1987).
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2.8.2 Native M r
Gel permeation chromatography on a Superose 12 column was used to estimate the native 
Mr of the purified protein. This was carried out at room temperature using a Pharmacia 
f.p.l.c. apparatus. The column was eluted with 50 mM-potassium phosphate pH 7,0.4 
mM-DTT (flow rate = 0.3 ml/min, fraction size 0.3 ml). The eluate was monitored at 280 
nm and the column calibrated with the following proteins
Protein
pig heart malate dehydrogenase 
pig muscle lactate dehydrogenase 
rabbit muscle aldolase 
rabbit muscle pyruvate kinase 
horse apoferritin
2.9 Preparation of S.coelicolor genomic
Total DNA of S.coelicolor JI3456 was prepared by Mrs. M. Stone and Ms. A. Wylie 
(Department of Genetics, University of Glasgow) essentially as described by Hopwood et 
al., (1985).
2.10 Small scale preparation of plasmid DNA
The method of Holmes and Quigley (1981) was used for small scale plasmid preparations.
1.5 ml of an overnight culture was harvested in a microfuge and the cell pellet resuspended 
in 350 pi of lysis buffer (50 mM-Tris/HCl pH 8.0,50 mM-EDTA, 8% (w/v) sucrose, 
0.5% (v/v) Triton X-100). Lysozyme was added (25 pi of a 10 mg/ml solution) and the 
mixture boiled for 45 seconds followed by centrifugation in a microfuge. The pellet was
Native Mr 
70,000 
140 000) 
160 000 
232 000 
440 000
DNA
66
removed using a toothpick and discarded. Plasmid DNA was precipitated by addition of 
l/10th volume of 3M-sodium acetate and an equal volume of isopropanol. After chilling at - 
20°C for 30 minutes, plasmid DNA was recovered by centrifugation (10 minutes). The 
plasmid DNA pellet was resuspended in 25 |il TE (10 mM-Tris/HCl pH 7.6,2mM-EDTA). 
A 2 pi aliquot was sufficient for a single restriction enzyme digest
2.11 Isolation of bacteriophage X DNA
2.11.1 Determination of phage titre
(a) Preparation of plating bacteria
50 ml of L-broth with 0.2% (w/v) maltose, 20 mM-MgS04 was inoculated with a single 
colony of the appropriate E.coli strain e.g. NM621, and grown overnight on an orbital 
shaker. The cells were pelleted by centrifugation (MSE18 7,000 rpm, 5 minutes, 4°C ) and 
resuspended in 0.5 volumes of sterile, ice cold 10 mM-MgS04. The cell suspension was 
diluted if the OD 600 was greater than 2 i.e. 1.6 x 109 cells/ml. The cells were stored at 4oC 
and remained viable for at least 3 weeks.
(b) Plating the phage
Serial 10-fold dilutions of X phage stock were prepared in phage buffer (10 mM-Tris HC1 
pH 7.5,10 mM-MgS04). Bacteriophage X infection was achieved by adding 100 |il aliquots 
of each dilution to 100 pi 0-5 x 108 cells) of plating bacteria suspension. The samples were 
incubated at 37°C for 20 minutes. 3 ml of X phage top agarose at a temperature of 45©C 
was added and the mixture was poured onto plates containing X phage bottom agar. The 
plates were left to stand for 5 minutes at room temperature to allow the top agarose to 
harden and then incubated at 37°C overnight. The plaques were counted and the titre
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determined for each dilution assayed.
2.11.2 Isolation of a single plaque
X phage were plated out at low density eg. 100-200 plaques per 10cm square plate (see 
section 2.11.1). A single plaque (which may have been identified by screening procedures, 
see section 2.21) was stabbed out of the plate into 1 ml phage buffer. 70 pi of DMSO was 
added to kill any cells. After two hours incubation at room remperature the bacteriophage 
particles have diffused out of the agar. An average plaque yields 10^-10^ infectious 
bacteriophage particles, which can be stored indefinitely at 4°C in phage buffer/DMSO 
without loss of viability.
2.11.3 Preparation of X phage plate lysates
Approximately 1.6 x 10$ cells, of prepared bacterial suspension were infected with 105 
plaque forming units (pfu) and plated out as described in 2.11.1. Plates were incubated 
overnight or until the plaques touched one another. 3 ml of phage buffer was added to the 
resulting lysates and plates agitated gently at room temperature for 2 hours. The phage 
buffer was transferred to microfuge tubes, centrifuged to remove bacterial debris and the 
supernatant retained. To the supernatants, 10 pi of 1 mg/ml DNase 1 and 10 pi of 10 
mg/ml RNase A was added and this was incubated at 37 °C for 1 hour. 70 pi of DMSO per 
1 ml phage buffer was added to the X phage lysates and they were stored at 40C. These 
lysates acted as phage stocks for storage or for use in the isolation of X phage DNA.
2.11.4 DNA Preparation from X phage lysates
An equal volume of 20% (w/v) PEG 8000,2M-NaCl in phage buffer was added to one 
volume of X phage lysate (see 2.11.3) and incubated for 1 hour at CK>C. The precipitated
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phage particles were recovered by centrifugation in a microfuge (10 minutes, 40Q and the 
supernatant discarded. The pellet was resuspended in 5 pi of 10% (w/v) SDS and 
incubated for 5 minutes at 68°C. 10 pi of 5M-NaCl was added to the mixture which was 
then extracted once with an equal volume of phenol:chloroform (see 2.14.1) then extracted 
once with chloroform alone. An equal volume of isopropanol was added to the retained 
aquaeous phase and following incubation at -70°C for 15 minutes the X phage DNA was 
recovered by centrifugation in a microfuge 05 minutes, 40Q. The DNA pellet was then 
washed with 70% (v/v) ethanol, allowed to air dry and dissolved in 50 pi of lxTE buffer. 
This DNA was suitable for restriction analysis, Southern blotting, and sub-cloning.
2.12 Digestion of DNA with restriction enzymes
The methods used were as described in Sambrook et al., (1989). Restriction digests were 
carried out using the BRL React buffers which were provided with each batch of enzyme. 
There are ten different React buffers with a range of salt concentrations, each one suitable 
for a range of enzymes. Analytical digests were carried out in a volume of 10 or 20 pi at 
370C. Preparative digests were carried out in larger volumes. When DNA was digested 
with two restriction enzymes, the endonuclease requiring the lower salt buffer was used 
first After the recommended duration of digestion the salt concentration was adjusted and 
the second enzyme added.
2.13 Agarose gel electrophoresis
DNA was separated at room temperature on horizontal submerged agarose gels as 
described by Sambrook et a/., (1989). The Tris-borate (TBE) and Tris-acetate (TAE) 
buffer systems were employed. A 0.8% (w/v) agarose gel was used to accurately size 
restriction fragments in the range of 0.8 -10 kb. Samples for agarose gels were prepared 
by addition of 0.2 volumes of 10 mM-Tris/HCl pH 7.2,20% (w/v) ficoll, 0.5% (w/v)
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bromophenol blue and 10 mg/ml ethidium bromide. Ethidium bromide (0.5 pg/ml) was 
added to both gel and buffer, and stained DNA bands visualised on a long wave U.V. 
transilluminator (U.V. Products Inc.). Restriction fragment markers of known size (Hind 
in  digested X DNA, section 2.1.5) were run alongside the unknown fragments.
2.14 Extraction and purification of DNA samples
2.14.1 Organic solvent extraction and ethanol precipitation
Protein was removed from DNA solutions by phenol/chloroform extraction. An equal 
volume of TE-saturated phenol/chloroform (1:1 v/v) was added to samples which were 
then mixed by vortexing and centrifuged in a microfuge for 5 minutes. The upper aqueous 
phase was removed to a fresh microfuge tube and the process repeated. Finally, traces of 
phenol were removed by extraction with an equal volume of chloroform in an identical 
manner. The final aqueous DNA pool was made 0.3 M-sodium acetate by adding 3M- 
sodium acetate and 2.5 volumes of ice-cold ethanol was added. The mixture was cooled at 
OoC overnight, -20OC for 1 hour, or -70OC for 15 minutes and the precipitated DNA 
recovered by centrifugation (12,000 rpm, 40C, 10 minutes) in a microfuge. DNA from 
electroelution and phage lysate preparations was further purified by chloroform 
/isoamylalcohol (24:1 v/v) extraction. This was carried out as for phenol/chloroform 
extraction.
2.14.2 Recovery of DNA from agarose gels by electroelution
The DNA band of interest was visualised by ethidium bromide staining and a hand-held 
long-wavelength ultraviolet lamp. The desired DNA band was excised, placed in a piece of 
dialysis tubing clipped at one end, 1 x TAE buffer added and the bag clipped to seal the gel 
slice. The gel slice was placed in a shallow layer of 1 x TAE in an electrophoresis tank. The 
DNA was electroeluted out of the gel and onto the inner wall of the bag by the applied
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electrophoretic voltage of 50 V over 2 to 3 hours, then the polarity of the current was 
reversed for 1 minute to release DNA from the wall of the bag. The DNA solution was 
transferred from the dialysis bag to sterile Eppendorf tubes and extracted once with 
chloroform/isoamylalcohol (24:1 v/v) and then recovered by ethanol precipitation (see 
2.14.1.1). DNA purified in this way was sufficiently pure for cloning purposes.
2.15 Ligations
The insert DNA was digested with the appropriate restriction enzymes, purified, extracted 
with organic solvents and ethanol precipitated. Plasmid vector pUC18 DNA was supplied 
linearised by digestion with the appropriate restriction enzymes and treated with bacterial 
alkaline phosphatase to yield DNA ready to use. This treatment prevented self-ligation of 
the vector and facilitated a low-background of false positive clones.
For ligations reactions where the insert size was similar to the vector size an equal 
concentration of foreign DNA to vector DNA was employed. For those reactions where the 
insert size was much greater to the vector size, at least a four-fold excess in concentration 
of foreign DNA to vector DNA was typical. Depending on the size of insert, ligation 
mixtures contained 25 ng vector and between 25 to 400 ng insert in a final volume between 
5 to 10 pi.
Vector plus insert were pre-incubated at 45°C for 5 minutes to melt any cohesive termini 
that had reannealed. The ligations were performed overnight in 66 mM-Tris/HCl pH 7.6, 
6.6 mM-MgCl2,0.5 mM-ATP, 10 mM-DTT at 16°C using 0.5 Units (Weiss et al.t 1968) 
of bacteriophage T4 DNA ligase.
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2.16 Transformation o f E.coli with plasmid DNA
2.16.1 Preparation of competent cells.
A single colony of E.coli DS941 from a stock minimal media plate was used to inoculate 
10 ml of 2 x YT which was incubated overnight at 37°C. 0.3 ml of overnight culture was 
used to inoculate 30 ml of 2 x YT which was grown at 370C for around 2 hours to an OD 
at 600 nm of 0.4 - 0.6. The cells were cooled on ice for 10 minutes and gently harvested 
(Centrax, 4000 rpm, 10 minutes). When being prepared by the CaCl2 method (Cohen et 
a if 1972) the cells were resuspended in one half of the original culture volume of ice-cold, 
sterile 50 mM-CaCl2,10 mM-Tris/HCl pH 8 and placed in an ice bath for 15 minutes. 
Following centrifugation (Centrax, 4000 rpm, 10 minutes) the cells were resuspended in 
l/15th original culture volume 50 mM-CaCl2,10 mM-Tris/HCl pH 8 and mixed in the ratio 
3:1 culture to glycerol and cells dispensed into chilled microfuge tubes in 200-400 pi 
aliquots. These cells were stored at -70°C.
For high transformation efficiency cells, the following steps were carried out (Hanahan, 
1983). Cells were prepared and harvested as above but were then resuspended in 2.5 ml of 
ice cold TFB (10 mM-MES/KOH pH 6.3,100 mM-RbCl, 45 mM-MnCl2,10 mM-CoCl2, 
3 mM-hexaminecobaltic chloride) and incubated on ice for 15 minutes. Then, 100 pi of 
DMSO was added and the cells were incubated on ice for 5 minutes. Next 100 pi of 2.25 
M-DTT, 40 mM-potassium acetate pH 6.0 was added and the cells further incubated on ice 
for 10 minutes. Finally, 100 pi of DMSO was added, then the cells were kept on ice and 
used on the day of preparation.
2.16.2 Transformation of competent cells
i
Transformations were carried out in sterile 1.5 ml microfuge tubes. Ligation mix refers to
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any DNA being used in the transforming process and usually was a ligation mixture. An 
aliquot of ligation mix containing up to 25 ng plasmid DNA was added to 100 |il aliquots 
of competent cells and the mixture was incubated on ice for at least 30 minutes. The 
DNA/cell mix was then heat shocked at 42°C for 2 minutes. 1 ml of L-broth was added to 
the tubes and they were incubated without shaking at 370C for 1 hour. The cells were then 
plated onto an appropriately prepared antibiotic/chromogenic containing LB plates and 
incubated overnight at 37oC.
2.16.3 Selection of pUC derived recombinant clones
The pUC plasmids have been constructed as cloning vectors using P-galactosidase activity 
as the basis of selection (Messing, 1983 ; Norrander et al., 1983 ; Yanisch-Perron et al., 
1985). The vector carries a segment of E.coli DNA that contains the regulatory sequences 
and the coding information for the first 146 amino acids of the p-galactosidase gene 
(lacZ). Vectors of this type are used in host cells (e.g. E.coli, DS941) that code for the 
carboxy-terminal portion of p-galactosidase, therefore though neither the host-encoded nor 
the plasmid-encoded fragments are themselves active, they can associate to form active 
enzyme. A polycloning site has been inserted, in-frame, within the coding region of the 
plasmid which does not affect the complementation, however insertion of additional DNA 
into the polycloning site generally destroys the complementation. Active p-galactosidase 
cleaves the chromogenic substrate X-Gal to produce a blue chromophore, when 
transformed cells are grown in the presence of the non-metabolizaable lac operon inducer 
IPTG. However in recombinant plasmids the ability for complementation is lost, the 
enzyme is inactive, and consequently the colonies appear white. False positive white 
colonies appear at low frequency, probably due to incorrect self-ligation of the vector 
(Yanisch-Penron et al., 1985).
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2.17 DNA transfer to nylon membranes (Southern blotting)
This method is based on that of Southern (1975). After electrophoresis the agarose gel was 
placed in 250 ml of 0.25 M-HC1 and soaked for 15 minutes. This depurination step was 
omitted if the DNA fragments were less than 10 kb in size. The gel was then placed in 250 
ml of denaturing solution (1.5 M-NaCl, 0.5 M-NaOH) for 1 hour. The DNA was blotted 
onto a nylon (Hybond-N, Amersham) membrane using alkali transfer buffer (0.15 M- 
NaCl, 0.25 M-NaOH) overnight then the membrane was washed in 2 x SSC (SSC = 0.15 
M-NaCl, 15 mM-sodium citrate pH 7.3) as described in detail in Sambrook et al., (1989). 
The filters were then baked at 8(X>C for 2 hours.
2.18 32p labelling of DNA
2.18.1 Labelling the 5' terminus of oligonucleotides with
bacteriophage T4 polynucleotide kinase
Bacteriophage T4 polynucleotide kinase can catalyze the transfer to a free hydroxyl group 
of the y-phosphate group from ATP on the 5' terminus of DNA. In a total reaction volume 
of 10 (il the mixture contained: 8 pmoles of purified oligonucleotide, kinase buffer (50 
mM-Tris/HCl pH8,10 mM-MgCl2,5 mM-DTT, 1 mM-spermidine), 8 pmoles (Y"32p) 
ATP and 10 units of T4 polynucleotide kinase. The reaction was carried out at 37°C for 30 
minutes by which time it had gone to completion. Unincorporated label was removed using 
gel filtration (section 2.18.2).
2.18.2 Removal of unincorporated radionucleotide
Unincorporated label from end-labelling reactions was removed by gel filtration 
chromatography on a 20 x 1 cm Sephadex G-50 column. Sephadex G-50 was hydrated in
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1 x TE and poured columns equilibrated in 1 x TE. The reaction mixture was mixed with an 
equal volume of Blue Dextran dye in 1 x TE and loaded directly on top of the column. The 
radioactivity was monitored as it passed down the column and as it approached the bottom, 
fractions were collected manually. Labelled oligonucleotide was co-eluted first with the 
Blue Dextran dye, followed by a trough then a second peak of radioactivity corresponding 
to unincorporated label. The fractions containing the largest number of counts were pooled.
2.19 Hybridisation of filter bound nucleic acid
The temperature of hybridisation and the salt concentration and temperature of washing 
solutions was dependent on the particular experiment being carried out and precise details 
are given in the text Hybond-N filters were not pre-wetted, but were placed directly into a 
polythene bag containing prehybridisation solution (6 x SSC, 0.05% (w/v) sodium 
pyrophosphate, 200 |ig/ml heparin, 0.05% (w/v) SDS); the volume of prehybridisation 
fluid was determined by filter surface area x 0.2. The bag was placed in an agitating 
waterbath and the filter prehybridised for at least 4 hours at 60°C. After prehybridisation 
the bag was opened, two thirds of the fluid was removed and labelled oligonucleotide 
(section 2.18.1) was added. For colony hybridisation filters, fresh hybridisation fluid was 
used. The bag was resealed and the hybridisation carried out for at least 90 minutes in a 
shaking waterbath at the appropriate temperature.
The hybridised filters were washed in large volumes of buffer appropriate in ionic strength 
for different experimental conditions. The temperature of this buffer varied experimentally. 
After washing, the filters were autoradiographed damp (under Saran wrap) and exposed to 
Fuji RX film using intensifying screens at -70OC. Films were developed by a Kodak X- 
OMAT processor.
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2.20 Screening of plasmid clones by colony hybridisation
Recombinant pUC clones were screened using a modification of the method described by 
Nygaard and Hall (1963). Nylon filters (Hybond-N, Amersham) were placed on duplicate 
agar plates containing the selective antibiotic. Bacterial colonies were crossed onto a master 
plate (containing antibiotic) then onto the filter containing plates. The plates were inverted 
and grown overnight at 370C. Alignment marks were made on the filters. The filters were 
removed and placed colony side up on pad of absorbent filter paper soaked in denaturation 
solution (1.5 M-NaCl, 0.5 M-NaOH) and left for 7 minutes. The filters were then 
transferred, colony side up, to a pad of filter paper soaked in neutralising solution (1.5 M- 
NaCl, 0.5 M-Tris/HCl pH 7.2,1 mM-EDTA). They were left for 3 minutes then this step 
was repeated with a ftesh pad soaked in the same solution. The filters were then washed in 
2 x SSC, transferred to dry filter paper and allowed to air dry, colony side up. Finally, the 
filters were baked at 8(K>C for 2 hours. The filter was then hybridised with a nucleic acid 
probe (section 2.19).
2.21 Screening a phage X library
(a) First round screening
Cells from a prepared bacterial suspension were infected (section 2.11.1) with phage from 
the bacteriophage X library at a ratio of 104 pfu/108  cells. 2 x 10^ pfu were plated onto 10 
x 10 cm petri dishes using 8 ml of 0.65% (w/v) top agarose in LB. The plates were 
incubated overnight at 37°C. Up to six impressions could be taken from one plate onto 
nylon membranes, provided time was allowed for fresh phage to diffuse to the top agarose 
surface. Alignment marks were made on the plate and the filter was removed and treated as 
described for colony filters (section 2.20).
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(b) Secondary screening
Desired plaque regions or single plaques were isolated as described in section 2.11.2. A 
lawn of bacteria (108 cells) were plated onto a 9 mm circular petri dish and a loopful of 
phage particles was streaked onto the plate. The plates were then grown up overnight at 
370C. A dozen individual plaques from this plate were picked and crossed onto a 10 x 10 
cm square plate overlaid with bacteria then grown up overnight at 37oC. An impression 
was taken of the plate onto duplicate nylon filters which were prepared as before (section
2.21 (a)).
When identified by hybridisation and subsequent autoradiography a plug of positive phage 
was stabbed from the secondary plate and stored (section 2.11.2).
2.22 Computer programs for the analysis of DNA and protein 
sequences.
The University of Wisconsin Genetics Computer Group (UWCGC) package of programs 
(Devereux et al., 1984) mounted on the University of Glasgow VAX Cluster (VMS3), 
was used for the manipulation and comparison of DNA sequences. This package contains 
programs for the comparison of DNA sequences with those in GenBank and EMBL 
(European Molecular Biology Laboratory, Heidelberg, Germany) databases which were 
also mounted on VMS3.
2.22.1 UWCGC programs
WordSearch :-searches for similarity between a new sequence and any group of 
sequences.
Segments :-aligns and displays the segments of similarity found by WordSearch.
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BestFit :-Finds the best region of similarity between two sequences, and inserts gaps if 
necessary to obtain optimal alignment.
2 .23  Removal of radioactive probe and re-use of filters
Radiactive probe was removed by one of two methods listed in the Amersham booklet 
"Blotting and hybridisation protocols for Hybond membranes". Filters were either 
incubated at 45°C for 30 minutes in 0.4 M-NaOH then transfered to a neutralisation 
solution (0.1 x SSC; 0.1% (w/v) SDS ; 0.2 M-Tris/HCl pH 7.5) and incubated for a 
further 15 minutes at 45°C. Alternatively, a boiling solution of 0.1% (w/v) SDS was 
poured over the filters and then the filters incubated at room temperature until the mixture 
cooled. The filters were then autoradiographed to check that the probe had been removed. 
The filter can then be pre-hybridized and hybridized with a new probe.
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Chapter 3 The purification and characterisation of 
the Streptomyces coelicolor DAHP synthase
Addendum
Prior to the development of the purification procedures, preliminary experiments were 
carried out in order to identify conditions of pH and buffer which were most suitable for 
the maintenance of S.coelicolor DAHP synthase activity. These experiments are described 
in section 3.10.2 (page 108) and the data displayed in Table 3.5.
3.1 Introduction
The purification of DAHP synthase from a wide variety of sources has been hindered by 
the low levels of activity found, the inconvenient and lengthy stopped assay procedure 
usually employed, and the instability of the enzyme in some organisms.
This chapter describes the development of both small and large scale purification 
procedures which yield electrophoretically homogeneous enzyme. Other purification 
procedures which either failed or were only partially successful are also described. 
Structural, kinetic and catalytic properties of the purified enzyme are also described.
3.2 Small scale purification procedure
Unless otherwise stated all manipulations following cell breakage were executed at 4°C. 
The buffers used in this procedure are listed (Table 3.1).
Step 1: Extraction and centrifugation
A 70 g batch (wet weight) of S.coelicolor cells was suspended in 20 ml 100 mM- 
potassium phosphate buffer, pH 7.0, containing 1.2 mM-PMSF, 3.5 mM-benzamidine and
0.4 mM-DTT (buffer A) and broken by two passages through a French pressure cell. This 
material was then centrifuged at 100 000 g for 1 hour. DAHP synthase was purified from 
the resulting cell-free extract.
Step 2 : Salt fractionation with (NH4)2S04
The crude extract was diluted to give a protein concentration of 10 mg/ml and solid 
(NH4)2S04 added to give 35% saturation (209 g/1). The mixture was stirred for 20 
minutes and the precipitated proteins removed by centrifugation at 28 000 g for 20 minutes.
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The supernatant was adjusted to 65% saturation with solid (NH4)2S04 (199 g/1) and 
stirred for 20 minutes. The precipitated protein was collected by centrifugation at 28 000 g 
for 20 minutes and resuspended in 15 ml of 50 mM-potassium phosphate buffer, pH 7,1.2 
mM-PMSF, 3.5 mM-benzamidine and 0.4 mM-DTT (buffer B) and dialysed overnight 
against 2 litres of buffer B. The distribution of enzyme activity in (NH4)2S04 fractions is 
illustrated in Table 3.2.
Steps 3,4 and 5 were carried out at room temperature using a Pharamacia f.p.l.c. system. 
Step 3 : Anion-exchange chromatography on Mono Q
The dialysed material was loaded onto a preparative Mono Q anion-exchange column 
(volume 8 ml) equilibrated in buffer B. The column was washed with buffer until the A280 
of the eluate had returned to the base-line value. Protein was eluted from the column with 
an 80 ml gradient of 0-0.5 M-Na2SC>4 in buffer B, flow rate 4 ml/minute. Fractions (2 ml) 
were collected, assayed for DAHP synthase and those containing the highest activity were 
retained (Figure 3.1).
Step 4 : Hydrophobic-interaction chromatography on phenyl-Superose
Retained fractions were made 1 M-(NH4)2S0 4  by the addition of solid (NH4)2S0 4  and 
applied to a phenyl-Superose hydrophobic-interaction column (volume 1 ml) equilibrated in 
50 mM-potassium phosphate buffer, pH 7,1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 
mM-DTT and 0.9 M-(NH4)2S04 (buffer C). After the A280 value of the eluate had 
returned to the pre-loading value a 0.9 to 0 M-(NH4)2S04 gradient was run in a volume of 
15 ml. The column was washed at 0.5 ml/min. and 0.5 ml fractions collected. After 
assaying for DAHP synthase activity, appropriate fractions were retained (Figure 3.2). 
These fractions were either dialysed against 500 ml of 215 mM-sodium phosphate buffer, 
pH 6.7,0.4 mM-DTT (buffer D) or desalted into buffer D using a Pharmacia f.p.l.c. 
desalting column (G - 50).
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Table 3.1 Buffers
The buffers used in this Chapter are listed below.
buffer A 100 mM-potassium phosphate, pH 7.0,1.2 mM-PMSF, 3.5 mM-
benzamidine, 0.4 mM-DTT
buffer B 50 mM-potassium phosphate, pH 7.0,1.2 mM-PMSF, 3.5 mM-
benzamidine, 0.4 mM-DTT
buffer C as buffer B, plus 0.9 M-(NH4)2S04
buffer D 215 mM-sodium phosphate, pH 6.7, 0.4 mM-DTT
buffer E 10 mM-potassium phosphate, pH 6.5,1.2 mM-PMSF, 3.5 mM-
benzamidine, 0.4 mM-DTT
buffer F 200 mM-potassium phosphate, pH 6.5,1.2 mM-PMSF, 3.5 mM-
benzamidine, 0.4 mM-DTT
buffer G 25 mM-sodium phosphate, pH 6.5,1.2 mM-PMSF, 3.5 mM-
benzamidine, 0.4 mM-DTT
buffer H 50 mM-potassium phosphate, pH 7.0,0.4 mM-DTT, 40% (v/v) glycerol
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Step 5 : Anion-exchange chromatography on Mono Q
The partially purified material was loaded onto an analytical Mono Q anion-exchange 
column (volume 1 ml) equilibrated in buffer D. Following washing with buffer D, protein 
was eluted with a 30 ml linear gradient of 215-320 mM-sodium phosphate (Figure 3.3). 
The flow rate was 1 ml/min. and 0.5 ml fractions were collected. Fractions containing the 
peak of DAHP synthase activity were pooled and dialysed against 50 mM-potassium 
phosphate buffer, pH 7,0.4 mM-DTT, 40% (v/v) glycerol (buffer H) for long term storage 
at -20OC.
3.3 Summary of the purification procedure
A summary of a typical purification scheme is shown in Table 3.3.
3.4 Purity of the S .c o e l ic o lo r  DAHP synthase
The S.coelicolor DAHP synthase was shown to be electrophoretically homogeneous under 
both denaturing and non-denaturing conditions. Non-denaturing PAGE of the purified 
enzyme showed a single band of protein upon silver staining (Figure 3.4). Both 10% and 
15% SDS gels of the purified enzyme also showed a single protein species when silver 
stained (Figure 3.5 : Figure 3.6).
3.5 Large scale purification procedure
Unless indicated to the contrary, all procedures were carried out at 4<>C after cell 
breakage.The buffers used in this procedure are listed (Table 3.1).
Step 1 : Extraction and centrifugation
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Table 3.2 Distribution of DAHP synthase activity in (NH4)2S04  
fractions
Enzyme was prepared as described in section 3.2 from 16g (wet weight) of S.coelicolor 
cells.
Fraction Protein Total Activity Specific Activity
(mg) (mU) (mU/mg)
Crude 136.5 445 3.3
0-30% 17.7 2.3 0.1
30-45% 20.7 87.6 4.2
45-65% 27.9 387 13.9
65-80% 2.7 2.3 0.8
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Figure 3.1 Chromatography on Mono Q
Enzyme from (NH4)2SC>4 fractionation was loaded on to a preparative Mono Q column 
and eluted with a sulphate gradient, as described in section 3.2.
( — ) A280 ( A) DAHP synthase activity (—) Na2SC>4 gradient
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Figure 3.2 Chrom atography on Phenyl-Superose
Enzyme from chromatography on Mono Q (preparative column) or chromatography on 
Phenyl Sepharose was loaded on to a Phenyl Superose column and eluted with a 
decreasing salt gradient as described in sections 3.2,3.5.
( — ) A2go ( A ) DAHP synthase activity (—) (NH4)2S04
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Figure 3.3 Chromatography on Mono Q
Material from chromatography on Phenyl Superose was loaded on to an analytical Mono 
Q column and eluted with a phosphate gradient as described in section 3.2.
( — ) A2gQ ( A ) DAHP synthase activity (—) phosphate gradient
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Table 3.3 Small scale purification of S.coelicolor DAHP synthase
The results presented are for a typical purification starting from 70g of S.coelicolor cells 
(section 3.2).
Step Total
Protein 
(mg)
1. Crude 727
2. (NH4)2S04 224 
fractionation
3. Mono Q 12 
chromatography
4. Phenyl Superose 0.4 
chromatography
5. Mono Q 0.075 
chromatography
Total Specific
Activity Activity
(mU) (mU/mg)
2058 3.0
1474 6.6
845 68.4
532 1301
200 2673
Yield Purification 
(%) (Fold)
100 1
72 2
40 25
26 460
10 810
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rFigure 3.4 Native tube gel electrophoresis of S.coelicolor 
DAHP synthase
A 1% gel was run as described in section 2.3 and stained for protein by the silver 
nitrate method as described in section 2.3.1. Material eluted from the final chromatographic 
step (section 3.2) containing DAHP synthase activity was loaded onto the gel.
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Figure 3.5 SDS PAGE of S.coelicolor DAHP synthase
A 10% Laemmli gel was run under denaturing conditions as described in section 2.3 and 
stained for protein using silver nitrate as described in section 2.3.1.
Lane A : Mr markers ; myosin, p-galactosidase, pnosphorylase b, BSA, ovalbumin, carbonic 
anhydrase (section 2.8.1).
Lanes B-F : material eluted from the final chromatographic column (section 3.2) containing 
DAHP synthase activity (Figure 3.3).
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Figure 3.6 SDS PAGE of S.coelicolor DAHP synthase
A 15% Laemmli gel was run under denaturing conditions as described in section 2.3 and 
stained for protein using silver nitrate as described in section 2.3.1.
Lane A : Mr markers ; myosin, p-galactosidase, phosphorylase b, BSA, ovalbumin, carbonic 
anhydrase (section 2.8.1).
Lanes B-D: material eluted from the final chromatographic column (section 3.2) containing 
DAHP synthase activity (Figure 3.3).
A 200 g batch (wet weight) of S.coelicolor cells was suspended, broken and a cell-free 
extract obtained as above (section 3.2).
Step 2 : Fractionation with (NH4)2SC>4
The 35-65% (NH4)2S04 fraction was obtained as described in section 3.2. The 
precipitated protein was redissolved in 15 ml buffer B and dialysed overnight against 2 x 2  
litres of buffer B.
Step 3 : DEAE-Sephacel chromatography
The dialysed material was loaded onto a column of DEAE-Sephacel (bed volume 50 ml) 
equilibrated in buffer B. The column was washed with five column volumes of buffer B, 
by which time the A280 of the eluate was zero. The column was then eluted with a 400 ml 
linear gradient of 0-0.5 M-Na2S04 in buffer B at a flow rate of 100 ml/hr. Fractions (10 
ml) containing high DAHP synthase activity were pooled for the next step and made to 1 M 
in (NH4)2S04 (Figure 3.7).
Step 4 : Phenyl-Sepharose chromatography
The sample was loaded onto a phenyl-Sepharose column (20 ml bed volume) pre­
equilibrated with buffer C. The column was washed with five column volumes of buffer C 
after which the A280 of the eluate was less than 0.1. A descending gradient of 0.9-0 M- 
(NH4)2S04 in a volume of 300 ml was run at a flow rate of 30 ml/hr and 5 ml fractions 
were collected. Fractions containing enzyme activity were pooled and made 1M- 
(NH4)2S04 (Figure 3.8).
Steps 5 and 6 were carried out at room temperature using a Pharmacia f.p.l.c. system 
(Figure 3.2).
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Figure 3.7 Chromatography on DEAE-Sephacel
Material from the (NH4)2S04 fractionation was loaded onto a DEAE-Sephacel column 
and eluted with a sulphate gradient as described in section 3.5.
C— ) ^280 ( A ) DAHP synthase activity (—) sulphate gradient
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Step 5 : Phenyl-Superose chromatography
This step was carried out as above (section 3.2).
Step 6 : Anion-exchange chromatography on Mono Q.
This was carried out as above (section 3.2) (Figure 3.9).
3.6 Summary of the purification procedure
The results obtained from a purification procedure on this scale are shown on Table 3.4.
3.7 Purity of the S .c o e lic o lo r  DAHP synthase
The S.coelicolor DAHP synthase was judged to be homogeneous by reverse phase 
h.p.l.c. (Figure 3.10) and electrophoretic analysis (Fig. 3.11).
3.8 Other attempted purification procedures
Following the optimisation of Step 4 (section 3.2) there remained six major polypeptide 
species in the highest activity pool (Fig. 3.12) and prior to the development of the final 
purification step (section 3.2 (step 5)) several alternative chromatographic procedures were 
investigated. The buffers used in these procedures are listed (Table 3.1).
3.8.1 Affinity chromatography
(a) Phosphocellulose
A sample of partially purified DAHP synthase from step 4 (section 3.2) was desalted into
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Figure 3.9 Chromatography on Mono Q
Enzyme from Phenyl-Superose was applied to an analytical Mono Q column and eluted 
with a phosphate gradient as described in section 3.5.
( — ) A2gQ ( A ) DAHP synthase activity (—) phosphate gradient
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Figure 3.10 Reverse phase h.p.I.c.
Enzyme from second Mono Q pool was loaded onto a Waters C18 reverse phase 
column and eluted with a gradient of acetonitrile/TFA, as described in section 3.7.
( — ) a 280
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Figure 3.11 SDS PAGE of S.coelicolor DAHP synthase
A 10% Laemmli gel was run under denaturing conditions as described in section 2.3 and 
Coomassie stained for protein as described in section 2.3.1. The size of the polypeptide species is 
indicated.
Lane A : Mr markers ; 7 )ig each of glutamate DH, aldolase and carbonic anhydrase (section 2.8.1). 
Lanes B-D : 5 pg of material from the peak DAHP synthase activity fractions as eluted from the 
final chromatographic column (section 3.5) (Figure 3.3).
Lane E : Mr markers ; 2 |ig each of myosin, P-galactosidase, phosphorylase b, BSA, 
ovalbumin, carbonic anhydrase (section 2.8.1).
97
Table 3.4 Large scale purification of S.coelicolor DAHP synthase
The results presented are for a typical purification starting from 200g of S.coelicolor cells 
(section 3.5).
Step Total Total Specific Yield Purification
Protein Activity Activity (%) (Fold)
(mg) (mU) (mU/mg)
1. Crude 1415 6868 4.9 100 1
2. (NH4)2S04 878 7731 8.8 113 1.8
fractionation
3. DEAE-Sephacel 149 2551 17.1 37 3.5
chromatography
4. Phenyl-Sepharose 24 459 19.0 6.7 3.9
chromatography
5. Phenyl-Superose 5 353 73.5 5.1 15
chromatography
6. MonoQ 1.2 172 143.3 2.5 33
chromatography
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Figure 3.12 Identification of polypeptide species in the 
Phenyl Superose pool
A 10% SDS PAGE gel was run as described in section 2.3 and stained for protein using the 
silver nitrate method (section 2.3.1). The size of the polypeptide species is indicated.
Lane A : Mr markers
Lanes B,C : Peak fractions of DAHP synthase activity following the Phenyl-Superose 
purification step (section 3.2)
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Figure 3.13 SDS PAGE analysis of hydroxylapatite and Mono S 
samples
A 10% SDS gel was run as described in section 2.3 and stained for protein by the silver 
nitrate method (section 2.3.1). The size of the identified polypeptides is indicated.
Lane A : Mr markers ; myosin, [3-galactosidase, phosphorylase b, BSA, ovalbumin, carbonic 
anhydrase (section 2.8.1).
Lanes B,C : peak activity hydroxylapatite fractions (section 3.8.1 (a))
Lanes D,E : flow through from Mono S column (section 3.8.3)
1 0 0
10 mM-potassium phosphate buffer, pH 6.5,1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 
mM-DTT (buffer E) using an f.p.l.c. desalting column (G-50). Phosphocellulose was pre­
cycled and a 5 ml volume column in a 10 ml disposable syringe was poured. The column 
was equilibrated with buffer E and sample loaded onto the column, which was then washed 
with buffer E until the A280 of the eluate was zero. The column was then eluted with 
200mM-potassium phosphate buffer, pH 6.5, 1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 
mM-DTT (buffer F) at 0.5 ml/min., collecting 2.5 ml fractions until the A280 of the eluate 
was again zero. The flow through and all fractions were assayed for DAHP synthase. 
Under these conditions DAHP synthase failed to bind to the column and so 
phosphocellulose was abandoned as a potential affinity matrix.
(b) Hydroxylapatite
A 0.5 ml bed volume hydroxylapatite column was poured in a 1 ml plastic Eppendorf 
pippette tip and equilibrated in buffer F. Partially purified samples of DAHP synthase from 
step 4 (section 3.2) were desalted into buffer F as before and loaded onto the column which 
was then washed with a further five column volumes of buffer F. Under these conditions 
DAHP synthase bound to hydroxylapatite. If the molarity of buffer F was increased to 25 
mM-potassium phosphate, pH 6.5, no activity was bound to the column. Substrate elution 
was attempted using buffer F containing a final concentration of 10 mM-PEP but this failed 
to remove DAHP synthase activity from the column; the activity was eluted using 50 mM- 
potassium phosphate buffer, pH 6.5,1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 mM- 
DTT. Peak fractions contained three major polypeptide species (Figure 3.13 tracks B,C). 
Although some purification was achieved, substrate elution with PEP had failed to yield 
homogeneous enzyme and this method was not utilized further
3.8.2 Gel filtration
A Pharmacia f.p.l.c. Superose 6 gel filtration column was equilibrated in 50 mM-potassium
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phosphate buffer, pH 7,1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 mM-DTT (buffer B). 
The two highest activity fractions from step 4 (section 3.2) were pooled and concentrated 
using an Amicon Centricon 10 microconcentrator to a volume of 100 |il and loaded onto the 
column. The column was washed at a flow rate of 0.5 ml/min. and 0.25 ml fractions were 
collected and assayed for DAHP synthase activity. The profile of eluted protein with DAHP 
synthase activity superimposed is shown (Figure 3.14). SDS PAGE analysis was carried 
out on the fractions containing enzyme activity (Figure 3.15) and the following conclusions 
drawn :- gel filtration chromatography had failed as a worthwhile purification step to follow 
step 4 (section 3.2); it conclusively showed that two of the polypeptide species present in 
peak fractions from step 4 (section 3.2) correlated with enzyme activity; the calculated 
subunit Mr's as judged by SDS PAGE of the two polypeptides were 54 kDa and 52 kDa, 
respectively.
3 .8 .3  Mono S cation-exchange chromatography
Pooled hydroxylapatite fractions (section 3.3.1(b)) were desalted into 25 mM-sodium 
phosphate buffer, pH 6.7,0.4 mM-DTT, 3.5 mM-benzamidine and 1.2 mM-PMSF (buffer 
G) and loaded onto a Pharmacia analytical Mono S cation-exchange column equilibrated 
with buffer G. The column had been previously washed with buffer G containing 0.5 M- 
NaCl. The column was washed with buffer G and eluate collected and assayed. The eluate 
contained DAHP synthase activity, and after SDS PAGE analysis (Fig. 3.13, tracks D,E) 
was shown to have the same polypeptide composition as the loaded material. Under these 
conditions DAHP synthase had failed to bind to the column, and no other contaminating 
polypeptides had bound to the column, consequently this purification method was not 
pursued further.
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Figure 3.14 Chromatography on Superose 6
Material from Phenyl-Superose (section 3.2) was applied to a Superose 6 gel permeation 
chromatography column as described in section 3.8.2.
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Figure 3.15 SDS PAGE analysis of Superose 6 fractions
A 10% SDS gel was run as described in section 2.3 and stained for protein by the silver 
nitrate method (section 2,3.1). The size of the identified polypeptides is indicated.
Lane A : Mr markers ; myosin, p-galactosidase, phosphorylase b, BSA, ovalbumin, carbonic 
anhydrase (section 2.8.1).
Lanes B-E : samples from across a protein peak with corresponding DAHP synthase 
activity.
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3 .9 M olecular weight determination
Molecular weight determinations of the S.coelicolor DAHP synthase were undertaken in 
order to determine the quaternary structure of the enzyme. Gel filtration experiments 
utilizing high performance chromatography were used to determine the native Mr. The 
subunit Mr of S.coelicolor DAHP synthase was determined by SDS PAGE.
3 .9 .1  Subunit Mr of the S .c o e l ic o lo r  DAHP synthase
The subunit Mr of the purified enzyme was determined under denaturing conditions by 
comparing electrophoretic mobility with the mobility of standard proteins of known Mr 
(Figure 3.16). Comparison of the mobility of DAHP synthase with these standards gave a 
subunit Mr of 54 000.
3 .9 .2  Native Mr of the S .c o e l ic o lo r  DAHP synthase
Standard proteins of known Mr were used to calibrate a Superose 12 gel filtration column 
which was run on a Pharmacia f.p.l.c. system. A standard curve of peak Ve against 
molecular weight was constructed (Figure 3.17). Purified fractions from step 3 (section 
3.2) were loaded onto the column in a final volume of 200 |il, the column was washed with 
buffer B at 0.3 ml/min. and 0.3 ml fractions collected and assayed. The measured peak Ve 
for DAHP synthase corresponded to a Mr of 107 000 indicating that the native enzyme is a 
dimer.
3 .10  Kinetic properties of S .c o e l ic o lo r  DAHP synthase
Kinetic analysis of S.coelicolor DAHP synthase was carried out using either assay method
(b) or (c) (section 2.4.1) and unless stated otherwise the concentrations of substrates were 
at a saturating level (section 2.4.1).
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Figure 3.16 SDS PAGE standard curve
SDS PAGE (10%) was performed as described in section 2.3. The Rf values of 
standard proteins (section 2.8.1) were calculated and plotted against the log Mr. The 
Rf of the purified S.coelicolor DAHP synthase is shown ( o ). The standard curve 
was fitted by eye.
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3 .1 0 .1  Substrate kinetics
The initial velocity (V) was determined as a function of the concentration of one substrate at 
a fixed saturating level of the other substrate. First PEP concentrations were kept constant 
at a saturating level of 0.5 mM and initial velocities of the reaction were measured with 
varying amounts of E4P (Figure 3.18). Then, comparable data were obtained with varied 
PEP concentrations and a fixed E4P concentration of 1 mM (Figure 3.19). Sets of data were 
determined using both continuous assay systems and an apparent Km for E4P of 280 pM 
and an apparent Km for PEP of 100 |iM derived. Km values were greater when the 
coupled assay method (section 2.4.1(b)) was used with a phosphate containing buffer, 
with inorganic phosphate exhibiting product inhibition. PEP acted as a normal Michaelis- 
Menten substrate, showing hyperbolic saturation (Figure 3.20) whereas E4P acted as an 
inhibitor at concentrations above 1.1 mM (Figure 3.21), this inhibition being competitive 
with respect to PEP (Figure 3.22).
3 .1 0 .2  The effect of pH on the reaction velocity and enzyme stability
The influence of pH upon enzyme activity and stability is shown. Partially purified enzyme 
was assayed directly under saturating conditions at different pH intervals in 
bistrispropane/HCl buffer. Activity increases rapidly with increasing pH to an optimum 
between pH 7 to pH 7.4; further increases in pH lead to a strong decrease in activity 
(Figure 3.23).
(N H 4)2S04 pellet aliquots were dialysed overnight against 50 mM-potassium phosphate 
buffer, 1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 mM-DTT at various pH intervals with 
activity found to be most stable at pH 7 (Table 3.5). Enzyme assays and enzyme 
purification procedures were consequently maintained around pH 7 wherever possible.
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Figure 3.18 Determination of apparent Km of DAHP synthase for 
PEP
Double-reciprocal plot of initial velocity against PEP concentrations at lmM-E4P.
DAHP synthase was assayed either by the direct or the coupled continous method as 
described in section 3.10.
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Figure 3.19 Determination of apparent Km of DAHP synthase for 
E4P
Double-reciprocal plot of initial velocity against E4P concentrations at 0.5 mM-PEP.
DAHP synthase was assayed either by the direct or the coupled continous assay as 
described in section 3.10.
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Figure 3.20 The initial DAHP synthase reaction against PEP 
concentration
DAHP synthase was assayed by the coupled assay method as described in section 3.10 
with [PEP] varied as stated and [E4P] fixed at 0.5 mM.
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Figure 3.21 The initial DAHP synthase reaction against E4P 
concentration
DAHP synthase activity was assayed by the direct method as described in section 3.10 
with [E4P1 varied as stated and [PEP] fixed at 0.5 mM.
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Figure 3.23 pH optima of the S.coelicolor uA H t' synthase
DAHP synthase was assayed by the direct method as described in section 3.10. The 
values plotted are the maximal measured at each pH . The curve was fitted by eye.
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Table 3.5 Stability of the S.coelicolor DAHP synthase under various 
buffer and pH conditions
Aliquots of the 35-65% (NH4)2S04 fraction were dialysed overnight at 4°C against either 
50 mM-potassium phosphate, 1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 mM-DTT, or 50 
mM-Tris/HCl, 1.2 mM-PMSF, 3.5 mM-benzamidine, 0.4 mM-DTT at the indicated pH as 
described in section 3.10.3. Samples were assayed under standard conditions by the 
coupled assay method (section 2.4.1.(a)). One sample was left untreated and contained 
(NH4)2S04.
Buffer PH Specific
Activity
(mU/mg)
% L 
in act
potassium 6 1.8 72
phosphate 6.5 3.7 41
7 4.1 34
7.5 3.8 40
+(NH4)2S04 7 6.3 0
Tris/HCl 7.5 0.5 92
8 0.4 94
8.5 0.1 98
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3 .1 0 .3 Metal ion dependence of enzyme activity
Inclusion of 5 mM-EDTA in extraction buffer (buffer A) apparently had no effect on DAHP 
synthase activity levels found in crude cell-free preparations, however overnight dialysis at 
4oC of (NH4)2SC>4 pellet aliquots against buffer B supplemented with 10 mM-EDTA 
resulted in almost total inactivation (Table 3.6) of the enzyme. Inclusion of 30 pM-CoCl2 
in the coupled assay mixture resulted in a partial recovery of measured DAHP synthase 
activity (Table 3.6).
DAHP synthase activity was also lost following overnight dialysis against Tris buffers at 
various pH values (Table 3.5), possibly as a result of the metal chelating properties of this 
buffer. Consequently phosphate buffers were employed throughout the purification and 
EDTA was not used.
3 .1 0 .4  Susceptibility to oxidation
Fresh DTT (0.4 mM) was included in all buffers following the observation that inactivated 
enzyme could be partially reactivated by the addition of this thiol reducing agent.
3 .11  Repression and inhibition of the S .c o e lic o lo r  DAHP synthase
Enzymes contributing significantly to the regulation of a pathway are frequently controlled 
at either the catalytic or allosteric level by product feedback inhibition or at the 
transcriptional level by repression and induction. The possibility that these control 
mechanisms influenced the S.coelicolor DAHP synthase activity was investigated.
3 .1 1 .1  Repression of synthesis of DAHP synthase
S.coelicolor cells were grown on a rich medium (YEME) and cell-free extracts prepared
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Table 3.6 Inactivation of S.coelicolor DAHP synthase by EDTA
Aliquots of the 35-65% (NH4)2S0 4  fraction were dialysed overnight at 4°C against buffer 
A (Table 3.1) containing EDTA as described in section 3.10.3; as a control, an aliquot was 
dialysed against buffer A alone. Fractions were assayed under standard conditions by the 
coupled assay method (section 2.4.1 (a)).
Incubated Assayed Total % Loss
with lOmM-EDTA with 30 fiM-CoCl2 Activity (mU) in activity
+ + 100 75
+ 62 85
+ 390 0
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and assayed for DAHP synthase activity. Assays could not be performed on this material 
due to the high background rate but activity could be purified (section 3.2) and assayed at 
subsequent stages. The specific activity of DAHP synthase, although lower at each stage of 
the purification (Table 3.7) than that found in extracts purified from minimal medium 
grown cells, was clearly not fully repressed.
3 .1 1 .2  Inhibition of enzyme activity
A range of skikimate pathway end-products and intermediates were evaluated for their 
ability to inhibit the S.coelicolor DAHP synthase (Table 3.8). Only tryptophan was found 
to elicit any significant effect where under specified conditions inhibition over control 
activity was up to 67%. (Table 3.8). At concentrations up to 1 mM, tyrosine and 
phenylalanine had no effect on enzyme activity, and similarly at concentrations up to 0.25 
mM, anthranilate and p-aminobenzoate gave no inhibitory result. The tryptophan inhibition 
was saturable with an apparent Ki of 70 JiM (Figure 3.24). This allosteric property was 
stable in extracts throughout the purification and stable for at least 6 months in purified 
extracts stored in buffer H at -20°C.
3 .12  Storage and stability of the S .c o e l ic o lo r  DAHP synthase
Enzyme stored in buffer H for 6 months at -20°C had lost 20% of the original activity with
the remaining activity fully sensitive to tryptophan inhibition.
3 .13  Discussion
This chapter reports the purification to homogeneity of a tryptophan-sensitive DAHP 
synthase from the gram-positive actinomycete Streptomyces coelicolor. The enzyme was 
prepared either in a four step procedure yielding jig amounts of material (Table 3.3) or in a 
five step protocol capable of providing the mg amounts of protein (Table 3.4) necessary for
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Table 3.7 Purification of S.coelicolor DAHP synthase from complex 
medium-grown cells.
The results presented are for a typical purification starting from 40g of S.coelicolor cells 
(section 3.11.1).
Step Total Total Specific Yield Purification
Protein Activity Activity % (fold)
(mg) (mU) (mU/mg)
1. Crude 400 ND ND ND ND
2.(NH4)2S04 219 350 1.6 100 1
fractionation
3. MonoQ 16.5 308 18.5 88 12
chromatography
4. Phenyl Superose 0.45 100 222.2 32.5 139
chromatography
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Table 3.8 Screening of putative inhibitors of S.coelicolor DAHP synthase
DAHP synthase was assayed either by the direct or the coupled assay method (section
2.4.1); the assay mixture was modified and contained 50 |iM-PEP, 100 |iM-E4P and the 
indicated effector concentration as described in section 3.11.2.
Effector Activity % Inhibition
[mM] (mU/ml)
NONE 369 0
0.12 mM-tryptophan 122 67
1.0 mM-tyrosine 394 0
1.0 mM-phenylalanine 386 0
0.25mM-anthranilate 352 0
0.25mM-p-aminobenzoate 390 0
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Figure 3.24 Saturation curve of tryptophan inhibition of the 
S .c o e l i c o lo r  DAHP synthase.
DAHP synthase was assayed by the direct method (section 2,4.1) with the addition of between 0 to 
250-|iM tryptophan as described in section 3.11.2. Assays contained final concentrations of 
50 M-M-PEP and 100 pM-E4P.
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//-terminal amino acid sequence analysis and peptide-generating experiments (Chapter 4).
The activity of the enzyme found in extracts made from cells grown on minimal media was 
low, typically 3-4 mU/mg protein (Table 3.3). This is similar to levels found in fungi 
(Nimmo and Coggins, 1981a) but approximately 100 fold less than that found in wild-type 
E.coli (Schoner and Herrmann, 1976). Progress was further hampered by the difficulties 
in growing S.coelicolor in liquid minimal medium and obtaining sufficient biomass with 
which to begin a purification. The adoption of Hobbs' new minimal medium (Hobbs et 
a iy 1989) as the growth medium gave biomass yields of around 17g wet weight of 
cells/litre of culture and protein yields of lOmg/g wet weight of cells. This protein yield is 
around 5 times lower than that found in extracts made from E.coli (J.Greene, personal 
communication).
The purification fold as judged by the final residual activity is 800-fold, with a 10% yield 
(Table 3.3). However a major loss of activity occurs at the last step, possibly due to much 
of the remaining metal attached to the enzyme being stripped off upon passage through the 
Mono Q column in a DTT-containing buffer (DTT has metal-chelating properties; the 
Mono Q support matrix may have similar properties). By estimates of protein before and 
after this step we calculate that the purification factor is nearer 2,000-fold (Table 3.3). The 
increase in the time taken to complete each step in the large scale purification results in an 
even poorer yield (Table 3.4); with either more metal cofactor being lost earlier in the 
procedure or the increase in the length of the purification facilitating increased oxidation. 
Closer analysis of yields from individual steps indicates that cold-room chromatographic 
procedures and other manipulations undertaken there such as dialysis resulted in the 
greatest losses in activity. The procedures carried out at room temperature on an f.p.l.c. 
apparatus gave a far higher recovery of activity. One possible conclusion is that the enzyme 
is partially cold-labile. These problems could be addressed by the inclusion of some 
divalent metal cations in all buffers, the use of an alternative reductant lacking chelating 
properties such as mercaptoethanol, and the purification being carried out at room
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temperature.
No evidence was found to indicate the presence of two or more isozymes of DAHP 
synthase as has been found in numerous other organisms (see section 1.2 .2), at no stage 
were separable activities detected nor was there a dramatic loss in activity indicating the loss 
of an isozyme. The cloned gene could be used as a tool in a gene disruption experiment to 
prove conclusively the presence of a single gene encoding a single enzyme. In the two 
reported partial purifications of the enzyme from two species of streptomycete (Gorisch and 
Lingens, 1971a; Lowe and Westlake, 1970) no isoenzymic forms of the activity were 
detected and it was concluded that a single enzyme was present.
Affinity chromatography has been used successfully in the rapid purification of minute 
amounts of biological material from a more complex mixture. It has been argued that 
hydroxylapatite and, more convincingly, phosphocellulose may act as "pseudo" affinity 
columns in cases where enzymes bind substrates possessing one or more phosphate 
moities such as PEP. These two materials have been used successfully in DAHP synthase 
purification protocols from a variety of organisms:- phosphocellulose in the purification 
from N.crassa (Nimmo and Coggins, 1981a) and from potato (Pinto et al., 1986); 
hydroxylapatite in the isolation from Nocardia mediteranei (Tianhui and Chiao, 1989) and 
from two of the E.coli isozymes (Schoner and Herrmann, 1976; McCandliss and 
Herrmann, 1978). In one of these examples that of the tryptophan inhibitable N.crassa 
enzyme, substrate elution from phosphocellulose with PEP containing buffers was the 
crucial step which facilitated a rapid, high yield purification.
Our attempts to utilize these media as a final purification step did not prove successful. The 
S.coelicolor DAHP synthase failed to bind,to phosphocellulose (section 3.8.1(a)) under 
conditions used previously to bind other PEP utilizing enzymes such as EPSP synthase 
from E.coli (Lewendon and Coggins, 1983) and the tryptophan sensitive DAHP synthase 
from N.crassa (Nimmo and Coggins, 1981a).
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The S.coelicolor DAHP synthase did bind to hydroxylapatite, but weakly and could not be 
dislodged by substrate (section 3.8.1(b)). It was concluded that these media were not in 
this case acting as a affinity columns but as general cationic exchangers. If hydroxylapatite 
was acting as a general cationic exchanger then one might expect another such exchanger to 
bind the activity at a similar pH and ionic strength. DAHP synthase from S.coelicolor 
failed to bind to the Mono S cationic exchanger under such conditions (section 3.8.3) but 
did bind to the Mono Q anionic exchanger (section 3.2). Although the mechanism of 
binding proteins to hydroxylapatite is not fully understood it appears unlikely to bind 
S.coelicolor in a ligand-recognising fashion.
The S.coelicolor DAHP synthase appears to be a homodimer with a subunit Mr of 54kDa. 
This is effectively confirmed by the single A-terminal sequence which was obtained for 
the enzyme (section 4.2). DAHP synthases from a variety of organisms display 
heterogeneity both in their subunit size and quaternary structure (Table 3.9). It is possible 
to crudely divide these enzymes into two classes on the basis of subunit size (Table 3.9), 
with one class displaying an estimated subunit Mr in the range 38-44 kDa (class 1) and the 
other with estimated Mr in the range 52-56 kDa (class 2). Errors in subunit Mr estimation 
may have broadened these criteria. The smaller class includes the enteric bacteria, yeast, 
Acinetobacter sp., and an acdnomycete representative. The larger subunit class includes 
plant, fungal and Streptomycete members, in particular S.coelicolor (Table 3.9).
A surprising difference in quaternary structure is observed between the DAHP synthases in 
both classes. The majority of enzymes in both classes are dimers or tetramers, with 
evidence that the quaternary structure confers effector sensitivity (de Boer et al., 1989) as 
in this case dissociated monomers were inhibitor insensitive. However, the existence of at 
least four monomeric class 1 forms (Byng et al.,1985; Paravicini et al., 1989; G.Braus, 
personal communication, 1991), three of which are sensitive to end-product inhibition, 
indicates that subunit organisation is not essential in conferring inhibition in all cases.
124
Table 3.9 Comparison of subunit size and oligomeric structure of DAHP 
synthases
Organism Subunit Mr (kDa) Native Mr (kDa) Oligomeric structure Class Reference
E.coli
phenylalanine 38(a) 160 (c,d) tetramer 1 (1). (2)
tyrosine 39 (a) 80(c) dimer 1 (3),(4)
tryptophan
A.calcoaceticus
39(a) 80 (c) dimer 1 (5),(6)
tyrosine 43 (c) (?) 43 (c) monomer 1 (7)
unregulated
S.cerevisiae
45 (c) (?) 45(c) monomer (7)
phenylalanine 42(a) 53(c) monomer (8). (9)
tyrosine 
P. aeruginosa
42(a) (c) monomer 1 (18)
tyrosine 35 (?) 137(c) tetramer 1 (12)
tryptophan 42 (?) 175(c) tetramer 1 (12)
N.mediterranei 35(b) 140 (c) tetramer (10)
Nocardia sp.239 43(c) 168 (c) tetramer 1 (11)
N.crassa
tryptophan 52(b) 200(d) tetramer 2 (13)
B.flavum 55(b) 220(c) tetramer 2 (14)
Carrot roots 5 3 (b) 103 (c) dimer 2 (16)
Potato 56(a) 110(c) dimer 2 (17)
S.aureofaciens 55 (?) 100 (c) dimer (?) 2 (15)
Streptomyces
sp.3022a
55 (?) -100(c) dimer (?) 2 (19)
S.rimosus 54 (b) ND (?) 2 (23)
S.coelicolor 55(b) 107(c) dimer 2 section 3.9
Notes on Table 3.9
(a) determined from nucleotide sequence (b) SDS PAGE analysis
(c) evaluated by gel filtration chromatography (d) sedunentation-equilibrium centrifugation
(?) inferred from data, but not conclusively known
The references are listed below Table 3.11
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In the majority of cases substrate kinetics have obeyed Michaelis-Menten behaviour. 
Preliminary experiments indicate co-operativity of substrate binding with the tetrameric 
E.coli phenylalanine-sensitive isozyme (C.Stephens, personal communication, 1990) and 
that this tetrameric enzyme may be truly allosteric in its substrate kinetics and regulatory 
behaviour. There is one other example of homotrophic behaviour, that of the DAHP 
synthase from Brevibacterium flavum (Sugimoto and Shiio, 1980), which was shown 
conclusively to be a typical allosteric enzyme with homotrophic cooperativity of binding of 
one substrate, PEP.
The steady-state kinetic parameters of the S.coelicolor DAHP synthase are compared with 
those evaluated from other organisms in Table 3.10. Kinetic values determined from 
purified, highly active, often over-produced enzyme are listed in rows one to five. The 
more sensitive direct PEP utilization assay (section 2.4.1(c)) was also employed in these 
studies. For each substrate the values are at least one order of magnitude lower than those 
determined from cruder, less active and often less stable preparations by other assay 
methods (rows 7-13). However, in general, most enzymes posses a higher affinity for PEP 
as opposed to E4P. There appears to be no correlation between the class of the enzyme and 
the Km values. This may reflect the varying quality of the enzyme preparations and data, 
especially when high Km's are reported.
The S.coelicolor DAHP synthase displayed a narrow activity pH optimum between 7 and 
7.4; the stability of the activity was preserved best in buffers of pH 7. Table 3.10 lists the 
pH optima of a number of microbial DAHP synthases which also lie within this interval. In 
plants an isozyme with a different pH profile has been described (section 1.2.2.1 (d)).
DAHP synthases from a variety of organisms are susceptible to inactivation by metal 
chelating agents such as EDTA (Staub and Denes, 1969a,b; Gorisch and Lingens, 1971a; 
Simpson and Davidson, 1976; Nimmo and Coggins, 1981a; Paravicini et al., 1989) and 
this inactivation can be protected against by bivalent metal ions and by substrate, such as
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Table 3.10 Kinetic parameters of microbial DAHP synthase enzymes
Organism
E.coli
pH
optimum
Km
PEPQiM)
Km
E4P(jiM)
Enzyme
preparation
Assay
used
Reference
1. phenylalanine 6.5-7.0 -5.8 ND PS D W
2. tyrosine 7.0 5.8 96.5 PS D (3)
3. tryptophan 
S.cerevisiae
7.0 9 50 OPS D (20)
4. phenylalanine 
N.crassa
6.8 18 130 OPS D (9)
5. tryptophan 6.5-7.5 12 2.7 PS D (13)
6. S.coelicolor 7.0-7.4 100 285 PPS(400) DC section 3.10
7. S.aureofaciens 7.0-7.5 300 160 PPS(14) CH (15)
8. Nocar dia 
sp.239
7.0-7.5 45 370 PPU(20) CH (ID
9. N.mediteranei 
P.aeruginosa
7.2 400 250 PS(120) CH (10)
10. tyrosine 6.8 1000 1000 PPS(ND) CH (12)
11. tryptophan 7.2 1110 560 PPS(ND) CH (12)
12. S.antibioticus 6.8 150 150 NHS(ND) CH (21)
13. Streptomyces 
sp.3022a
7.2 100 100 PPS(ND) CH (19)
Notes on Table 3.10
O - overproduced P- purified to homogeneity
PP- partially purified (fold) U -unstable
NH- ammonium sulphate fraction D -direct PEP utilization assay
CH -stopped chemical assay
The references are listed below Table 3.11
S- stable
ND- not determined 
C -coupled assay
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PEP. The identity of the metal is thought to be Fe2+ in the E.coli isozymes (McCandliss 
and Herrmann, 1978 ; Ray and Bauerle, 1991) and the phenylalanine isozyme of 
Saccharomyces cerevisiae (Paravicini et a l , 1989), although the former finding is 
disputed for the tyrosine-sensitive E.coli isozyme which may be a copper metalloenzyme 
(Baasov and Knowles, 1989). The S.coelicolor DAHP synthase was similarly inactivated 
by EDTA but no protection studies were undertaken.
The most likely explanation for the ubiquitous presence of metal in DAHP synthases is that 
they form part of the group of metalloaldolases, designated class II (reviewed in Lai and 
Horecker, 1972). These aldolases use a divalent metal cation to stabilise or promote the 
formation of a carbanion group on the substrate which is essential for reactivity. Class II 
aldolases are characterised by their inhibition by chelating agents and exhibit sharp pH 
optima (Rutter, 1964).
In common with the majority of successful purifications of DAHP synthase from different 
organisms that from S.coelicolor included DTT in buffers in order to prevent the oxidation 
of sulfhydryl groups and to preserve activity. The two notable exceptions are the 
purification procedures of the E.coli phenylalanine and tyrosine sensitive isozymes 
(Schoner and Herrmann, 1976; McCandliss et a l , 1978) which did not include a 
reductant, however the presence of PEP in all buffers also appears to protect active-site 
sulfhydryl groups from oxidation, as its removal results in inactivation.
Many DAHP synthases can be inhibited by thiol-modifying reagents (Moldovanyi and 
Denes, 1968 ; Staub and Denes, 1969a,b; Gorisch andLingens, 1971a; Huisman and 
Kosuge, 1974 ; Shiio and Sugimoto, 1979a,b ; Ray and Bauerle, 1991) with PEP but not 
E4P providing protection against inactivation. It was concluded (Staub and Denes, 
1969a,b) that DTNB-sensitive sulfhydryl groups were implicated either in the PEP binding 
site or the catalytic site. Sugimoto and Shiio (1979a,b) concluded that in Brevibacterium 
flavum a single sulfhydryl group per mol of subunit was essential for activity, whereas for
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the E.coli phenylalanine-sensitive isozyme two groups per subunit monomer were thought 
to be essential (C.Stephens,personal communication, 1990), with the identity of these 
groups currently being determined.
Ganem (1978) has suggested an enzyme-bound sulphur-containing intermediate to explain 
these modification experiments and other isotope labelling data (discussed in section
1.2.1). Furthermore, the possibility that the sulfhydryl group is involved in co-ordinating 
the metal ion cofactor remains plausible as metal ions are able to partially protect against 
DTNB inactivation (C.Stephens, personal communication, 1990) of the E.coli 
phenylalanine-sensitive isozyme.
Enzyme catalysed reactions early in a biosynthetic pathway are likely targets for regulation 
of the metabolic flow. DAHP synthase is a target for a variety of forms of feedback 
inhibition in different microorganisms and repression control is also found in some 
organisms (section 1.2.3).
The S.coelicolor DAHP synthase activity was found to be inhibited solely by tryptophan 
with an apparent Ki of 70jiM under the assay conditions employed; the maximal inhibition 
under these conditions was 67% of control. Superfamily-B prokaryotes (excepting the 
GroupV pseudomonads), fungi and yeast posses two or more isoenzymic forms of DAHP 
synthase (Jensen and Nasser, 1968 ; Lingens et al., 1966; Jensen and Ahmad, 1988). 
Gram-positive bacteria of the Actinomycetales, including Nocardia and Streptomyces 
species posses a single DAHP synthase (Lowe and Westlake, 1970; Gorisch and Lingens, 
197 la,b ; de Boer et a/.,1989 ; Tianhui and Chiao, 1989) which, with one exception, is 
inhibited only by tryptophan at physiologically relevant effector concentrations. The DAHP 
synthase of Streptomyces sp.3022a was found to be aromatic inhibitor insensitive (Lowe 
and Westlake, 1970), but this study employed a commercial production strain which may 
have possessed a mutant deregulated phenotype.
The effect of tryptophan on the three streptomycete DAHP synthases is summarised in
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Table 3.11 and compared with another actinomycete representative and the E.coli 
tryptophan isozyme. The streptomycete enzymes are comparitively poorly inhibited by 
tryptophan and, in common with other tryptophan sensitive species, usually only partial 
inhibition is observed. The inability of tryptophan to elicit total inhibition is logical in a 
single isozyme system as a surfeit of this single amino acid end-product would prevent the 
synthesis of any other products if total inhibition occurred.
DAHP synthase activity was found in S.coelicolor cells grown on a rich medium and this 
activity could be purified in an analagous fashion to material derived from minimal medium 
grown cells (Table 3.7). No evidence of repression control has been found for DAHP 
synthase and other shikimate pathway enzymes in the Actinomycetales (Lowe and 
Westlake, 1970 ; Gorisch and Lingens, 1971b ; de Boer et al., 1989), although one group 
(Murphy and Katz, 1980) claimed the activity was repressible, but other explanations of 
their results such as specific degradation were not considered and the experimental method 
employed may not have been satisfactory. One example of feedback activation by 
secondary products on primary metabolism in Penicillium cyclopium, in particular the 
aromatic amino acid biosynthesis enzymes DAHP synthase, chorismate mutase and 
anthranilate synthase has been reported (Roos and Schmauder, 1989). Here, the addition of 
secondary product to cultures resulted in stimulation in the synthesis of these enzymes. It 
would be of great interest to investigate the possibility of a similar mechanism existing in an 
aromatic containing antibiotic producing streptomycete. In contrast, in the enteric bacteria 
and yeast, exquisitely sensitive repression control systems have been described (section
1.2.3).
From the evidence outlined above it would appear that the metabolic control of the 
shikimate pathway in S.coelicolor follows an exo-orientated pattern as described by 
Jensen and Hall (1982). In summary, microorganisms can be classified into two groups 
according to the control system features of their respective amino acid biosynthetic 
machinery. One group, where control is orientated to exogeneous substrates, display
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Table 3.11 Comparison of selected tryptophan inhibitable microbial DAHP 
synthases
Organism Maximal Saturating Apparent [substrate] Reference
inhibition (%) tryptophan (pM) Ki(pM) PEP E4P
S.coelicolor 67 120 70 l/2Km V2Km section 3.11
S.antibioticus 65 100 55 1/2Km ‘^Km (21)
S.aureofaciens 65 200 110 i iV2Km (15)
Maximal Ki
inhibition(%) (pM)
Nocardia 94 3 (ID
sp.239
E.coli 60 2 (22), (20)
References cited in Tables 3.9, 3.10 and 3.11
(I) McCandliss and Herrmann, (1978)
(3) Schoner and Herrmann, (1976)
(5) Poling et al., (1981)
(7) Byng et al., (1985)
(9) Paravicini et al., (1989)
(II) de Boer et al., (1989)
(13) Nimmo and Coggins, (1981b)
(15) Gorisch and Lingens, (1971a,b)
(17) Dyer et al., (1990)
(19) Lowe and Westlake, (1971)
(21) Murphy and Katz, (1980)
(23) Stuart, (1990)
(2) Davies and Davidson, (1982)
(4) Schultz et a/., (1984)
(6) Ray et al., (1988)
(8) Paravicini et al., (1988)
(10) Tianhui and Chiao, (1989)
(12) Whitaker et al., (1982)
(14) Sugimoto and Shiio, (1980)
(16) Pinto et al., (1986)
(18) GJBraus, personal communication (1991)
(20) Ray and Bauerle, (1991)
(22) Pittard and Gibson, (1970)
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complex allosteric regulation both early and at branchpoints of the pathway, this early 
control being exerted by at least two different terminal end-products, and repression control 
by amino acid end products. The other, where control is orientated to endogeneous 
products, frequently exhibit poorer early control governed by a single end product, limited 
terminal branchlet regulation and no repression control.
These contrasting control strategies were rationalised with respect to an organisms 
individual ecological niche. In E.coli, which undergoes periods of nutrient excess then 
limitation, competitive success is reliant upon combining efficiency of amino acid 
biosynthesis during starvation with prudent use of exogeneous substrates upon nutrient 
excess; consequently they possess biosynthetic machinery highly responsive to exogeneous 
amino acids. Other organisms, such as S.coelicolor which scavenge and may exist in a 
near-permanent state of nutrient limitation, respond poorly to exogeneous amino acids and 
have a constitutive biosynthetic capacity. However, exquisite transcriptional control does 
exist in S.coelicolor which has reserved this metabolically expensive mechanism for its 
outstanding metabolic specialities, antibiotic biosynthesis and colony differentiation 
(Buttner et al.,1988 ; Chater, 1989; section 1.10.1). With regard to the goal of over­
producing aromatic precursors for antibiotic production, this simpler endo-oriented 
regulatory arrangement would appear to facilitate this objective.
We have reported the inhibitory effects of high E4P concentrations on the S.coelicolor 
DAHP synthase, furthermore high concentrations of other sugar phosphates have been 
found inhibitory (Lowe and Westlake, 1970; Tianhui and Chiao, 1989). Inhibition by both 
substrates at high concentrations has been described (Nimmo and Coggins, 1981a,b) but 
more commonly E4P alone exhibits this phenomenon, with this inhibition competitive with 
respect to PEP. One explanation of these results is that assuming PEP binds first (as has 
been shown, discussed in section 1.2 .1) and this binding is rate limiting to catalysis then 
excess E4P could compete with PEP for binding at a single site and consequently inhibit 
catalysis. The other sugar phosphates could act in an analagous fashion.
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Chapter 4 Primary structure analysis of DAHP synthase 
from Streptomyces coelicolor
4.1 Introduction
This chapter describes the determination of the A-terminal sequence of the S.coelicolor 
DAHP synthase and the sequences of some peptides derived from the intact polypeptide by 
digestion with proteases. These sequences were used to design two synthetic homologous 
oligonucleotide probes. Primary sequence comparisons were carried out between the 
E.coli isoenzymes and the one cloned S.cerevisiae isoenzyme and a consensus 
heterologous oligonucleotide designed which was complementary to a putative active site 
sequence.
4.2 W-terminal sequence of the S .c o e l ic o lo r  DAHP synthase
The N-terminal amino acid sequence of the S.coelicolor DAHP synthase was determined 
by automatic sequencing of the intact protein as described in Materials and Methods 
(sections 2.7.3 and 2.7.4). The yield of each residue recovered from each cycle of the 
sequence and the derived sequence is shown in Figure 4.1. The iV-terminal amino acid 
was found to be proline indicating that this region has been subjected to post-translational 
modification to remove the expected methionine residue. The first twenty-six amino acids 
were identified unambiguously.
4.3 Preparation of peptides from the S .c o e l ic o lo r  DAHP synthase
Direct A-terminal sequencing was initially unsuccessful when attempted with intact protein 
prepared for sequencing by exhaustive dialysis against ammonium bicarbonate buffer. 
Amino acid sequence data was obtained by sequencing peptides generated from a complete 
clostripain and a complete tryptic digest of the S.coelicolor DAHP synthase as described in 
Materials and Methods (section 2.7.2). Clostripain is a thiol protease which cleaves on the
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Figure 4.1 The AMerminal amino acid sequence of the S.coelicolor
DAHP synthase
Approximately one nanomole of DAHP synthase was sequenced directly following 
purification and desalting by reverse phase h.p.l.c.
Sequence PTH-amino p moles
number acid recovered
1 Pro 976
2 Glu 324
3 Asn 434
4 Asn 602
5 Gin 435
6 Lys 700
7 Pro 740
8 Leu 477
9 Thr 249
10 Thr 342
11 Val 418
12 Ala 580
13 Gly 491
14 Ala 656
15 Pro 445
16 Val 292
17 Pro 557
18 Asp 121
19 Asn 167
20 Gin 152
21 Asn 239
22 Ser 67
23 Leu 242
24 Thr 95
25 Ser 69
26 Gly 290
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C-terminal side of arginyl residues and to a much lesser extent on the C-terminal side of 
lysyl residues upon prolonged incubation. Trypsin is a serine protease which also cleaves 
on the C-terminal side of arginyl and lysyl residues. The lysyl cleavage reaction can be 
eliminated in both cases by succinylation of the lysyl residues. Two peptides generated by 
clostripain action and two peptides generated by trypsin were purified and sequenced.
4.3.1 h.p.l.c. separation of peptides produced by a clostripain digest
of the S .c o e l ic o lo r  DAHP synthase
The peptides generated by the action of clostripain on the S.coelicolor DAHP synthase 
were separated by reverse phase chromatography on a Waters p Bondapak C18 column 
attached to a Beckman h.p.l.c. as described in Materials and Methods (section 2.1.4). The 
material eluting from the column was monitored at 220 nm and several discrete peaks 
collected by hand, labelled and despatched for automatic pulsed liquid-phase sequencing 
(Figure 4.2).
4.3.2 h.p.l.c. separation of peptides produced by a tryptic digest of
the S .c o e lic o lo r  DAHP synthase
The peptides derived from the tryptic digest of the S.coelicolor DAHP synthase were 
separated by reverse phase chromatography as above (section 4.3.1). Peaks numbered one 
to eight were collected and sent to be sequenced (Figure 4.3).
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Figure 4.2 h.p.l.c. purification of peptides generated by a clostripain
digest o f the S.coelicolor DAHP synthase
A Waters |i Bondapak Cl 8 column was equilibrated in H2O/ TFA and developed with an 
acetonitrile gradient in TFA which resolved several peaks. The peaks numbered 1-7 were 
collected manually, lyophilized and despatched for sequencing.
Flow rate was 0.5ml/min.
Gradient: 0-40% (v/v) CH3CN in 40 min.
40-60% (v/v) CH3CN in 10 min.
60% (v/v) CH3CN for 5 min.
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Figure 4.3 h.p.l.c. purification o f peptides generated by a tryptic digest
of the S.coelicolor DAHP synthase
A Waters C l8 |i Bondapak C l8 column was equilibrated in H2O/TFA and an acetonitrile 
gradient developed. The peaks numbered 1-8 were collected manually, concentrated by 
rotary evaporation, and sent for sequencing.
Flow rate was 0.5ml/min.
Gradient: 0-40% (v/v) CH3CN in 45 min.
40-70% (v/v) CH3CN in 15 min.
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4 .4  Sequencing of peptides
4.4.1 Sequencing of clostripain peptides
Seven peptide peaks were selected from the h.p.l.c. elution profile. Two of these peptides, 
labelled 1 and 7 on Figure 4.3 were sequenced as described in Materials and Methods 
(section 2.7.5). The remaining samples comprised mixtures of peptides and unambiguous 
sequence determination was not possible. The derived sequences are shown in Figure 4.4.
4.4.2 Sequencing of tryptic peptides
Eight peptide peaks were selected from the h.p.l.c. elution profile. Two of these peptides, 
numbered 1 and 7 on Figure 4.3 were sequenced as in Materials and Methods (section
2.7.4). Samples 5 and 6 were shown to be mixtures of two peptides, but upon further 
purification too little material was left for sequencing. The yields of residues recovered 
from each cycle of the sequencer for each of the peptides are shown along with the derived 
amino acid sequences in Figure 4.5.
4.5 Amino acid composition of the S .c o e l ic o lo r  DAHP synthase
Amino acid composition analysis was carried out as described in Materials and Methods 
(section 2.7.6). Table 4.1 shows the aminp acid composition of DAHP synthase from 
S.coelicolor.
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Figure 4.4 The amino acid sequence of clostripain peptides 1 and 7
Peptide 1 Val-Phe-Ser-Glu-Ile-Gly-?
1 6
Peptide 7 7-Pro-Met-Leu-Leu-Gln-Asp-Val-Trp-Phe-Leu-Gln-Lys 
1 13
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Figure 4.5 Sequence of tryptic peptides
The yields of PTH amino acids during sequencing of tryptic peptides 1 and 7. The initial 
amount of peptide sequencing was 0.5 and 1 nmoles, respectively.
Peptide 1 Peptide 7
Cycle PTH-amino pmoles Cycle PTH-amino pmoles
number acid recovered number acid recovered
1 Phe 300 1 ? ?
2 Asp 33 2 Pro 540
3 Leu 60 3 Met 749
4 Arg 19 4 Leu 733
5 Leu 613
6 Gin 278
7 Asp 68
8 Val 331
9 ? ?
The sequence of peptide 7 reported in this table confirmed the earlier sequence in Figure
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Table 4.1 The amino acid composition of S.coelicolor DAHP synthase
nino acid % composition
Asx 15.2
Glx 11.2
Ser 4.2
Gly 8.8
His 3.6
Arg 8.1
Thr 4.8
Ala 10
Pro 6.1
Tyr 3
Val 5.5
lie 3.3
Leu 5.8
Phe 6.1
Lys 4.2
These data are averages of two runs on two different analysers (section 2.7.6). The 
conditions employed for acid hydrolysis destroy tryptophan, and sample was not pre­
treated with performic acid to allow identification of cysteine and methionine residues and 
the analyses of these amino acids are excluded. The values are therefore expressed as the 
percentages of the amino acids determined, with tryptophan, cysteine and methionine 
arbitrarily assigned a value of 0%.
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4.6 Design of homologous and heterologous oligonucleotide
probes
Oligonucleotide probes have been extensively used in "reverse genetics", to allow the 
isolation of the gene coding a protein of known sequence. Probes are designed from the 
potential coding sequences of a peptide fragment of known sequence. Recent advances in 
automated protein microsequencing has made it feasible to isolate genes encoding very 
minor polypeptide species. Mixtures of oligonucleotides are employed designed against 
sequences with minimum codon degeneracy, such as those flanking methionine or 
tryptophan residues. Other least ambiguous codons represent the amino acids asparagine, 
aspartate, cysteine, histidine, phenylalanine, tyrosine, glutamate, glutamine and lysine. 
Furthermore, less degenerate oligonucleotides can be designed when a degree of codon 
preference exists in a given species. For example, within protein coding regions of DNA of 
Streptomyces sp., DNA has a GC content of over 70% and in the third position of any 
codon there is a 90% chance that the base is guanine or cytosine (Hopwood et al., 1987).
4.6.1 Design of a synthetic oligonucleotide corresponding to N -
terminal amino acid sequence
An oligonucleotide probe (32 mer, five degeneracies) was designed corresponding to the 
sequence of residues 2-12 of S.coelicolor DAHP synthase using the known streptomycete 
codon usage (Hopwood et a l 1987). The anti-sense oligonucleotide was constructed to 
facilitate mRNA analysis and is shown (Figure 4.6).
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Figure 4.6 The design of the oligonucleotide against the S.coelicolor
DAHP synthase A-term inus
The rationale for the probe design as described in section 4.6.1 is illustrated. The amino acid sequence is 
shown with the corresponding codon favoured in Streptomyces sp .; if two codons are equally favoured, a 
degeneracy is introduced in the third base position of the codon. The complementary anti-sense sequence is 
then derived and the oligonucleotide probe synthesised.
1 25
PENNQKPLTTVAGAPVPDNQNSLTSG N-terminal protein 
sequence
3 ’
GAG AAC AAC CAG AAG CCG CTG ACG ACG GTG GC
C C C C C
sense strand
CTC TTG TTG GTC TTC GGC GAC TGC TGC CAC CG
G G G G G
anti-sense strand
3 '
143
4.6.2 Design of a synthetic oligonucleotide corresponding to internal
peptide sequence
An oligonucleotide probe was designed corresponding to the sequence of residues 2-10 of 
a common tryptic/clostripain peptide (24 mer, 4 degeneracies) and the complementary anti­
sense sequence synthesized, see Figure 4.7.
4.6.3 Design of an oligonucleotide corresponding to a putative active 
site sequence
Mutational analysis of the E.coli tryptophan sensitive isozyme has revealed putative active 
site residues (Ray et al., 1988) which lie within two stretches of highly conserved protein 
sequence which are found in all three E.coli isozymes and the two cloned S.cerevisiae 
isozymes (Figure 4.8). Employing the rules of streptomycete codon bias an oligonucleotide 
probe was designed corresponding to this stretch of 16 conserved amino acids and is 
shown (47 mer, 8 degeneracies) in Figure 4.9.
4.7 Alignment of S .c o e l ic o lo r  DAHP synthase amino acid
sequences with the protein sequence data base
WordSearch, Bestfit and Segments programmes were used to carry out comparisons of the
S.coelicolor sequences with the protein sequence data base as described in Materials and 
Methods (section 2.22).
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Figure 4.7 The design of the oligonucleotide against internal peptide
sequence from the S.coelicolor DAHP synthase
The rationale for the probe design as described in section 4.6.2 is illustrated. The amino acid sequence is 
shown with the corresponding codon favoured in Streptomyces sp.; if two codons are equally favoured, a 
degeneracy is introduced in the third base position of the codon. The complementary anti-sense sequence is 
then derived and the oligonucleotide probe synthesised.
1 13
7PM LLQDVW FLEK tryptic/clostripain 
peptide sequence
3 '
CCG ATG CTC CTC CAG GAC GTG TGG TTC 
C G G C
sense strand
GGC TAC GAG GAG GTC CTG CAG ACC AAG 
G C C G
anti-sense strand
3 ’ 5 '
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A r o 3   M F I K  NDHAGDRKRL EDVfRIKGYDP
E c o o r o g  .............................................. MNYQN D D L R I K E I K E
A r o 4  MSESPMFAAN GMPKVNQGAE E D V R 1LGYDP
E c o o r o f  ........................................... MOKDAL NNV H I  TDEQV
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TF 
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F
fS/TlF
DL
FtVAL
CL
EL
3HE
LEK
3VO
<AA
ALR
5 0
ISAKGEEN
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A TP T S L ET
H l s l o q e a o
TPGVATH
51
A r o 3  I I K aE d SVCD 
E c o o r o g  V A HARKAI HK  
A r o 4  AKRGRREA1D  
E c o o r o f  I AD S RK S 1 SD  
E c o o r o h  V T D S R R R I E K
LN 
L
I T  
IA
G K D D R L
KGNDDRL
GKDDRV
G P D P
D K
I VVVI
V I
RLL VV  
RLL V I  I
SLHICPC  
GPCS 
PCS 
PCS  
GPCS I
V 3
CG
PKA A 
PVAjA 
LE 
PE71 
LT
A AO 
AL
A AM
DY ACR
TR
ALR
APR
100
L A K I S E K L S K  
L L AL RE E L KD  
LKKLSDELKG  
FKALAAEVSO
l q s l r n o y o s
101
A r o 3  DL 
E c o o r o g  E 
A r o 4  DL 
E c o o r o f  5L  
E c o o r o h  R
151  
A r o 3  EKLjPj 
E c o o r o g  SGL 
A r o 4  IGL  
E c o o r o f  MGL 
E c o o r o h  LGVP
IAGEVL
LMSW
LVSF
AAGEF 
I GSEVL  
LATEAL  
TATEF
MNN S F 0 1 N  
MON SFQJN  
VNN T F N I N K  
MDG SFDVEA  
gpLNG SYRVN
KG
OG
1 5 0  
M F I K L V . 
L L L D I N O  
L F VN L TN  
R k L L L E L V N
r|<l l l q v n e
IGAR TTES  
IGAR TTES  
IGAR TTES  
IGAR TTES  
IGAR TTESQll
gLShCNH
qIl h
QfTH
RE
RE
HRE
R
HR
asjgJl  s
A
FF
9CFV
SF
SGL
a s g l :
ASGL 
ASA LSJCFf/
200 I
SMFjVGF
GF
GF 
GF 
FtVGF
201
A r o 3  KNGTDGGLQV  
E c o o r o g  K NG TD GTI KV  
A r o 4  KNGT . . LNV 
E c o o r o f  KNGTOGSLAT  
E c o o r o h  KNGTDGNTRI
MR AA 
INAA
AH
GA
ICA 
A| IC A 
CAC 
NAM 
VO A I RlAAlAQ
:q a a a h
4RAAA0
EHY
PHC
PHR
I’M
LSVTKP  
LSVTKW 
GVTKH  
V GI NOA  
h f C L S P D K N
T A I V G  
S A I V N  
AA I TT 
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M T I Y Q
TE G
SG
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DCHI  
HCFV  
DGHV 
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NGt
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RG 
RG 
RG 
RG 
IM RG
251  
A r o 3  GKNG
E c o o r o g  GK
A r o 4  CKKGT 
E c o o r o f  GK
T N F DKE SVQNTKKQLE KAGLTDDSQK R | M |  
E P W S A K  HVAEVKEGLN K A G L P . . . .  A QVM IDF
My DAK SVAEAKAOLP . A G S  N GLMI DY
APNYSPA OVAOCEKEME O A G L R . . . . P  SLMVDC 
E c o o r o h  G K k . P N Y H A D  D I A A A C D T L H  E F D L P . . . . E  HLVVqF
CCS
NKD
3 0 °  
DFKNQPK
OFKK OVD
DFRNQPK
YRRQPA
OHRRGLE
A r o3  
E c o o r o g  
A r o4  
E c o o r o f  
E c o o r o h
30 1
AKCIYClGlLT EHENSLCJCMM 
V G A 0 V C G 3 I A  G G E K A I I G V M
VNDVVCE
a e s v v a Jq
V C E DI C G 3
IA N G ENA I T| 
IK O G N R S I I
I R  N G S T A I A G I
G V M 
GLM
E NtGjRjO 
E S HLVEGN3
I
l lESHlMEGMO  
E S MI HEGNP  
Ml A E S r LREG
Y G C S VDI PKEGGREG LK 
SL . . E . SGEP LAYGkH  
G I P A E . GKAG LKYG S I
S . S E Q . P R S E  MKjYGtvtS V
K I V GSOP LTYCOS
3 5 0  
TCU 
TC A 
TC A 
TO A 
TOP
A r o 3  
E c o o r o g  
A r o4  
E c o o r o f
3 51  3 7 7
cjlGWESTEQV LEL LAEGVRN RRKALKK  
CIGWEDTDAL LROLANAVKA R R G . .  .
C I GWETTEOV LRKLAAAVRQ RREVNKK
c i s w e m t d a l  l r e i h o d l n g  o l t a r v a
E c o o r o h  CLGWEDRORL VEKLASAVQT RF
Figure 4.8 Sequence alignment of DAHP synthases from
S.cerevisiae  and E .co li
Sequences were aligned as described in section 4.6.3. Amino acid residues conserved in all five sequences 
are boxed. The sequence used to design the heterologous probe is hatched (Adapted from G. Braus, personal 
communication, 1991).
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Figure 4.9 The heterologous oligonucleotide designed against a putative 
conserved active-site sequence
The rationale for the probe design as described in section 4.6.3 is illustrated. The amino acid sequence is shown with 
the corresponding codon favoured in Streptomyces sp.; if two codons are equally favoured, a degeneracy is introduced 
in the third base position of the codon. In this case the sense strand sequence was used.
95 110
EK PR TT V G W K G LIN D P E.coli aroG sequence
5 ' 3 ’
GAG AAG CCG CCG ACC ACC GTC GGC TGG AAG GGC CTC ATC AAC GGC CC 
C C G G G G G
sense strand
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4.7.1 Comparison of the S.coelicolor DAHP synthase iV-terminal
sequence with the protein sequence data base
Among enzyme sequences bovine catalase showed the greatest similarity to the 
S.coelicolor DAHP synthase N-terminal sequence (Figure 4.10). A similarity rating 
(which scores positively for identical residues and for chemically similar residues and 
negatively for gaps introduced to improve alignment) of 12 was calculated for this 
comparison. One other protein, black beetle virus coat protein precursor, also scored 12, 
and the next highest score, 11, was human catalase. Four other protein sequences shared 7 
or more identities with the 26 amino acid sequence of the N-terminus, without the 
introduction of any gaps in the sequences; these were B.thuringiensis parasporal crystal 
protein, Rhodospirillum rubrum ATP synthase, human cytochrome P450 (Arol)and 
human apolipoprotein A precursor, respectively. Twenty-five proteins gave a similarity 
ratings of 10.
4.7.2 Comparison of the S.coelicolor DAHP synthase internal
peptide sequence with the protein sequence data base
The unambiguously identified 12 residues of the common tryptic/clostripain peptide were 
compared with the protein sequence data base as above. Human mitochondrial NADH 
ubiquinone reductase with seven out of twelve residues matching shared the greatest 
similarity (Figure 4.11). Another thirty-two protein sequences possessed six out of twelve 
identities including members of the catalase family (Figure 4.10) and the E.coli 
phenylalanine sensitive DAHP synthase (Figure 4.12).
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Figure 4.10 Alignment of the S.coelicolor DAHP synthase sequence with
bovine catalase
Sequences were aligned as described in sections 4.7.1 and 4.7.2. Bovine catalase is compared with the first 26 
amino acid residues of the S.coelicolor DAHP synthase and the clostripain/tryptic peptide sequence. Identical 
amino acids are indicated by double dots.
17 59
QRAAQKPDVLTTGGGNPVGDKLNSLTVGPRGPLLVQDWFTDE bovine catalase
•  • •  •  •  •  •  •  •  •  • • •  •
•  • •  • • •  •  • •  •  • • • •  •  •  •  • • •  •
PENNQKP. . LTTVAGAPVPDNQNSLTSG 7PMLLQDVWFLEK S.coelicolor
1 2 6 1 13 DAHP synthase
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Figure 4.11 Alignment of the S.coelicolor DAHP synthase peptide 
sequence with NADH ubiquinone reductase
Sequences were aligned as described in section 4.7.2. NADH ubiquinone reductase is compared with the amino 
acid residues of the S.coelicolor DAHP synthase clostripain/tryptic peptide sequence. Identical amino acids are 
indicated by double dots.
NADH ubiquinone reductase 
S.coelicolor DAHP synthase
549  560
PLLLLDLTWLEK
•  •  •  •  •  •  •
•  •  •  •  •  •  •
7PMLLQDVWFLEK
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Figure 4.12 Alignment of the S.coelicolor DAHP synthase with the 
E.coli phenylalanine sensitive isozyme
Sequences were aligned as described in section 4.7.2. E.coli DAHP synthase (phenylalanine inhibitable) is 
compared with the amino acid residues of the S.coelicolor DAHP synthase clostripain/tryptic peptide 
sequence. Identical amino acids are indicated by double dots, residues conserved between the three E.coli 
isozymes are asterixed.
15 * * * 26
K E L L P P  V A LLEK  E.coli aroG
•  •  •  •  •  •
•  «  •  •  •  •
? PM LLQDVW FLEK S.coelicolor DAHP synthase
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4.8 D iscu ssion
The first twenty-six amino acid residues of the S.coelicolor DAHP synthase were 
identified unambiguously from the //-terminus (Figure 4.1) and the sequence manually 
compared with the //-terminal regions of the E.coli isozymes (Schultz and Herrman,
1981), the phenylalanine sensitive isozyme from S.cerevisiae (Paravicini et al., 1988) and 
the tryptophan activated enzyme from Solanum tuberosum (Dyer et al., 1990). No 
significant identity was found although this was not unexpected as the first 41 residues of 
the otherwise highly homologous E.coli isozymes share only 6 amino acid identities (Ray 
et al., 1988). Indeed, one must beware of drawing conclusions from //-terminal 
sequence data alone. Thus on the basis of the sequence of the first 40 amino acids of the 
E.coli isozymes it was wrongly concluded that the three isoenzymes evolved 
independently and not from a common ancestor (Poling et al., 1981). However, when the 
complete sequences of the isozymes were determined (Davies and Davidson, 1982; Schultz 
et al., 1984; Ray et al., 1988) it became apparent that the three genes were highly 
homologous, with 40% of the amino acid sequence identical (Ray et al., 1988).
Comparison of the //-terminal sequence with the protein sequence data base produced a 
potentially curious result. Bovine catalase, and to a lesser extent human and yeast catalases, 
exhibited the greatest similarity to the S.coelicolor DAHP synthase. It is hard to assess the 
significance of these findings. Assessing the significance of alignments over short regions 
(20-40 residues) presents problems if the alignment occurs with repeating amino acids or 
amongst the most frequently occurring amino acids (e.g. glycine, alanine, leucine). The 
chance of a match occurring by chance is significant (Doolittle, 1981) and the catalase 
alignment involves common amino acids. Because of these difficulties we do not regard 
these matches as significant and certainly do not regard them as evidence for any 
evolutionary relationship between catalase and DAHP synthase.
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A further possibility is that the apparently conserved sequence is associated with a specific 
type of secondary structure. The corresponding region of the bovine catalase sequence lies 
between two a-helices of the A-terminal domain (Murthy et al., 1981) and forms three p- 
tums. The A-terminal domain is involved in subunit interaction, is distinct from the 
catalytic and heme binding region of the enzyme, and is amongst the least conserved 
between the catalase sequences. The conserved S.coelicolor Gly-13 and Asn-20 residues 
(Figure 4.10) could similarly participate in the formation of two p-tums corresponding to 
two of the three p-tums found in the bovine catalase structure (Milner-White and Poet,
1987).
The region of greatest similarity between the E.coli isozymes is the stretch between 
residues 52 and 190, which includes blocks of virtually identical sequence (Ray et al.,
1988). It was against one of these sequence blocks that our conserved heterologous probe 
was designed.
We carried out proteolytic digests of intact S.coelicolor DAHP synthase in order to obtain 
enough suitable sequence with which to design oligonucleotide probes and to undertake 
comparative studes, with the hope of identifying a region sharing sequence identities with 
the published DAHP synthase sequences. Considering the amount of time spent preparing 
and purifying the peptides, we were disappointed with the quantity of sequence data we 
obtained. Only one peptide sequence was sufficiently long to be useful for probe design 
and sequence comparison analysis. WordSearch analysis yielded a set of proteins with six 
and, in one case, seven matches (Figure 4.11) with the twelve residues of the peptide 
sequence. One of these sequences was a DAHP synthase sequence, that of the E.coli 
phenylalanine-sensitive isozyme, but of the six identities found (Figure 4.12), only one 
was conserved in all three of the E.coli DAHP synthases. The sequence is located at the 
A-terminal region of the enzyme, and as this region is the least conserved between the
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isozymes it seems unlikely that this sequence alignment is of any significance.
Therefore, we can conclude that this peptide is not derived from a region of the 
S.coelicolor DAHP synthase exhibiting strong sequence identity with a conserved region 
of the E.coli isozymes and the other protein alignments derived, including the best one, 
that with NADH ubiquinone reductase, would not appear to be significant
The GC codon bias of streptomycetes, believed to have developed as a mechanism to 
enable control of cellular differentiation (Chater, 1989) may impose constraints on the 
amino acid composition of streptomycete proteins. The amino acid composition of globular 
proteins functioning in solution in an aqueous environment is remarkably similar 
(Creighton, 1983). However, residues such as Lys, Arg, lie, whose favoured 
streptomycete codon possesses only one G or C base per codon triplet may be predicted to 
be less abundant than in organisms without such a codon bias. From our limited data, Lys 
and lie with a frequency of 4.2 and 3.3% respectively, are significantly lower than the 
average values listed in the Atlas of Protein Sequence and Structure of 6 and 5%, 
respectively. Nevertheless, an overall comparison of many more streptomycete proteins 
requires to be undertaken before the generality of this conclusion can be confirmed.
In conclusion, the limited sequence data obtained from the S.coelicolor DAHP synthase is 
disimilar to the homologous E.coli and S.cerevisiae isoenzymes. Overall sequence 
identity between the potato (Dyer et al., 1990) and the other published sequences is less 
than 25%, and to detect this level of similarity a complete amino acid sequence was 
required, as some regions exhibited no similarity at all. A full comparison must therefore 
wait until more of the S.coelicolor sequence has been obtained.
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Chapter 5 The cloning of the DAHP synthase gene 
from Streptomyces coelicolor
5 .1 Introduction
This chapter describes attempts to clone the S.coelicolor DAHP synthase gene by "reverse 
genetics". Hybridisation signals were identified following screening of genomic digests of 
S.coelicolor DNA with oligonucleotide probes. An appropriate restriction fragment was 
partially purified by size fractionation and used to generate an S.coelicolor genomic sub­
library containing BamH. I fragments from 8-14 kb in size subcloned into vector pUCl8.
A genuine positive could not be isolated from this sub-library. A S.coelicolor genomic 
library constructed in XGEM-11 was then screened. Two putative positive plaques were 
identified, isolated and purified. DNA was prepared from one isolate and analysed further. 
The pattern of hybridising restriction fragments was identical to that already seen for the 
genomic digests. It would appear likely that this phage insert contains the gene which codes 
for the S.coelicolor DAHP synthase.
5 .2  The oligonucleotides used as probes
Amino acid sequence derived from the S.coelicolor DAHP synthase was used to design 
two homologous oligonucleotide probes using the rationale outlined in section 4.6. A third 
heterologous oligonucleotide designed against a sequence conserved between the E.coli 
and S.cerevisiae DAHP synthase isoenzymes (Figure 4.8) and implicated in catalysis (Ray 
et al., 1988) was also synthesised (section 4.6.3). These oligonucleotides designed to 
detect the coding sequences of the //-terminal region, the internal peptide, and the putative 
active site peptide, respectively, are shown (Figure 4.6,4.7 and 4.9).
5 .3  Southern blot analysis of digests of S.coelicolor genomic 
DNA
S.coelicolor genomic DNA was prepared and digested with a range of restriction enzymes 
as described in Materials and Methods (sections 2.9,2.12). 5 1xg of genomic DNA was
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used for each digest 10 fig of total mammalian DNA (haploid genome size of 3 x 109 bp) 
is required to detect sequences which occur at the single copy level on a Southern blot 
(Sambrook et al.t 1989). It was assumed that the S.coelicolor DAHP synthase gene 
would be present in a single copy within the S.coelicolor genome (genome size 8 x 106 
bp) (D. Hopwood, personal communication, 1991). Therefore, a digest of 5 |ig of 
genomic DNA was estimated to be sufficient to allow detection.
The cleaved DNA was separated by agarose gel electrophoresis as described in section 2.13 
(Figure 5.1). To improve the resolution of the separated DNA bands, gels were ran 
overnight at 20 V using a Tris-acetate buffer system. The DNA was then transferred to 
nylon filters as described in section 2.17, and the filters probed with the appropriate 
oligonucleotides following the method of Binnie, 1990.
5 .3 .1  Probing with the iV-terminal oligonucleotide
Filters containing genomic S.coelicolor DNA cut with one of four restriction enzymes 
were prepared (section 5.3) and prehybridised as described in section 2.19.
The ^ /-terminal oligonucleotide was end-labelled with 32p and separated from 
unincorporated label as described in section 2.18. Aliquots of the radioactively labelled 
oligonucleotide were then added to a polythene bag containing the filter and the 
hybridisation solution. The hybridisation solution was as follows:- 6 x SSC, 0.05% (w/v) 
sodium pyrophosphate, 0.05% (w/v) SDS. The bag was sealed and probe plus filter 
incubated as described in section 2.19. Hybridisation reactions were carried out at a range 
of temperatures, 60°C being the highest temperature employed.
The hybridised filters were then washed as described in section 2.19. The oligonucleotide 
remained bound when washed at a temperature of 65°C and ionic strength of 1 x SSC.
Filters were then autoradiographed as described in section 2.19 for 38 hours. Autorads
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from a lower stringency hybridisation (hybridising at 50°C, washing at 55°C) (Figure 5.2) 
and a higher stringency (hybridising at 60°C, washing at 65°C) (Figure 5.3) are also 
shown.
At the highest stringency (hybridising at 60°C in 6 x SSC; washing at 65°C in 1 x SSC), 
a single hybridising restriction band is seen for each digest. The size of the hybridising 
DNA band for each restriction digest following incubation with the A-terminal probe is 
given in Table 5.1.
5.3.2 Probing with the peptide oligonucleotide
Fresh filters were prepared as before (section 5.3) or filters re-used following the removal 
of old probe (section 2.23). The probe labelling and hybridisation reactions were carried 
out as before (section 5.3.1). Hybridisation reactions were carried out at a range of 
temperatures, 60°C being the highest temperature employed.The oligonucleotide remained 
bound when washed at a temperature of 65°C and ionic strength of 1 x SSC.
At the highest stringency (hybridising at 60°C in 6 x SSC; washing at 65°C in 1 x SSC) a 
single hybridising restriction band is seen following autoradiography for 40 hours (Figure 
5.4). The size of the hybridising DNA band for each restriction digest following incubation 
with the peptide probe is given (Table 5.1). In this case the Pst I digest track contains no 
signal. On closer analysis it became apparent that one of the possible degenerate sequences 
corresponding to our probe contains a Pst I restriction site. The DNA must have been 
cleaved in this region preventing hybrid formation.
5 .3 .3  Probing with the consensus oligonucleotide
Fresh filters were prepared as before (section 5.3) or filters re-used following the removal 
of old probe (section 2.23). The probe labelling and hybridisation reactions were carried
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23 kb
—  9.4 kb
—  6.6 kb
—  4.4 kb
^  2.3 kb 
—  2 kb
0.5 kb
Figure 5.1 Agarose gel electrophoresis of restriction digests of 
S.coelicolor genomic DNA
Gel was run as described in section 5.3. 5 jig of DNA per lane was digested (section 2.12) with the 
following the enzymes
Lane 1 : BamH I 
Lane 2 : Sal I 
Lane 3 : Sst I 
Lane 4 : Pst I
Lane 5 : uncut genomic DNA 
Lane 6 : X-Hind III Mr markers
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Figure 5.2 Autoradiograph of a Southern blot of digested genomic
S.coelicolor DNA probed with the iV-terminal 
oligonucleotide
DNA was digested with a range of restriction enzymes, the products separated by agarose electrophoresis 
(Figure 5.1) and transferred to a nylon filter by the method of Southern (section 5.3). The reaction with 
the A-terminal oligonucleotide was carried out under less stringent hybridisation (50°C, 6 x SSC) and 
washing (55°C, 6 x SSC) conditions as described in section 5.3.1.
Lane 1 : Sst I 
Lane 2 : BamH I 
Lane 3 : Sa il 
Lane 4 : Pst I
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Figure 5.3 Autoradiograph of a Southern blot of digested genomic
S.coelicolor DNA probed with the N-term inal
o ligon ucleotide
DNA was digested with a range of restriction enzymes, the products separated by agarose electrophoresis 
(Figure 5.1) and transferred to a nylon Filter by the method of Southern (section 5.3). The reaction with 
the N-terminal oligonucleotide was carried out under stringent hybridisation (60°C, 6 x SSC) and 
washing (65°C, 1 x SSC) conditions as described in section 5.3.1.
Lane 1 : BamH I 
Lane2: Sail 
Lane 3 : Sst I 
Lane 4 : Pst I
Lane 5 : uncut genomic DNA
The size of the single strongly hybridising band for each lane is indicated and listed (Table 5.1).
1 2  3 4
11 kb
5.5 kb
1.7 kb
Figure 5.4 Autoradiograph of a Southern blot of digested genomic
S.coelicolor DNA probed with the peptide 
oligonucleotide
DNA was digested with a range of restriction enzymes, the products separated by agarose electrophoresis 
(Figure 5.1) and transferred to a nylon filter by the method of Southern (section 5.3). The reaction with 
the peptide oligonucleotide was carried out under stringent hybridisation (60°C, 6 x SSC) and washing 
(65°C, 1 x SSC) conditions as described in section 5.3.2.
Lane 1 : Sst I 
Lane 2 : BamH I 
Lane 3 : Sal I 
Lane 4 : Pst I
The size of the single strongly hybridising band for each lane is indicated and listed (Table 5.1).
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Table 5.1 Size of hybridising restriction fragments obtained from 
digests of S.coelicolor genomic DNA
Restriction enzyme(s) Probe Fragment size(kb) Reference
Sst I IV-terminal 5.5 Figure 5.3
f t peptide i t Figure 5.4
BamH I //-terminal 11 Figure 5.3
i t peptide t i Figure 5.4
Sail //-terminal 1.7 Figure 5.3
i t peptide i i Figure 5.4
Pst I ^-terminal 10 Figure 5.3
t i peptide none Figure 5.4
Sphl //-terminal 5.6 Figure 5.6
t f peptide i i Figure 5.7
Kpn I //-terminal 8 Figure 5.6
t t peptide i i Figure 5.7
BamH 1/Pst I //-terminal 5.9 Figure 5.6
if peptide none Figure 5.7
Pst 1/Sst I //-terminal 4.7 Figure 5.6
i t peptide none Figure 5.7
Pst 1/Kpn I //-terminal 4.5 Figure 5.6
i i peptide none Figure 5.7
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out as before (section 5.3.1). Hybridisation reactions were carried out at a range of 
temperatures between 50°C and 60°C and the filters were washed in high salt buffer (6 x 
SSC) within the same temperature range.
Following autoradiograhy (40 hour exposure) no discrete hybridising restriction fragments 
could be visualised. At the lowest stringency (hybridising and washing at 50°C in 6 x 
SSC), a smear was present in the area of the high Mr DNA on the autorad. This would 
appear to be the result of non-specific hybridisation. At moderately more stringent 
conditions (hybridising at 50°C and washing at 55°C in 6 x SSC) this high Mr signal was 
removed and no other bands were seen.
Consequently, use of this probe was discontinued.
5 .4  Choosing an appropriately sized restriction fragment to clone
In selecting an optimal restriction digest fragment for cloning the following criteria were 
employed
(1) the fragment must be large enough to ensure a reasonable chance o f cloning the entire 
DAHP synthase gene as opposed to only part of the gene.
The subunit size of the S.coelicolor DAHP synthase would indicate a polypeptide 
composed of around 500 amino acids, which could be encoded by a DNA fragment of 
around 1.5 kb. Allowing for a degree of overlap either side of the coding region it was 
decided that a restriction fragment of around 5 kb would be ideal.
(2) the fragment must be generated by the action o f restriction enzymes found in the 
plasmidpUC18 polylinker region.
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This would allow us to use the pUC18 plasmid, one of a series, which in addition to 
carrying a selectable antibiotic marker, possess IPTG-inducible histochemical selection 
when used in an appropriate host (section 2.16.3). This property facilitates easy 
identification of recombinants.
(3) ideally the fragment should be generated by the action of two restriction enzymes 
found in the pUC18 poly linker region, thus allowing directional cloning of the DNA 
fragment and preventing self-ligation of the plasmid.
(4) if a double digest fragment of the appropriate size could not be obtained then a 
restriction enzyme cutting to leave a 5’ phosphate overhang would be the next choice. 
Enzymes which leave a 3' hydroxyl overhang cannot be readily dephosphorylated by 
alkaline phosphatase at the 5 'position and such overhanging linearised plasmids readily 
self-ligate.
5 .4 .1  Digestion of S .c o e l ic o lo r  genomic DNA with pairs of
restriction enzymes
S.coelicolor genomic DNA was prepared and digested with a range of restriction enzymes 
whose recognition sequences lie within in the pUC18 polylinker cloning region. Single and 
double digests were carried out, cleaved DNA fragments separated by agarose 
electrophoresis (Figure 5.5) and filters prepared as before (section 5.3).
Filters were incubated with the N-terminal probe and washed under the conditions of 
highest stringency previously described (section 5.3.1). Filters were autoradiographed for 
80 hours and a pattern of hybridising restriction fragments obtained (Figure 5.6). The size 
of each hybridising DNA band is given (Table 5.1).
Filters were stripped of probe (section 2.23) and the procedure repeated with the internal 
peptide oligonucleotide (Figure 5.7). The size of each hybridising DNA band is given
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23 kb
9.4 kb
6.6 kb
4.4 kb
2.3 kb 
2 kb
0.5 kb
Figure 5.5 Agarose gel electrophoresis of double and single 
restriction digests of S.coelicolor genomic DNA
Gel was run as described in section 5.4.1. 5jig of DNA per lane was digested (section 2.12) with the 
following the enzymes
Lane 1 : X-Hind HI Mr markers
Lane 2 : Sst I
Lane 3 : BamH I
Lane 4 : Pst I
Lane 5 : Sph I
Lane 6 : Kpn I
Lane 7 : BamH I /Sst  I
Lane 8 : B am H l /P s t l
Lane 9 : BamH I /  Sph I
Lane 10: BamH 11 Kpn I
Lane 11 : Pst I /Sst  I
Lane 12: Pst I /  Kpn I
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Figure 5.6 Autoradiograph of a Southern blot of single and double
digests of genomic S.coelicolor DNA probed with the
TV-terminal oligonucleotide
DNA from a genomic digest (Figure 5.5) was transferred to a nylon filter by the method of Southern 
(section 5.3). The reaction with the TV-terminal oligonucleotide was carried out under stringent 
hybridisation (60°C, 6 x SSC) and washing (65°C, 1 x SSC) conditions as described in section 5.3.1.
Lane 1: Sst I
Lane 2 : BamH I
Lane 3 : Pst I
Lane 4 : Sph I
Lane 5 : Kpn I
Lane 6 : BamH I / Sst I
Lane 7 : BamH I / Pst I
Lane 8: BamH I / Sph I
Lane 9 : B am H l /K pn l
Lane 10: Pst I /Sst  I
Lane 11 : Pst I /Kpn  I
The size of the single strongly hybridising band for each lane is indicated and listed (Table 5.1). Where the 
product of a double digestion is not smaller than the single digestion product for either of the individual 
restriction enzymes (ie. the digests in Lanes 6 ,8 ,9 , respectively) the fragment size is not listed.
Figure 5.7 Autoradiograph of a Southern blot of single and double
digests of genomic S.coelicolor  DNA probed with the
peptide oligonucleotide
DNA from a genomic digest (Figure 5.5) was transferred to a nylon filter by the method of Southern 
(section 5.3). The reaction with the peptide oligonucleotide was carried out under stringent hybridisation 
(60°C, 6 x SSC) and washing (65°C, 1 x SSC) conditions as described in section 5.3.2.
Lane 1 : Sst I
Lane 2 : BamH. I
Lane 3 : Pst I
Lane 4 : Sph I
Lane 5 : Kpn I
Lane 6 : BamH 11 Sst \
Lane 7 : BamH I /Pst  I
Lane 8 : BamH I /  Sph I
Lane 9 : BamH I /  Kpn I
Lane 10: Pst I /S s t  I
Lane 11 : Pst I /  Kpn I
The size of the single strongly hybridising band for each lane is indicated and listed (Table 5.1). Where the 
product of a double digestion is not smaller than the single digestion product for either of the individual 
restriction enzymes (ie. the digests in Lanes 6, 8,9, respectively) the fragment size is not listed.
(Table 5.1).
5 . 4 . 2  The choice of restriction fragment
The results obtained from probing double and single digests of S.coelicolor genomic DNA 
were used to decide which restriction fragment to clone. The GC bias of Streptomyces 
DNA now hindered our efforts as conventional restriction enzymes cut GC rich DNA 
relatively infrequently.
Double restriction digests employing polylinker restriction enzymes gave only two suitably 
sized 5 kb fragments, a Pst l/Kpn I fragment of 4.5 kb and a Pst I/Sst I fragment 4.7 kb 
(Table 5.1), but as the internal peptide probe contains a Pst I site they cannot be used as 
they could not contain the whole gene (section 5.3.2).
Digestion with the restriction enzymes Sst I and Sph I gave a suitably sized fragments of
5.5 kb and 5.6 kb, respectively (Table 5.1) but these enzymes cut to leave 3* hydroxyl 
overhangs and were not suitable (section 5.4).
The 1.7 kb fragment generated by the action of the Sal I enzyme was considered too small 
to have a reasonable chance of containing the whole gene (Table 5.1) (section 5.4)
A range of single restriction enzyme digests gave fragment sizes between 8 and 11 kb 
(Table 5.1) including those generated by Kpn I (8 kb), Pst I (10 kb) and BamH I (11 
kb). Kpn I cuts to leave a 3' hydroxyl overhang and the Pst I fragment is also not suitable 
(section 5.3.2,5.4), therefore it was decided to isolate and enrich for the 11 kb BamH I 
fragment and to ligate it into an appropriately cut and dephosphorylated preparation of 
plasmid pUC18. (This procedure was made easier with the availability of plasmid ready cut 
with BamH I and treated with bacterial alkaline phosphatase.)
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5 .5  Attempts to isolate the S.coelicolor DAHP synthase gene from
a genomic sub-library in pUC18
5.5.1 Size fractionation and purification of fragments from a 
Bam H  I digestion of S.coelicolor genomic DNA
A sample of S.coelicolor genomic DNA was digested exhaustively with BamH I (section 
2.12) and the resulting fragments separated by agarose electrophoresis (section 2.13) 
(Figure 5.8). Restriction fragments of the appropriate size were located, excised from the 
gel, and recovered from the gel by electroelution (section 2.14.2).The sizes of the 
recovered fragments were estimated by agarose gel analysis. DNA from the genomic digest 
gel was blotted onto nylon filters by the method of Southern (section 2.17) and probed 
with the N-terminal oligonucleotide (section 5.3.1) to verify that the correct fragment size 
of DNA had been excised and purified from the gel.
5.5 .2  Ligation of BamH  I fragments into plasmid pUC18
Purified BamH I DNA fragments (section 5.5.1) were ligated into plasmid pUC18 as 
described in section 2.15. Appropriate test ligations were carried out using cut A.-DNA 
(section 2.1.5) and agarose gel analysis was carried out to establish that control and sample 
ligations had been successful.
5 .5 .3  Transformation of E.coli with plasmid DNA
Test plasmid (uncut pUC18) and plasmid ligated with the purified BamH I fragments were 
used to transform E.coli as described in section 2.16. Following each round of 
transformation recombinants were picked and retained for screening. Plasmid DNA was 
made from a selection of recombinants (section 2.10) and digested with BamH I to check 
that the size of the insert in the plasmids was correct
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Figure 5.8 Purification and electroelution of BamH 1 restriction 
fragments of 8-14 kb in size from a total digest of 
S.coelicolor genomic DNA
The gel was run and the BamH I fragments electroeluted as described in section 5.5.1. 150 jig of DNA 
was digested (section 2.12) with the restriction enzyme BamH. I
Lane 1: X-Hind III Mr markers
Lane 2 : BamH I digestion products (V30 & of total digest)
Lane 3 : BamH I digestion products
(the remainder of the digest with excised band removed)
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5 . 5 . 4  Screening recombinants for the S.coelicolor DAHP synthase
gene by colony hybridisation
Recombinant pUC clones were screened (570 in total) as described in section 2.20 with 
both the iV-terminal and the internal peptide oligonucleotide probes. Positive clones could 
not be identified when hybridisation reactions were carried using the conditions employed 
for earlier hybridisation experiments involving S.coelicolor genomic DNA (section 5.3). 
This method of isolating the S.coelicolor DAHP synthase gene was therefore abandoned.
5 .6  Attempts to isolate the S .c o e l ic o lo r  DAHP synthase gene from
a genomic library constructed in A.GEM-11
A S.coelicolor genomic library was constructed in AGEM-11 by Mr. R.D. Taylor 
(Departments of Biochemistry and Genetics, University of Glasgow). Total genomic DNA 
was partially digested with the frequently cutting restriction enzyme Sou 3A, generating a 
near random pattern of fragments. 11-14 kb size fragments were purified and ligated with 
the XGEM-11 arms to generate the primary library of recombinant phage. This library was 
then amplified, stored and used as required in the gene screening programme.
5.6 .1  Primary screening
Plating bacteria were prepared (section 2.11.1 (a)) and infected with phage of titre 
measured (section 2.11.1) to be 2000 plaque forming units per plate (section 2.21(a)). 
Plates were incubated overnight and impressions of the plate onto nylon filters obtained as 
described in section 2.21 (a).
The filters were prepared (section 2.20) and probed with the N-terminal oligonucleotide 
probe (sections 2.19,5.3.1). Following autoradiography for 124 hours two putative 
positive signals were identified and designated XGW 4 (Figure 5.9) and AGW 5 (Figure
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Figure 5.9 Autoradiograph of primary filter 4 screened with the N~
terminal oligonucleotide
Filters were prepared and screened with the ^-terminal oligonucleotide as described in section 5.6.1. The 
large, strongly hybridising plaque XGW 4 (circled) was purified to homogeneity and further characterised. 
Other spots were spurious as they did not occur on a duplicate filter.
Figure 5.10 Autoradiograph of primary filter 5 screened with the N -
terminal oligonucleotide
Filters were prepared and screened with the //-terminal oligonucleotide as described in section 5.6.1. The 
large, strongly hybridising plaque XGW 5 (circled) was purified to homogeneity and further characterised. 
Other spots were spurious as they did not occur on a duplicate filter.
5.10), respectively.
5 .6 .2  Secondary screening
The putative positive plaques were isolated (section 2.11.2) and purified (section 2.21 (b)). 
Secondary filters were prepared as before (sections 2.20, 2.21 (a)), with 15 and 12 plaques 
picked and streaked out for the XGW 4and the^GW 5 isolates, respectively.
The filters were then probed with the N-terminal oligonucleotide as before (sections 2.19, 
5.31). Following autoradiography for 13 hours the positive signals were confirmed. 2 out 
of 15 of the plaques purified as the A.GW 4 isolate were positive (Figure 5.11), and 1 out 
of the 12 plaques purified as the A.GW 5 isolate was positive (Figure 5.12).
5.6 .3  Characterisation of the hybridising plaque XGW 4
DNA was prepared from the XGW 4 isolate (section 2.11.4), digested with Sal I, BamH.
I and Sst I (section 2.12) and the digestion products separated by agarose gel 
electrophoresis (section 2.13) (Figure 5.13). Two bands corresponding to the A.GEM-11 
arms were present in each of the lanes containing recombinant phage together with one or 
more genomic DNA insert bands.
The Southern blot of this gel (section 2.17) was probed with both the N-terminal and 
internal peptide oligonucleotides as before (sections 2.19, 5.3.1,5.3.2). Following 
autoradiography, a single hybridising band is seen for each digest (Figures 5.14,15). The 
size of these bands (Table 5.2) corresponds to those obtained from analysis of genomic 
digests of S.coelicolor DNA (Table 5.1). This confirms that the homology to the probe 
lies within the insert bands and establishes the authenticity of the clone.
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Figure 5.11 Autoradiograph of the A.GW 4 secondary filter screened 
with the A-terminal probe
The putative positive plaque XGW 4 was isolated, purified and duplicate secondary filters prepared as 
described in section 5.6.2. Positive plaques were indicated by dark crosses and plugs were prepared from 
these for long-term storage (section 2.11.2).
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Figure 5.12 Autoradiograph of the A.GW 5 secondary filter screened 
with the A-terminal oligonucleotide
The putative positive plaque XGW 5 was isolated, purified and duplicate secondary filters prepared as 
described in section 5.6.2. The positive plaque was indicated by a dark cross and plugs were prepared from 
this for long-term storage (section 2.11.2).
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Figure 5.13 Agarose gel electrophoresis of restriction digests of 
XGW  4 DNA
DNA was prepared from XGW 4 as described in section 5.6.3.0.5 jig of XGW 4 DNA per lane was 
digested (section 5.6.3) with the following the enzymes
Lane 1: X-Hind III Mr markers 
Lane 2 : uncut 
Lane 3 : BamH I 
Lane4: Sail
Each digest possesses two bands of 20 kb and 9 kb which correspond to the size of the arms of the 
AGEM-11 vector. Lane 2 possesses a single band of >23 kb which represents uncut A.GW 4. For the 
BamH I and Sal I digests the insert fragment sizes are listed above. An Sst I digest was also prepared 
and product fragments separated by agarose electrophoresis (data not shown). A fragment of 5.5 kb was 
identified, but smaller fragments could not be visualised.
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11 kb
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—  1.7 kb
Figure 5.14 Autoradiograph of a Southern blot of digested XGW 4
DNA probed with the /V-terminal oligonucleotide
A.GW 4 DNA was digested with a range of restriction enzymes (Figure 5.11) and was transferred to a nylon 
filter by the method of Southern (section 5.3). The reaction with the //-terminal oligonucleotide was 
carried out under stringent hybridisation (60°C, 6 x SSC) and washing (65°C, 6 x SSC) conditions as 
described in section 5.6.3.
Lane 1 : Sst I 
Lane 2 : BamH I 
Lane 3 : Sal I 
Lane 4 : uncut
The size of the single strongly hybridising band for each lane is indicated and listed (Table 5.2).
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Figure 5.15 Autoradiograph of a Southern blot of digested XGW 4
DNA probed with the peptide oligonucleotide
A.GW 4 DNA was digested with a range of restriction enzymes (Figure 5.11) and was transferred to a nylon 
filter by the method of Southern (section 5.3). The reaction with the peptide oligonucleotide was carried 
out under stringent hybridisation (60°C, 6 x SSC) and washing (65°C, 6 x SSC) conditions as described 
in section 5.6.3.
Lane 1 : Sst I 
Lane 2 : BamH I 
Lane 3 : Sal I 
Lane 4 : uncut
The size of the single strongly hybridising band for each lane is indicated and listed (Table 5.2).
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Table 5.2 Size of hybridising restriction fragments obtained from 
digests of XGW 4 DNA
Restriction enzyme(s) 
Sst I
it
BamH I
ii
Sail
II
Probe Fragment size(kb) Reference
Af-terminal 5.5 Figure 5.12
peptide " Figure 5.13
N-terminal 11 Figure 5.12
peptide " Figure 5.13
iV-terminal 1.7 Figure 5.12
peptide " Figure 5.13
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5 .7 D iscu ssion
Following digestion of S.coelicolor genomic DNA and hybridisation with various probes, 
restriction fragments were identified which could contain the S.coelicolor DAHP synthase 
gene. Following the failure to clone the gene from a genomic sub-library in vector pUC18, 
a S.coelicolor X library was screened and two hybridising plaques isolated. One of these 
was characterised further by restriction analysis. The hybridising bands corresponds to 
those seen in the earlier genomic digest experiments.
The signal obtained from probing S.coelicolor genomic DNA is sufficiently strong at 
conditions of high stringency to conclude that this represents a genuine specific 
hybridisation event. The stringency of a hybridisation reaction is governed by the factors of 
temperature and salt concentration. The hybridisation temperature affects the stability of 
hybrid DNA. If it is too low then non-specific binding to non-target DNA may occur 
(Figure 5.2), if it is too high then the Tm, the melting temperature of the duplex, may be 
exceeded and hybrid formation prevented. Hybridisation protocols advise temperatures in 
the range 5-10°C below the Tm for a given duplex (Binnie, 1990). The salt concentration 
was kept high (6 x SSC; 1 x SSC = 0.15 M-NaCl, 0.015 M-sodium citrate) to promote 
hybrid formation, then lowered (1 x SSC) during washing to remove probe bound non- 
specifically or weakly because of mismatches with the target DNA. These ionic conditions 
should favour the formation and detection of perfectly matched hybrids (Binnie, 1990).
Equations to calculate the Tm for any given duplex exist (Suggs et al., 1981; Anderson 
and Young, 1985 ; Albretsen et al., 1988). Factors influencing the Tm value include base 
composition (GC rich duplexes have a higher thermal stability than AT rich duplexes) and 
probe length. However, none of these equations are valid for the length and GC 
composition of the probes used in this study, or under the hybridisation conditions 
employed. In practice the Tm of an oligonucleotide-DNA duplex is determined empirically 
by carrying out a low stringency hybridisation and wash, and then making conditions
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progressively more stringent (ie. temperature increased, ionic strength decreased) until a 
single specific signal is retained
The more stringent the hybridisation and washing conditions employed the less one would 
expect mismatches between the oligonucleotide and the target DNA. Probes of similar 
length to those employed in this study have been used to isolate other genes from 
S.coelicolor (P.J. White, personal communication, 1990). In the case of the cloning of the 
gene encoding the enzyme 3-dehydroquinase, a 38-mer oligonucleotide containing two 
degeneracies was designed corresponding to N-terminal protein sequence. Stringent 
hybridisation and washing conditions, identical to those employed for the S.coelicolor 
DAHP synthase cloning, were used to isolate the gene. Subsequent sequencing of the DNA 
corresponding to the region complementary to the oligonucleotide probe revealed a single 
mismatch between the probe and target DNA sequences. By analogy, we expect there to be 
a similar absence of mismatches between the two homologous oligonucleotide probes 
employed in this study and the target DNA sequence corresponding to the DAHP synthase 
gene. Additionally, the fact that two probes have been used to isolate the same DNA 
fragment under conditions of such stringency make it highly unlikely that a DNA fragment 
has been isolated and cloned that does not correspond to the S.coelicolor DAHP synthase 
gene.
No strongly hybridising DNA fragments were identified following incubation of digests of 
S.coelicolor genomic DNA with a third oligonucleotide probe designed against a putative 
active-site sequence conserved between the E.coli and S.cerevisiae DAHP synthase 
isoenzymes (section 4.6.3). Following the failure of this work, the potato DAHP synthase 
sequence became available (Dyer et al., 1990) and was shown to share only two amino 
acid sequence identities with the sequence used to design the heterologous oligonucleotide 
probe (Figures 4.8,4.9), corresponding to residues 97 and 105 of the E.coli aroG 
sequence (Figure 5.16). In the five DAHP synthase sequences from E.coli and 
S.cerevisiae around 40% of the amino acid residues are common to all, but one can 
conclude from the potato sequence data that sequences from microbial and plant sources
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Figure 5.16 Alignment of DAHP synthase sequences from around
the putative active-site residues from microbial and 
plant sources corresponding to the consensus peptide 
probe
Sequences were aligned as described in section 2.22. Identical amino acids are indicated by bold type, a gap in 
the sequence by a dash.
101 115
Q L P E Y P N Q .  E E - L R S V L  Solatium tuberosum
97 112
E K P R T T V G W K G L I N D P  E.coli aroF
95 110
E K P R T T V G W K G L I N D P  E.coliaroG
94 109
E K P R T T V G W K G L I S D P  E.coliaroH
105 120
E K P R T T V G W K G L I N D P  S.cerevisiae aro3
111 126
E K P R T T V G W K G L I N D P  S.cerevisiae aro4
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exhibit a considerably lower level of sequence similarity than the microbial sequences.
Other microbial DAHP synthase sequences, including that of S.coelicolor, may exhibit a 
sequence similarity intermediate between the highly homologous E.coli and S.cerevisiae 
isoenzymes and the less homologous potato sequence. To ensure a reasonable chance of 
success when carrying out heterologous probing with relatively short oligonucleotides (eg. 
around 40 bp) where more than two nucleotide mismatches may be enough to prevent 
duplex formation at conditions of high stringency (R.D. Taylor, personal communication, 
1991), one must be convinced that specific residues within a sequence are catalytically 
essential and that this sequence is conserved within a number of evolutionary distant 
species. With hindsight it can be seen that these criteria were not fulfilled for our 
heterologous probe.
We failed to isolate recombinants strongly hybridising to either of the homologous 
oligonucleotide probes from a genomic sub-library in vector pUC18, We had calculated, 
from the size of the S.coelicolor genome (8 x 106 bp) (D. Hopwood, personal 
communication, 1991) and an estimate of the enrichment factor achieved by agarose 
electrophoresis of digested DNA, that in screening 200 recombinants our sequence should 
be represented. We screened 570 recombinants in total without success. Agarose gel 
analysis of digested plasmid purified from a random selection of recombinants revealed that 
only 30% possessed an insert fragment of the correct size (data not shown). Others 
represented cloned partial digest fragments, with these inserts containing one or more 
internal BamH. I restriction sites, despite our efforts to determine that digestion was 
complete. Additionally, control transformations with cut and dephosphorylated pUC18 
which was ligated without insert and should not have produced any white recombinants 
did, at a frequency of 8%. Plasmid prepared from this type of white colony could no longer 
be cut by BamH I and we assumed that the free cohesive termini of the cut plasmid had *
been degraded and the recognition sequence lost. The cumulative effect of these two points 
reduces the number of representative 8-14 kb BamH I fragment containing recombinants
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to around 170, concomitantly reducing the chances of having a reasonable chance of 
detecting the correct gene.
Two hybridising plaques were identified and purified from the S.coelicolor genomic 
library constructed in XGEM-11. Given the size of the S.coelicolor genome (8 x 106 bp) 
and following the equation of Clark and Carbon (1976), one would expect to screen 5,756 
independant recombinant plaques of the insert size 11-14 bp in order to have a reasonable 
chance (ie. a 99% probability) of including and identifying the desired sequence. From 
filters estimated to contain around 10,000 plaques we isolated two strongly hybridising 
plaques. This result would indicate that the amplification of the X library had not resulted in 
serious distortion in the frequency of the occurrence of the target DNA sequence.
One of the hybridising plaques was characterised further. The hybridising restriction digest 
pattern of fragments obtained from XGW 4 agrees with that previously obtained from 
experiments with genomic digests. The 11 kb BamH I X insert which hybridises to both 
homologous oligonucleotide probes is sufficiently large to encode the entire DAHP 
synthase gene. Further restriction digest mapping and sub-cloning is required before it can 
be concluded that the entire coding sequence lies within this insert
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Chapter 6 General discussion and future prospects
6 .1 Introduction
The preceding chapters have described in detail the progress made in fulfilling the original 
project objectives. It has been shown for S.coelicolor
(1) that only one DAHP synthase inhibitable by tryptophan is present.
(2) that this enzyme possesses catalytic properties consistent with those reported from other 
sources.
(3) that this activity is constitutively expressed.
(4) that the subunit Mr determined corresponds to those found for other plant, fungal, 
streptomycete, and corynebacteria DAHP synthases.
(5) that the limited amino acid sequence data obtained is dissimilar to the E.coli and 
S.cerevisiae isoenzymes.
Importantly, sufficient data has been obtained to enable us to conclude that in S.coelicolor, 
flux to aromatic amino acids, cofactors, and vitamins by way of the shikimate pathway is 
modulated by the end-product tryptophan acting via DAHP synthase.
6 .2  Evolutionary implications of the regulation of DAHP synthase
DAHP synthase is a regulatory enzyme subject to possibly the most diverse pattern of 
feedback inhibition known for a single enzyme. This diversity of allosteric control was 
initially appreciated following a survey of species spanning 32 genera of microorganisms 
(Jensen et al., 1967). This pattern, its use in delineating genealogical clusters, and its use in 
deducing evolutionary events, have already been described (sections 1.2.2.1; 1.2.2.1 (a)). It 
is pertinent to speculate as to how and why such a myriad of patterns arose.
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The influence of the environment on the life-style of a microorganism and consequently on the 
control of DAHP synthase has already been discussed (section 3.13), with the conclusion that 
particular regulatory patterns may be rationalised as adaptations to specific niches. In many 
present day prokaryotes allosteric regulation is focussed at the initial pathway step and is not 
always developed at terminal-branch or mid-pathway steps. This form of pathway regulation 
appears adequate for many organisms (eg. cyanobacteria, corynebacteria, streptomycetes) 
(Jensen and Hall, 1982) who possess a single DAHP synthase.
If this method suffices for one group of organisms, why do other groups require two or more 
isoenzyme forms ? The enteric bacteria possess three isoenzymes of DAHP synthase, and it 
has been suggested that enteric enzymes may be inflexible with regard to altering substrate 
specificity. Hence, a mutation to produce a single activity cumulatively inhibited by two or 
more effectors would be less likely than a gene duplication event leading to an isoenzyme with 
altered effector sensitivity (Baumberg, 1981). Sequence evidence from the enteric isoenzymes 
certainly favours a common evolutionary origin (Pittard, 1987), with a single binding pocket 
modified to accomodate different effectors (Weaver and Herrmann, 1990). The other proposal 
of domain recruitment of effector binding regions now appears unlikely (Schultz et al,
1984).
A further explanation for the apparently illogical plethora of regulatory mechanisms is that 
these present-day mechanisms may not reflect an optimal adaptation to current conditions, but 
are instead historical. A given feature may have been advantageous to an ancestor under very 
different cicumstances. The system was retained with modifications superimposed, rather than 
the de novo development of a new optimal system (Baumberg, 1981).
Further speculation on evolutionary events leading to the curent regulatory diversity should 
wait until many more DAHP synthase sequences from diverse organisms have been obtained.
1 8 6
Future work
The low levels of shikimate pathway enzymes found in most organisms has hindered the 
development of suitable purification procedures. Consequently, the application of chemical 
modification studies to identify catalytically important residues and elucidate possible reaction 
mechanisms has been delayed by a lack of protein. Where recombinant organisms, over­
expressing individual shikimate pathway genes are available, rapid progress has been made in 
this field (eg. Kleanthous et al., 1990). It should now be possible to overexpress the 
S.coelicolor DAHP synthase gene (using an appropriate streptomycete expression vector) in 
an amenable heterologous host (eg. S.lividans) and facilitate future physical and mechanistic 
studies.
A full analysis of the relationship between the S.coelicolor DAHP synthase and those from 
other organisms must await the determination of its full nucleotide sequence. From the data 
we have already obtained it is likely that the S.coelicolor DAHP synthase sequence may be 
dissimmilar to the highly homologous E.coli and S.cerevisiae sequences. The clustering of 
antibiotic biosynthesis genes has been discussed (section 1.10.1). Additionally, other 
biosynthetic genes may also be clustered in streptomycetes. The clustering of three tryptophan 
biosynthesis genes on a 7.2 kb sized DNA restriction fragment in S.griseus IMRU 3570 
(Lezcano et al., 1990) has been reported, as has the localisation of three shikimate pathway 
genes from the corynebacterium, Brevibacterium lactofermentum, to an 8.5 kb DNA 
fragment (Matsui et al., 1988). It would therefore be of interest to determine the nucleotide 
sequence up and downstream of the DAHP synthase coding region, in order to identify any 
other protein encoding regions and to determine by sequence comparison analysis the possible 
identity of these genes.
The study of metabolic flux in all organisms has been revolutionised by the application of flux 
control theory (Kacser and Bums, 1973), which provides a framework for the rational
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manipulation of the flow of intermediates through a pathway. Each catalytic step in a pathway 
possesses a unique 'flux control coefficient' which can be regarded as a measure of the 
importance of that step in controlling overall flux through the pathway. This coefficient can be 
measured by varying a particular enzyme level and measuring its effect on pathway 
intermediates and end-product formation. In practice this is usually achieved by placing a 
cloned gene under the control of a modulatable promoter.
Although no single biosynthetic step is solely responsible for control of flux, a few enzyme 
catalysed steps may be expected to be most important. In the case of the shikimate pathway, 
DAHP synthase would be expected to be such an enzyme. Using the cloned S.coelicolor 
DAHP synthase gene, analysis of the effect of varied amounts of activity on flux through the 
shikimate pathway during growth and antibiotic formation could be determined. These studies 
could also be undertaken using S.coelicolor recombinants constructed to produce aromatic 
containing secondary metabolites. The ultimate objective in obtaining these data would be to 
remove any metabolic 'blocks' which could reduce maximal antibiotic production.
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